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ABSTRACT

NEUROPSYCHOLOGICAL FUNCTIONING AND ATTRITION RATES IN
OUTPATIENT SUBSTANCE DEPENDENCE TREATMENT
Sandra M. Adams, LCSW, CSAC, ICS
Marquette University, 2010

Numerous neuropsychological factors have been associated with substance
dependence, however, very few studies have evaluated the relationship of the
neuropsychological functioning and attrition rates in substance dependence treatment.
This study examined the relationship of neuropsychological functioning and attrition
rates in 68 homeless, substance dependent men participating in outpatient treatment at
the 7C’s Community Counseling Clinic located in the Guesthouse of Milwaukee,
Wisconsin. A neuropsychological battery including the Delis Kaplan Executive
Functioning System, the Conners’ Continuous Performance Test II, the Wechsler
Abbreviated Scale of Intelligence (WASI) and the Wechsler Test of Adult Reading
was given to all participants to evaluate neuropsychological function. The
neuropsychological functioning was used to predict attrition rates using Survival
Analysis and Logistic Regression. The results indicate that the neuropsychological
functioning of this group of adult males showed statistically significant impaired
functioning on all measures. Of the neuropsychological variables, only the WASI IQ
predicted attrition and length of stay which showed a curvilinear relationship to drop
out and attrition. Participants with a moderately low WASI IQ score (77-95) were
significantly more likely to drop out (p = .012) and more likely to have shorter
lengths of stay in treatment (p= .028). In addition, the neuropsychological variables
did show a relationship with drop out and length of stay when looking at cases with a
median IQ below 94 and those with no prior AODA treatment. Finally, results of
calculations on effect size and power analysis show that with a larger sample size (98170) we could increase the possibility that the neuropsychological variables would
predict drop out and attrition and could attain power between .80 and .95.
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Chapter I: Introduction
Substance Abuse and Dependence in the United States
Prevalence of Substance Use Disorders
Recent statistics from the National Survey on Drug Use and Health (NSDUH,
2008) indicated that an estimated 22.3 million Americans aged 12 or older in 2007
met diagnostic criteria for substance dependence or abuse over the past year. Of
these, 3.2 million had dependence or abuse issues with both alcohol and illicit drugs,
3.7 million were dependent on or abused drugs but not alcohol, and 15.5 million were
dependent on or abused alcohol but not drugs (NSDUH, 2008). NSDUH (2008) also
stated that between 2002 and 2007 there was no change in the number of people with
substance dependence or abuse (22.0 million in 2002, 22.3 million in 2007; NSDUH,
2008)
Effects of Substance Use Disorders on Individuals and Society
Substance use disorders have an impact on society, families and individuals
(American Psychiatric Association {APA}, 2000). Substance use can be associated
with violent behavior manifested by fights or criminal activity resulting in injury to
the person using the substance or to others (APA, 2000). Likewise, automobile, home
and industrial accidents can be a major complication of substance use (APA, 2000).
Furthermore, according to the Diagnostic and Statistical Manual of Mental DisordersFourth Edition, Text Revision (DSM-IV-TR) approximately half of all highway
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fatalities involve either a driver or pedestrian who is intoxicated (APA, 2000). The
DSM-IV-TR (APA, 2000) also reported that one in five intensive care admissions are
related to alcohol. In addition, most, if not all, psychoactive substances cross from a
pregnant woman’s blood through the placenta, potentially causing adverse effects on
the developing fetus (APA, 2000). When taken repeatedly in high doses by the
mother, a number of substances (e.g., cocaine, opioids, alcohol, sedatives, hypnotics
and anxiolytics) are capable of causing physiological dependence and withdrawal in
the newborn (APA, 2000). Finally, the DSM-IV-TR (2000) reports that possibly 10
percent of individuals with a substance dependence diagnosis commit suicide.
Defining Substance Abuse and Dependence
Substance Abuse is defined based on the criteria listed in the DSM-IV-TR,
2000 that include:
A. A maladaptive pattern of substance use leading to clinically significant
impairment or distress, as manifested by one (or more) of the following, occurring
within a 12 month period:
(1) recurrent substance use resulting in a failure to fulfill major role obligations
at work, school or home ( e.g., repeated absences or poor work performance
related to substance use; substance-related absences, suspensions, or expulsions
from school; neglect of children or household)
(2) recurrent substance use in situations in which it is physically hazardous
(e.g., driving an automobile or operating a machine when impaired by
substance use),
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(3) recurrent substance-related legal problems (e.g., arrests for substancerelated disorderly conduct),
(4) continued substance use despite having persistent or recurrent social or
interpersonal problems caused or exacerbated by the effects of the substance
(e.g., arguments with spouse about consequences of intoxication, physical
fights).
B. The symptoms have never met the criteria for Substance Dependence for this
class of substance (APA, 2000, p. 199).
Substance Dependence is also defined based on the criteria listed in the DSMIV-TR which states:
A maladaptive pattern of substance use, leading to clinically significant impairment
or distress, as manifested by three (or more) of the following, occurring at any time in
the same 12-month period:
(1) tolerance, as defined by either of the following:
(a) a need for markedly increased amounts of the substance to achieve
intoxication or desired effect,
(b) markedly diminished effect with continued use of the same amount of the
substance,
(2) withdrawal, as manifested by either of the following:
(a) the characteristic withdrawal syndrome for the substance [For example,
with alcohol withdrawal, two or more of the following symptoms are
necessary: autonomic hyperactivity, increased hand tremor, insomnia,
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psychomotor agitation, anxiety, nausea or vomiting; and rarely, grand mal
seizures or transient visual, tactile, or auditory hallucinations or illusions.]
(b) the same or closely related substance is taken to relieve or avoid
withdrawal symptoms,
(3) substance is often taken in larger amounts or over a longer period than
intended,
(4) there is persistent desire or unsuccessful efforts to cut down or control the
substance use,
(5) a great deal of time is spent in activities necessary to obtain the substance, use
the substance, or recover from its effects,
(6) important social, occupational, or recreational activities are given up or
reduced because of substance use,
(7) the substance use is continued despite knowledge of having a persistent or
recurrent physical or psychological problem that is likely to have been caused or
exacerbated by the substance (e.g., current cocaine use despite recognition of
cocaine-induced depression, or continued drinking despite recognition that an
ulcer was made worse by alcohol consumption; APA, 2000, p. 197).
This study is a pilot study and one of the first to investigate the effects of
neurocognitive functioning on treatment retention. Therefore, in order to increase the
likelihood of detecting smaller effect sizes this study aims to maximize the
heterogeneity of the sample for this study by only including participants who meet the
criteria for the diagnosis of Substance Dependence.
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Health Related Effects on Individuals with Substance Use Disorders
Another important area to consider is the impact of substance abuse and
dependence on the physical health of the individual. Individuals with substance
related disorders often experience deterioration in their general health related to
method of induction of substance (i.e., snorting), malnutrition and inadequate
personal hygiene (APA, 2000). For example, using a substance intranasally can cause
erosion of the nasal septum. The use of contaminated needles can result in human
immunodeficiency virus (HIV), hepatitis, tetanus, endocarditis, malaria or other
infectious or contagious diseases (APA, 2000). The use of stimulants can result in
sudden death from cardiac arrhythmias, myocardial infarction, cerebral vascular
accident or respiratory arrest (APA, 2000). Likewise, many medical conditions are
commonly associated with alcohol use as alcohol affects nearly every organ in the
body. For example, there is an increased rate of cancer of the esophagus and stomach,
elevated triglycerides, and peripheral neuropathy in individuals with high alcohol use
rates (APA, 2000). Furthermore, liver cirrhosis and pancreatitis are seen in
approximately 15% of those who use alcohol heavily (APA, 2000).
Neurological, Neuropsychological and Cognitive Effects of Substance Use Disorders
With regards to central nervous system impact, neurological effects on
individuals with substance use disorders include cognitive deficits, memory
impairment and degenerative changes in the cerebellum (APA, 2000; Oscar-Berman,
Shagrin, Evert & Epstein, 1997). Likewise, multiple negative effects on the frontal
lobe (which is associated with executive functions) of the brain, such as reduced
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volume and blood flow, have been reported in people with substance use disorders
(Bates, Bowden & Barry, 2002; Moselhy, Georgiou & Kahn, 2001; Sullivan,
Harding, Pentney, Dlugos, Martin, & Parks, 2003). In fact, many neuropsychological
and cognitive deficits have been associated with impairment in functioning for people
with a substance use disorder. For example, in people with substance use disorders,
reductions in problem solving abilities, abstracting abilities (Oscar-Berman et al.,
1997; Ratti, Giardini & Soragna, 2002), verbal fluency and response flexibility (all
considered parts of executive functioning) have been found (Dao-Castellana et al.,
1998), as have impaired memory and overall executive functioning (Cunha &
Novaes, 2004; Rosselli, Ardila, Lubomski, Murray & King, 2001).
Executive functions as an area of interest for this study.
Of the many possible types of neuropsychological impairment, the
impairment of the executive functions is what we are primarily interested in for this
study. As mentioned above, multiple negative effects on the frontal lobe, which is the
lobe associated with executive functioning, have been found in people with substance
use disorders (Bates et al., 2002; Cunha & Novaes, 2004; Lezak, 1995; Moselhy et
al., 2001; Sullivan et al., 2003). The executive functions are all “necessary for
appropriate, socially responsible, and effectively self-serving adult conduct” (Lezak,
1995, p. 650). There are multiple components and possible behavioral disorders
associated with impairment in the executive functions which could result in
misinterpretation by clinicians and observers (Lezak, 1995) possibly leading to
further stigma of individuals with a substance use disorder. The executive functions
and impairments will be explicitly defined and discussed in Chapter II.
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Homelessness and Substance Dependence
Though homelessness is not the primary area of interest for this study, it is
important as the individuals assessed in this study are homeless male residents of the
Guesthouse of Milwaukee, Inc. In addition, just as the prevalence of individuals
struggling with substance use issues has been well documented in the literature, the
prevalence of individuals struggling with homelessness is also well documented
(Institute for the Study of Homelessness and Poverty, retrieved January 12, 2006 &
March 21, 2009; National Coalition for the Homeless, retrieved January 12, 2006 &
March 21, 2009; U.S. Department of Health and Human Services, retrieved January
12, 2006 & March 21, 2009). Finally, the relationship between homelessness and
substance use disorders is also established in the literature (National Coalition for the
Homeless, retrieved January 12, 2006 & March 21, 2009; SAMHSA, 2003; SollidayMcRoy, Campbell, Melchert, Young & Cisler, 2004; U.S. Department of Health and
Human Services, retrieved January 12, 2006 & March 21, 2009) as is the relationship
of homelessness and neuropsychological deficits (Gonzalez, Dieter, Natale & Tanner,
2001; Seidman et al., 1997; Solliday-McRoy et al., 2004). Therefore, assessing the
relationship of executive functioning and attrition rates in homeless individuals
involved in substance dependence treatment seems quite appropriate.
Treatment for Substance Dependence
The National Survey on Drug Use and Health (2008) classifies one as needing
treatment if the person has a substance use disorder or one who received treatment at
a specialty facility (i.e., hospital inpatient, drug or alcohol rehabilitation, or mental
health centers). In 2007, the estimated number of people aged 12 or older needing
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treatment for an alcohol or drug problem was 23.2 million (9.4 percent of the total
population; NSDUH, 2008). Of these 23.2 million, 2.4 million received treatment at a
specialty facility in the past year (NSDUH, 2008). Thus, 20.8 million people needed
but did not receive treatment at a specialty treatment facility in 2004 (NSDUH, 2008).
Barriers to Treatment for Substance Dependence
Unfortunately, not everyone who needs substance use treatment actually
receives substance use treatment. Of the 20.8 million people who needed but did not
receive treatment in 2004, an estimated 1.3 million (6.4%) reported that they felt they
needed treatment for their substance use problem (NSDUH, 2008). Of these 1.3
million, 380,000 (28.5%) reported that they made an effort but were unable to get
treatment and 955,000 (71.5%) reported making no effort to get to treatment
(NSDUH, 20048).
Based on combined data from 2003 and 2004, the NSDUH (2004) reports that
of the people who felt they needed but did not receive treatment 40% stated they did
not seek treatment because they were not ready to stop using and 34.5% reported cost
or insurance barriers, 21.6% reported stigma and 13.9% reported they felt they did not
need treatment (at the time) or could handle the problem without treatment. However,
among the people who made an effort but were unable to get treatment, 42.5%
reported cost or insurance barrier, 25.3% reported they were not ready to stop using,
21.5% report other access barriers and 17.8% report stigma (NSDUH, 2004).
Combined data from 2004 and 2007, the NSDUH (2008) reports that of people who
felt they needed treatment but did not receive treatment 38.7% said they were not
ready to stop, 31.1 % had no insurance and could not afford treatment, 11.6 %
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reported concern regarding possible negative effect on job, 11.65% reported not
knowing where to go for treatment and 11.1% reported concern of negative opinion
of others (NSDUH, 2008). A differentiation could be made between internal and
external barriers as reasons people did not receive treatment. For example, lack of
insurance and negative stigma could be considered external barriers whereas being
not ready to quit or feeling one can handle the problem on their own could be
considered internal barriers. Finally, along with lack of financial resources and health
insurance, research has also indicated that lack of transportation may be a barrier to
engaging in treatment (Knight & Longmore, 1994). For example, if the person has no
reliable mode of transportation to the treatment facility, or if the treatment facility is
located too far from the person’s geographical location, the person may not enter
treatment, or may not stay engaged once starting treatment due to the difficulty in
getting to treatment.
Neuropsychological impairment as a barrier to treatment
One possible barrier to substance dependence treatment currently under
investigation is that of neuropsychological impairment. Bates, Bowden and Barry
(2002) have suggested that neuropsychological impairment may limit an individual’s
treatment engagement and/or may impede treatment completion in traditional
outpatient substance abuse treatment. In fact, as discussed above, neuropsychological
impairment resulting from substance use disorders is known to often be severe, but it
is also true that neurological impairment frequently goes unassessed, unrecognized
and untreated in individuals seeking treatment (Bates et al., 2002; Cunha & Novaes,
2004). Although research has begun to evaluate the neuropsychological functioning
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and impairment of patients with substance abuse and mental health diagnoses (e.g.
Bates et al., 2002, Lezak, 1995; Ratti et al., 2002, Sullivan, Fama, Rosenbloom &
Pfefferbaum, 2002; Uekermann, Daum, Schlebusch, Wiebel & Trenckmann, 2002),
which will be discussed later, neuropsychology as it relates to substance use disorders
is a relatively new arena of study (Fals-Stewart & Bates, 2003).
Stigma and Substance Use Disorders
As mentioned in the NSDUH (2008) study above, concern about stigma has
also been identified as a treatment barrier. Stigma, which involves the harm that may
come from the label of mental illness or substance dependence, may impede
treatment participation (Corrigan, 2004). People who are labeled mentally ill or
substance dependent can be harmed publicly with stereotypes (e.g., “All people with
mental illness and/or substance dependence are dangerous”), prejudice (e.g., “I agree,
people with mental illness and/or substance dependence are dangerous and I am
afraid of them”), and discrimination (e.g., “I do not want to be near them; don’t hire
them at my job”; Corrigan, 2004, p.617). Stigma may lead to people avoiding seeking
treatment or staying in treatment in order to avoid the label and escape the public
stigma (Corrigan, 2004). However, these barriers to treatment could also offer vital
information for development of interventions specifically designed to break down
treatment barriers.
“They must not have been ready.” “Maybe they didn’t want it bad enough.”
“I guess he just doesn’t love us enough.” “The bottle is more important than his kid.”
How often do we as counselors, as well as other people in the substance abuser’s life,
make these statements about someone who has failed to follow through with a
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treatment plan for a substance abuse or dependency problem? In fact, negative stigma
and judgments are not only made about substance abusers who do not complete
treatment, but individuals with substance abuse problems are often judged and
stigmatized harshly for even having the problem in the first place (Knight &
Longmore, 1994). Many people, inside and outside of the substance abuse treatment
field, seem to assume that the path to solving the problem is obvious - if you have a
substance abuse or dependence problem, you go to one of many treatment facilities
and get it fixed. On the surface, failure to follow through with prescribed treatment
may appear to be a compliance issue. I have heard the stigma substance abusers face
reflected in many clinicians’ descriptions of people who do not follow through with
treatment as “non-compliant,” “lazy,” “deviant,” or having “complete disregard for
themselves or their families.” Overall, many researchers identify stigma as a barrier to
substance use treatment (Corrigan, 2004; NSDUH, 2002 & 2004 & 2008; World
Health Organization, 2004). Specifically, the World Health Organization (2004)
identifies stigma as one of the main barriers to treatment and care of people with
substance dependence and related problems. In addition, the National Mental Health
Resource Center reported that no group encounters more stigma than homeless
persons with co-occurring (mental health and substance use) disorders (National
Mental Health Association retrieved January 12, 2006). Regardless of the level of
substance use or which substance a person takes, they have the same rights to health
care, education and work opportunities as any other individual (World Health
Organization, 2004).
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In short, stigma has been identified as one of the relevant factors in
identification and treatment of substance use disorders (Corrigan, 2004; NSDUH,
2002 & 2004 & 2008; World Health Organization, 2004). Likewise, multiple
neuropsychological deficits have been associated with substance use disorders (Bates
et al., 2002; Lezak, 1995; Moselhy et al., 2001; Oscar-Berman et al., 1997; Sullivan
et al., 2003) which may be affecting the level of stigma of individuals with a
substance use disorder.
Neuropsychology of Substance Use Disorders
Research has suggested that alcoholism affects cognitive functioning such as
recall, recognition (Knight & Longmore, 1994, Sullivan et al, 2002) abstract thinking,
cognitive flexibility, and persistence and inhibition of competing responses (Zinn,
Stein & Swartzwelder, 2004). Over the last decade, researchers have begun to
specifically evaluate areas of the brain involved (Ratti et al., 2002). The same is true
for drug abusing and dependent patients. Alcohol and drug abuse and dependence are
associated with neuroanatomical changes that affect cognitive abilities such as
reasoning, learning, memory, decision making and inhibition (Beatty, Tivis, Stott,
Nixon & Parsons, 2000; Knight & Longmore, 1994, Pfefferbaum, Sullivan,
Rosenbloom, Mathalon & Lim, 1998). Neuroimaging techniques reveal cortical
shrinkage (Pfefferbaum et al., 1998), enlarged ventricles and increased space between
the gyri of the cerebral cortex (Lilliquist & Bigler, 1992). This has been related to
changes in neurobehavioral performance on specific neuropsychological tests of
verbal problem solving, conceptual shifting, perceptual-spatial abilities, abstracting,
motor speed, information processing and memory (Fals-Stewart & Bates, 2003).

13

Given these findings, when developing appropriate treatment programs, it
would seem necessary to evaluate the patient’s abilities and deficits and develop a
program that fits their needs. Though research suggests that the neuropsychological
deficits may affect treatment efficacy and attrition rates (Sullivan et al., 2002; Zinn et
al., 2004), there is a paucity of research connecting neuropsychological deficits and
treatment attrition despite use of numerous search engines (including Medline, Ovid,
PubMed, PsychInfo, PsychArticles, ScienceDirect, Google) and multiple library
systems (including Marquette University and the Medical College of Wisconsin)
using multiple search terms (including, but not limited to, “neuropsychology,
neuropsychological impairment/deficit, frontal lobe, attrition, drop out, treatment
length, executive functioning, cognitive deficits” and various combinations of all of
these).
Identifying neuropsychological deficits may be helpful in the development of
treatment programs aimed at those substance dependent clients who have
neuropsychological impairments (Kass & Silver, 1990). For example, executive
function deficits such as deficits in planning and strategizing could affect treatment
compliance. If one struggles with planning future events, attendance at treatment
could be affected (Zinn et al., 2004). All of these neuropsychological deficits could
affect attrition rates which will both be discussed in further detail in Chapter II.
Knight and Longmore (1994) have suggested that clients’ neuropsychological deficits
related to substance use or of other origin may affect clients’ attrition rates in
substance use disorder treatment programs. However, the connection between
neuropsychological impairment and attrition has not been empirically well
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established. To date, we do not know the extent to which neuropsychological
impairment has an impact on client attrition from substance use disorder treatment.
Without such knowledge, we cannot effectively plan and implement substance use
disorder treatment programs that might aid individuals suffering from substance use
disorders and neuropsychological impairment.
Attrition and Relapse Rates Among Clients in Treatment for Substance Dependence
The purpose of this study is to explore the relationship of neuropsychological
functioning and attrition rates in individuals who have engaged in outpatient
substance use treatment. Attrition, referring to patients who enter but then drop out of
treatment, has been studied through the National Outcomes Measures (2002) and
reported on by many sources (Broome, Flynn & Simpson, 1999; DATOS, 2001;
Franey & Ashton, 2002; Office of Applied Studies, 2004; Simpson et al., 1997;
Simpson, Joe & Rowan-Szal, 1997; Stark, 1992).
The specific statistics reported for drop out rates for people in substance
dependence treatment help to confirm the problem of attrition. For example, the
medium length of stay specific to outpatient treatment is 76 days, based on 34 states
submitting discharge information in 2005 (SAMHSA, 2008). The National Outcomes
Measures collected data from 23 states during the year 2002 and found that the
median length of stay for completion of outpatient treatment was 78 days (Office of
Applied Studies, 2004). However, the median length of stay prior to dropping out was
only 32 days In 2002 (Office of Applied Studies, 2004) and 45 days in 2005
(SAMHSA, 2008). Median length of stay for homeless individuals in intensive
outpatient treatment was reported to be 45 days in 2005 (SAMHSA, 2008). Likewise,
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drop out rates for homeless people from substance abuse treatment have been
reported at 66% (SAMHSA, 1998), drop out rates for people with cocaine addiction
in outpatient have been reported at 55% (Agosti, Nunes, Ocepek-Welikson, 1996),
people with drug abuse in general have been reported to have between 40% to 60%
drop out rate according to Marlowe and Dematteo (2003) and 55% according to
Sayre, Schmitz, Stotts, Averill, Rhoades and Grabowski (2002). The literature on
predicting attrition has been inconclusive. Variables such as sociodemographics,
gender, psychiatric comorbidity and substance use severity have all been evaluated in
relation to treatment drop out (Sayre et al, 2002).
Another important variable related to clients dropping out of treatment is
client relapse. Relapse and attrition have an interactive relationship as each may be a
cause or influence of the other. Many variables, including dropping out of treatment,
have been related to relapse in substance abuse treatment (Franey & Ashton, 2002).
Some of the variables identified include type of drug use (United Nations, 2002),
gender (Stocker, retrieved September 20, 2005), support systems (United Nations,
2002), certain medications (United Nations, 2002; World Health Organization, 2004),
length and intensity of treatment (Franey & Ashton, 2002; United Nations, 2002) and
neuropsychological impairment (Miller, 1991). All of these will be discussed in detail
in Chapter II.
The discrepancy between amount of time to treatment completion and actual
time spent in treatment for patients who drop out is very important as duration of
treatment has been identified as one of the best predictors of outcome for substance
abuse treatment (Corrigan, Bogner, Lamb-Hart, Heinemann & Moore, 2005).
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Therefore, evaluating variables that may be related to treatment attrition and relapse,
such as neuropsychological functioning, would provide valuable, useful information.
Statement of the Problem
Substance abuse and dependence has tremendous effects on the individual and
his or her family, as well as on society (APA, 2000). In addition, there are multiple
barriers that have been identified as reasons people do not get the treatment they need
(NSDUH, 2008). Likewise, many of the people who enter treatment do not complete
treatment (NSDUH, 2008). Although we know that individuals suffering from
substance dependence also may suffer from neuropsychological deficits, as well as
that treatment attrition rates are high for those entering substance dependence
treatment, we do not know if or how neuropsychological deficits may affect treatment
engagement and attrition. It may be that an understanding of the potential relationship
between neuropsychological functioning and attrition could aid researchers and
clinicians who are endeavoring to develop helpful treatment programs to do so.
Purpose of the Study
The purpose of this study was to assess the neuropsychological functioning of
clients who meet diagnostic criteria for substance dependence according to the
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - Text
Revision (DSM IV-TR; APA, 2000) and to examine the relationship between
neuropsychological functioning and treatment attrition rates. Specifically, the
executive functioning of individuals was evaluated. Furthermore, the relationships
between substance use diagnosis, treatment attrition, and neuropsychological
functioning was investigated. It may be that understanding how deficits in
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neuropsychological functioning affect an individual’s behaviors (e.g., relapse,
missing treatment sessions, and dropping out of treatment) may help to change
attitudes of clinicians and others who may currently negatively stigmatize those with
substance use disorders (e.g., believing that the individual is lazy, unmotivated, etc.).
Understanding the relationships between substance use diagnosis, attrition, and
neuropsychological functioning could prove extremely useful in substance use
disorder program development, treatment planning, clinician training and stigma
reduction.
Research Questions
This study intended to address the following research questions:
(1) What is the level of neuropsychological functioning/impairment of this sample of
substance dependent men?
(2) Do deficits in client’s neuropsychological abilities including concept
identification, cognitive flexibility, divided attention, perseveration, and impulse
control predict rates of attrition from substance abuse treatment?
(3) How does neuropsychological functioning relate to relapse rates in those clients
seeking treatment for substance dependence?
Definition of Terms
Attrition – “A decline in a population over time” (Reber, 1985, p. 69). For the
purpose of this study, attrition refers to the number of participants who begin, but do
not complete, treatment due to dropping out.
Executive Functioning - Those capacities that enable a person to engage successfully
in independent, purposive, self-serving behavior (Lezak, 1995). Executive
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functioning has to do with how a behavior is expressed. Questions about executive
functions include how or whether a person goes about doing something, whereas
questions about cognitive functions are phrased in terms of what or how much one
knows (Lezak, 1995). Executive functioning has been identified as a function of the
frontal lobe (Lezak, 1995; Moselhy, 2001; Snyder & Nussbaum, 1998).
Homeless – The term “homeless” will be limited to those individuals seeking refuge
at the Guesthouse of Milwaukee, Inc. (a local homeless shelter).
Neuropsychological Functioning
Clinical Neuropsychology - The behavioral expression of brain dysfunction
(Lezak, 1995); “a sub-discipline within physiological psychology that focuses on the
interrelationships between neurological processes and behavior” (Reber, 1985,
p.491).
Cognitive Functions - The information handling aspects of behavior,
analogous to computer operations of input, storage, processing and output. In more
detail, (a) receptive functions involve the ability to select, acquire, classify and
integrate information; (b) memory and learning involve information storage and
retrieval, (c) thinking concerns the mental organization and reorganization of
information; and (d) expressive functions are the means though which information is
communicated or acted upon (Lezak, 1995). Though these categories can be
described as separate concepts, they are interdependent (Lezak, 1995).
Relapse- Any episode of alcohol or drug use by the participant after the date of
admission to the substance use treatment program will be considered a relapse.
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Substance Dependence - Substance Dependence is defined based on the criteria listed
in the DSM-IV-TR which states:
A maladaptive pattern of substance use, leading to clinically significant impairment
or distress, as manifested by three (or more) of the following, occurring at any time in
the same 12-month period:
(1) tolerance, as defined by either of the following:
(a) a need for markedly increased amounts of the substance to achieve
intoxication or desired effect,
(b) markedly diminished effect with continued use of the same amount of the
substance,
(2) withdrawal, as manifested by either of the following:
(a) the characteristic withdrawal syndrome for the substance [For example,
with alcohol withdrawal, two or more of the following symptoms are
necessary: autonomic hyperactivity, increased hand tremor, insomnia,
psychomotor agitation, anxiety, nausea or vomiting; and rarely, grand mal
seizures or transient visual, tactile, or auditory hallucinations or illusions.]
(b) the same or closely related substance is taken to relieve or avoid
withdrawal symptoms,
(3) substance is often taken in larger amounts or over a longer period than
intended, (4) there is persistent desire or unsuccessful efforts to cut down or
control the substance use,
(5) a great deal of time is spent in activities necessary to obtain the substance, use
the substance, or recover from its effects,
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(6) important social, occupational, or recreational activities are given up or
reduced because of substance use,
(7) the substance use is continued despite knowledge of having a persistent or
recurrent physical or psychological problem that is likely to have been caused or
exacerbated by the substance (e.g., current cocaine use despite recognition of
cocaine-induced depression, or continued drinking despite recognition that an
ulcer was made worse by alcohol consumption; APA, 2000, p. 197).
Importance of the Study
A mere 1.9 million of the 22.2 million people identified as needing treatment
for a substance abuse or dependence disorder received treatment in 2003, 2.33 million
received treatment of the 23.48 million identified in need in 2004 and 2.4 million of
23.2 million identified as in need in 2008 (SAMHSA, 2005; NSDUH, 2008). For
those who wanted but did not enter treatment, factors such as lack of resources
including money, medical insurance and transportation, as well as the stigma
associated with having a substance dependence problem have been identified as
barriers to treatment (Knight & Longmore, 1994; SAMHSA, 2005; NSDUH, 2008).
However, the specific reasons individuals enter treatment and then drop out appear to
be less clearly understood. The Office of Applied Studies (2004) discussed the
median day of dropout (i.e., day 32), but did not discuss why the participant dropped
out. Often times when a client does not continue in treatment it is viewed as noncompliance (Glyngdal, Sorenson & Kistrup, 2002). There is strong evidence that the
degree to which clients engage and participate in treatment activities is related to the
success of substance abuse treatment (Northwest Frontier Addiction Technology
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Transfer Center, 2003). Success is not specifically defined in this article but seems to
be suggested as following through with recommended treatment. Attrition from
substance abuse treatment has been identified by some as one of the greatest
problems interfering with the effectiveness of treatment programs (Jacobsen, 2004).
To quote Shavelson (2001), “If there is a single consistent finding that has come out
of rehab research it is that the longer clients can be maintained in the programs the
more likely they are to emerge clean and sober, and stay that way.” (Shavelson, 2001,
p. 300). Quite obviously, one cannot be expected to benefit from treatment they are
not present for. Furthermore, although much research has been conducted regarding
neuropsychological impairment resulting from substance abuse and dependence, the
research is limited in regards to neuropsychological impairment and treatment
attrition. Though over 150 resources were used to research this study, only one was
found that researched neuropsychological functioning and attrition rates (Fals-Stewart
& Lucente, 1994). However, Fals-Stewart and Lucente’s study (1994) included
personality disorders with the neuropsychological impairment as it evaluated attrition
rates. Likewise, as previously discussed, support exists for the problem of attrition
including rates between 40% and 66% (Marlowe & Dematteo, 2003; SAMHSA,
1998). The literature on predicting attrition has been inconclusive. Variables such as
sociodemographics, gender, psychiatric comorbidity and substance use severity have
all been evaluated in relation to treatment drop out (Sayre et al, 2002).
The purpose of this study is to explore the relationship of neuropsychological
functioning and attrition rates in individuals who have engaged in outpatient
treatment. These results may provide important implications for treatment planning,
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program development and training of clinicians to more effectively meet the needs of
patients with a substance dependence disorder.
Brief Introduction to Proposed Methodology
Participants were recruited from the population of clients entering outpatient
treatment for substance use disorders at the 7C’s clinic within the Guesthouse. All
participants agreed to informed, voluntary participation in the study. Participants all
had a substance use diagnosis as defined by the DSM-IV-TR and confirmed by an
assessment including the Form 90, Addiction Severity Index (ASI) and the Mini
International Neuropsychiatric Interview (MINI). Participants had their current level
of neuropsychological functioning assessed through the neuropsychological test
battery established for this study which included subtests of the Delis-Kaplan, the
Conners’ Continuous Performance Test II and the WASI. We intended to have data
from our established sample size of 100 collected over the course of six months by
four clinicians (Addiction Counseling students in training) trained in the use of all
assessment tools by licensed psychologists (Dr. Campbell & Dr. Young). As will be
discussed later, our final sample size was less than 100. Participants were observed
for three months or until the date they dropped out or were discontinued from
treatment. Therefore, we intended that over the course of six months, approximately
four to five participants per week would need to be evaluated for the study. We
intended to complete data collection within nine months which allowed for three
months past the six month mark allowing for the three months of observation for the
final participants included. This data collection was also supervised by a licensed
psychologist (Dr. Todd Campbell) available on a regular basis for questions and
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consultation and a neuropsychologist who was also available for questions and
consultation (Dr. Terry Young).
The statistical methodologies proposed and used in this study are Survival
Analysis (SA) and Logistic Regression (LR). Survival Analysis traditionally has been
used for medical research as it is useful for longitudinal studies for things such as
survival rates with cancer or organ transplants (Parmar & Machin, 1995). Survival
Analysis can be utilized for longitudinal data such as the length in outpatient
treatment that we will be studying (Corning & Malofeeva, 2004; Gerstman, 2003,
Pamar & Machin, 1995). One difference between survival data and other types of
numeric continuous data is that the time to the event occurring (e.g., day of drop out
or end of successful treatment) might not be observed in all participants in particular
studies due to variables such as death of participants or an end of treatment date that
is beyond the length of the study. This non-observed event is accounted for in
survival analysis (Corning & Malofeeva, 2004; Parmar & Machin, 1995) making it a
very appropriate method for this study. Logistic Regression will allow us to evaluate
the relationship between neuropsychological function and the dichotomous variables
of drop out vs. no drop out. The different statistical methods allow us to evaluate all
important variables in this study.
The dependent variables for this study include the total length of time spent in
outpatient treatment prior to drop out and whether or not the participant drops out.
The independent variable is the level of neuropsychological functioning or
impairment. The null hypothesis of this study is that there will be no relationship
between the level of neuropsychological functioning and a participant’s length of
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attendance in outpatient substance dependence treatment or drop out status. We had
also intended to evaluate relapse rates, but as will be discussed below, we were
unable to address this issue.
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Chapter II: Review of the Literature
This chapter will assist the reader in gaining an understanding of the history of
neuropsychological assessment, as well as, the anatomy of neuropsychological
functioning. Finally, research specific to executive functioning, substance dependence
and dual diagnosis will be presented, as well as, research specific to attrition rates.
Neuropsychology as a Clinical Discipline
Defining Neuropsychology
Neuropsychology is an applied science concerned with the behavioral
expression of brain dysfunction (Lezak, 1995; Lezak, Howieson, Loring, Hannay &
Fischer, 2004). Clinical neuropsychologists deal with a variety of questions regarding
human behavior and brain functioning, a wide range of normal and abnormal
behaviors and diverse people with regards to demographics, culture and pathology
(Lezak, 1995). Therefore, the practice of neuropsychology requires of its practitioners
flexibility of mind, curiosity about the myriad of factors of human behavior and
inventiveness with regard to clinical interventions in even the most routine work
undertaken (Lezak, 1995; Snyder & Nussbaum, 1998; Stirling, 2002)
Neuropsychologists interact with professionals from many other
psychological and medical clinical disciplines, including other psychologists,
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psychiatirists, counselors, family practice physicians, gerontologists and emergency
room personnel (Lezak, 1995; Lezak et al, 2004; Meier, 1992; Snyder & Nussbaum,
1998). The interaction of neuropsychology with other disciplines allows for a more
thorough diagnosis and treatment plan with attention to details regarding brain
functioning, strengths and weaknesses for multiple presenting concerns including(but
not limited to) behavioral disorders, mood disorders, head injuries, learning
disabilities and dementias (Lezak, 1995). At one time, clinical psycholgogists
determined brain damage mainly with Wechsler’s intelligence tests. Traditional tests
are still very useul, but not specific enough to identify specific signs of brain damage
such as language deficits and attention problems (Lezak, 1995). With specialized
training, neuropsychologists evaluate aspects of intelligence, reasoning, abstraction,
attention, executive functions, learning, memory, language, auditory, visual, motor
functions and constructional tasks (Lezak, 1995). The neuropsychologist uses
specialized assessments to examine the relationship between the brain and behavior
helping to identify brain damage, cognitive dysfunction and patient strengths and
weaknesses, all of which can be extremely helpful in patient treatment planning and
rehabilitation (Seidman, 1998).
Development of Clinical Neuropsychology
Clinical Neuropsychology evolved from its parent disciplines of neurology
and psychology, developing an identity of its own in the 1940s (Lezak, 1995). In the
1940s, prior to performing a craniotomy, neurosurgeons relied on
electroencephalograms (EEG’s), X-rays and neuropsychological reports for
localization giving the neuropsychologists a well-defined niche (Lezak, 1995; Ruff,

27

2003). However, in the 1970s when computerized tomography became available, the
neuropsychologist’s role in localization became less important. Therefore, the
neuropsychologist’s role shifted focus to obtaining quantitative descriptions of a
patient’s cognitive status (Ruff, 2003). Likewise, Lezak (1995) reports, that in the
1940s “psychology’s looser constructs were undergoing reexamination in the cold
light of operationalism” (Lezak, 1995, p. 3). More specifically, the prominence of
“intuitive modus operandi of the earlier armchair and couch theoreticians was giving
way to more rigorous-appearing actuarial (statistical probability) techniques” (Lezak,
1995, p. 3). In strict actuarial approaches, the neuropsychologist need not even see the
patient, but rather draw conclusions from scores obtained by a technician (Lezak,
1995). However, through the development of testing batteries developed by some of
the leaders in the field, neuropsychology developed into more of a mix of the intuitive
and actuarial (Lezak, 1995). Some of the leaders and batteries are discussed in the
Neuropsychological Assessment section below.
To further distinguish the neuropsychologists in the field of psychology, the
formation of the International Neuropsychological Society (INS) was organized in
1966 at the Albert Einstein College of Medicine. This was a landmark for the formal
organizational structure of clinical neuropsychology (Meier, 1992). The organization
of the INS provided the necessary organizing of a group of neuropsychologists that
had been gathering at APA (Meier, 1992). In the 1970s, the organization grew to
become international, as well as interdisciplinary, with psychologists, psychiatrists,
neurolinguists, neurosurgeons and more becoming members (Meier, 1992). The INS
also began publication of The Journal of Clinical Neuropsychology, later renamed
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Journal of Clinical and Experimental Neuropsychology (Meier, 1992). As the INS
continued to assume a position of leadership, the stage was set for establishing a
division within the American Psychological Association (APA). Finally, in 1980, the
Division of Clinical Neuropsychology (Division 40) was formed within APA (Meier,
1992). Though relatively still young as a field, neuropsychology’s growth can be
noted in an increasing number of clinical practicum sites, journals, clinical internship
sites and curriculum planning focused specifically on neuropsychology (Snyder &
Nussbaum, 1998).
Neuropsychological Assessment
Early Neuropsychological Test Batteries
As discussed by Lewis and Sinnett (1987), the first neuropsychological test
battery was developed by Goldstein and Scheerer. Goldstein, a neuropsychiatrist, and
Scheerer were both trained in the Gestalt psychology tradition drawing on experience
with brain injured German soldiers in World War I (Lewis & Sinnett, 1987).
However, the lack of standardization, lack of objective scoring, lack of reliability and
validity data made clinicians hesitant to adopt the battery (Lewis & Sinnett, 1987).
Halstead-Reitan Neuropsychological Test Battery.
A few years later, in 1947 W.C. Halstead, a Northwestern University PhD,
initiated the development of the first standardized neuropsychological test battery, as
well as the formation of the first neuropsychology laboratory in the United States
(Lewis & Sinnett, 1987). Halstead and his graduate student, Ralph Reitan, together
developed the Halstead-Reitan Neuropsychological Test Battery (Lewis & Sinnett,
1987), currently one of three commonly used batteries in the United States (Seidman,
1998).
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The version of Halstead Reitan Battery (HRB) that is most commonly used
at present consists of five subtests including the (a) Category Test, (b) Tactual
Performance Test, (c) Rhythm Test, (d) Speech Sounds Perception Test, and (e)
Finger Oscillation Test or Finger Tapping Test (Lezak, 1995). The two tests that were
part of the original seven that are not commonly used any longer include the Critical
Flicker Fusion Test and the Time Sense Test (Lezak, 1995). A distinctive feature of
Reitan’s handling of examination data of the HRB was his reliance on test scores for
predicting nature and site of a lesion (Lezak, 1995). Although the HRB has practical
limitations in that it takes a long time to administer and is not considered suitable for
thorough examination of patients with sensory or motor handicaps, it offers one of the
more reliable psychological means for identifying patients with brain damage (Lezak,
1995).
Luria Nebraska Battery.
Russian neuropsychologist A. R. Luria was the primary developer of the Luria
Nebraska Battery (Lezak, 1995). Luria’s contributions to neuropsychological testing
consist of obtaining sensitive, qualitative, behavioral descriptions, emphasizing the
uniqueness of each individual patient (Lezak, 1995). Luria’s approach to
neuropsychological assessment was clinically focused versus empirically focused
(Lezak, 1995). He often administered his assessment battery at a patient’s bedside
paying particular attention to the means the patient used to solve a problem rather
than the outcome of the test (Lezak, 1995). Luria was more concerned with what he
observed clinically versus what the results of the test indicated. As a result of the
manner in which Luria approached and administered testing, the data collected on
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each individual was rich, but due to the lack of standardized administration
procedures (i.e., the testing procedures changed dependent upon the patient’s
responses, Luria’s approach to testing did not allow for duplication (Lewis & Sinnett,
1987). As Luria’s approach was very individualized and was difficult to duplicate, it
had many qualitative characteristics. Luria’s approach to neuropsychological
assessment led to many present day neuropsychologists approaching assessment from
an integrated qualitative-quantitative approach (Lezak, 1995). Specifically, the
assessor can take advantage of the standardized assessments for quantitative analysis
while also using clinical training to assist in the attention to more qualitative features
for a more eclectic evaluation (Lezak, 1995).

Boston Process.
According to Seidman (1998), the third neuropsychological test battery widely
used at present is the Boston Process Neuropsychological Approach, which has many
variants. The examiner begins with few measures and focuses the assessment more
precisely as more information is learned about the patient (Seidman, 1998). This
approach lends itself to a more flexible model of assessment again incorporating the
qualitative and quantitative pieces (Seidman, 1998).
Although the Boston approach has many variants, most versions include tests
of intelligence, memory, abstraction, naming ability, visuo-constructional,
organizational and tests of executive function (Seidman, 1998). Sometimes other tests
are added to evaluate dementia, aphasia and personality issues. The emphasis with the
Boston battery is more on how patients perform rather than merely whether they
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succeed or fail (Seidman, 1998). Therefore, examiners can use the Boston approach
to identify possible damage even when the final performance score falls within the
identified normal range (Seidman, 1998). Furthermore, Seidman (1998) supports the
use of the Boston Process battery when the possibility of malingering is high (such as
legal cases with the possibility for monetary gain) because processes are more
difficult to fake than are results (Seidman, 1998)

Neuropsychological assessment battery for this study.
The instruments used for this study included specific subtests of the DelisKaplan Executive Function System (D-KEFS) and the Conners’ Continuous
Performance Test II (CPT II) for evaluation of neuropsychological strengths and
weaknesses. Furthermore, the Wechsler Abbreviated Scale of Intelligence (WASI)
was used for an estimate of general intellectual ability and the Form 90 and Addiction
Severity Index (ASI) for substance dependence assessment. In addition, the Addiction
Severity Index (ASI) was used to evaluate the severity of problem areas associated
with alcohol and drug dependence and the Mini International Neuropsychiatric
Interview (MINI) was used to establish any other DSM-IV diagnoses. All of these
assessments will be discussed in detail in Chapter III.
Overview of Frontal Lobe Anatomy and Functions
Due to the complex nature of neuroanatomy, this review is meant to be basic,
certainly not all-inclusive and exhaustive. The next section provides an overview of
the anatomy and specific functions of the frontal lobe.
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Frontal Lobe Anatomy
Very simply stated, the brain is divided into two hemispheres, left and right.
Furthermore, the cerebral cortex is divided into four lobes: (a) frontal, (b) parietal, (c)
temporal, and (d) occipital (Society for Neuroscience, 2002). For the purpose of this
study, our focus will be on the frontal lobes.
In humans, the frontal lobes account for approximately one-third of the
cerebral cortex (Goldman-Rakic, 1987). The frontal lobe can be subdivided into a
number of functional subsystems including: (a) primary motor cortex – responsible
for critical to fine motor movement, receives projections from posterior cortical areas
involved in somatosensory perceptions as well as subcortical input from the ventral
lateral thalamic nucleus, (b) premotor area - involved in sensorimotor integration and
complex volitional movement having connections to the parietal lobe, (c) frontal eye
fields - permit volitional eye movement in the contralateral visual fields necessary for
voluntary gaze and visual search, (d) orbital and basal areas - affecting anosmia
(deficiency in smell) and disinhibited personality changes, though few measures are
available of orbitofrontal functions in humans, (e) supplemental motor and anterior
cingulate gyrus - areas possibly forming a reciprocal system responsible for
environmental search and inhibition of exploratory behavior, and (f) the dorsolateral
prefrontal subsystem - responsible for executive functions (Kandel, Schwartz &
Jessell, 1991; Malloy & Richardson, 1994; Snyder & Nussbaum,1998). Due to the
impact alcohol and drugs have been found to have on the dorsolateral prefrontal
subsystem (which will be discussed in further detail in the next section), the executive
functions of the dorsolateral prefrontal subsystem are the neuropsychological
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components we are most interested in for the purpose of this study (Knight &
Longmore, 1995; Lezak, 1995; Moselhy, 2001).
Dorsolateral Prefrontal Subsystem and the Executive Functions
As previously mentioned, the dorsolateral prefrontal subsystem is considered
mostly responsible for executive functions (Kandel, Schwartz & Jessell, 1991; Malloy
& Richardson, 1994; Snyder & Nussbaum, 1998). The executive functions are
necessary for appropriate, socially responsible and effective self-serving conduct
(Lezak, 1995). The executive functions can be conceptualized as having four
components, each involving a set of activity-related behaviors and all having a fair
amount of overlap (Lezak, 1995). The four components are (a) volition, (b) planning
(c) purposive action, and (d) effective performance (Lezak, 1995; Lezak et al, 2004).

Volition.
Volition, in short, is the capacity for intentional behavior (Lezak, 1995).
Volition requires the capacity to formulate a goal or intention. It may be easiest to
describe volition by examining deficits in volition. People who lack volitional
abilities simply cannot think of anything to do or may be unable to initiate activities
except in response to external stimuli such as someone giving them continuous
prompting. There are various levels of volitional impairment ranging from mild to
much more severe (Lezak, 1995). A mild case of volitional impairment could involve
someone successfully engaging in games, chores or familiar routines without
prompting, but being unable to assume longer term responsibilities (such as
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employment) without outside guidance. Someone with more severe impairment may
know the proper use of eating utensils, but may not take the initiative to eat the food
placed in front of them without continuous prompting (Lezak, 1995; Shallice &
Burgess, 1991).

Planning.
Planning abilities involve the identification and organization of the necessary
skills and resources needed to carry out a plan or goal (Klein, 2000). For example, a
patient with planning deficits may not be able to plan a future activity such as the
steps needed to assemble a swing set (Klein, 2000). One must be able to look ahead,
conceive alternatives and weigh out choices. Planning abilities involve reasonably
intact memory, good impulse control and capacity for sustained attention (Lezak,
1995). One might find it necessary to repeat questions or instructions several times to
patients with planning deficits in order for the patient to be able to direct his or her
effort and concentration on completing the task (Stuss & Benson, 1984).
Planning deficits would certainly have implications for treatment. For
example, a clinician working with clients who have deficits in planning would need to
use repetition when giving instructions or facilitating participation in therapy.
Likewise, the clinician may need to use redirection and attention gathering tactics
repeatedly and frequently. For example, the clinician may need to verbally redirect
clients to remind them to stay on task and maintain their attention to a particular task.
Finally, clients may need verbal reminders of appointments repeated in the form of
letters, phone calls or any other available sources.
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Purposive action.
The translation of a plan into an activity is purposive action (Lezak, 1995).
This involves the ability to initiate, maintain, switch, and stop sequences of behavior
in an ordered manner (Lezak, 1995). For example, a patient might have a plan to
attend an Alcoholics Anonymous meeting, but actually turning that plan into the
action of going does not happen. A deficit in purposive action is most important when
the actions are not routine. Overlearned, familiar, or automatic tasks are much less
vulnerable to frontal lobe damage than more novel tasks (Lezak, 1995). For example,
the overlearned task of putting one’s shoes on is less likely to be impaired than the
attendance at a new meeting in the community.
There are multiple aspects of purposive action that can be impaired. One’s
ability to self regulate can affect their success at productivity (Lezak, 1995). This gap
between planning and activity becomes apparent in patients who are “all talk, no
action”. This is different from the occasional tendency of someone to not follow
through on their word. The gap between planning and action is frequent and persistent
giving it a pathological flavor. Flexibility and the capacity to shift one’s behavior or
thoughts can also be impaired (Zinn et al., 2004), resulting in difficulty conforming to
social norms or expectations, rigidity in thinking or behaviors or a tendency to
perseverate with behaviors or thought streams (Lezak, 1995; Ratti et al., 2002). For
example, a patient who perseverates with behaviors or thought streams might have
the exact same routine daily or tell the clinician the same story over and over. The
client with rigidity or perseveration issues may present to clinicians as someone who
is unmotivated, difficult to redirect or disruptive. Using multiple methods of
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redirection and reinforcement could prove helpful versus becoming frustrated and
assuming the client is not motivated to participate in treatment.
Effective performance.
A patient’s performance on any activity can only be as effective as his/her
ability to monitor, self-correct and regulate the qualitative aspects of the delivery of
the action (Lezak, 1995). Some patients who suffer deficiencies in executive
functioning, including problems in effective performance, may not perceive errors
they have made on any task or may perceive errors but do nothing to correct them
(Lezak, 1995). They may perform any task erratically or just simply unsuccessfully
(Lezak, 1995). Patients with frontal lobe impairment may also have insensitivity to
possible consequences (i.e., punishment or reward) which affects their ability to make
sound decisions (Bechara, Tranel & Damasio, 2000). A patient’s lack of effective
performance on any given task may be the result of not perceiving errors or
perceiving but not correcting the errors (Lezak, 1995). The lack of self correction
may result from an abnormal sense of self awareness or possibly just inertia (lack of
purposive action; Lezak, 1995). If one does not perceive what they are doing, it is
difficult to correct. Likewise, if one has no inertia, they also would not correct any
possible errors.
Another syndrome associated with abnormalities of self-awareness is that of
confabulation (Lezak, 1995). Confabulation is defined as the presentation of
incorrect, sometimes bizarre information to standard questions (Lezak, 1995). For
example, when asked about their recent substance use, the client might report a long
story about wild events at work. They might talk while the clinician is speaking and
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not directly respond to specific questions without repeated redirection and
clarification. Once the response is made, the answer might contain a series of
formations of false memory, perceptions or beliefs mixed with some truth, pouring
out of irrelevant associations or the response may contain no reality at all.
Confabulation is not necessarily related to a memory disturbance, but instead is due to
the ability to self correct (Stuss & Benson, 1984). Therefore, the patient’s lack of
effectiveness with any task may be due to multiple issues of self correction, self
awareness and self regulation (Stuss & Benson, 1984).
Frontal Lobe Functions
Historically, frontal lobe functions have been poorly understood (Lezak, 1995;
Snyder & Nussbaum, 1998). For example, for many years clinicians referred to the
prefrontal lobes as the silent areas because sensorimotor signs were often absent after
prefrontal damage (Snyder & Nussbaum, 1998). However, due to continued research
on humans and animals, as well as developments in structural and functional
neuroimaging, we now have a much greater understanding of this area of the brain
(Snyder & Nussbaum, 1998).
As described with deficits in volition, planning, purposive action and effective
performance, frontal lobe disorders affect how a person responds to others, which can
affect the content of any response (Lezak, 1995). Disorders affecting the frontal lobes
tend not to disrupt cognitive functions (such as reporting on specific knowledge) as
obviously as does damage in other areas of the brain such as occipital (Lezak, 1995).
Therefore, frontal lobe dysfunction may be harder to detect, go undetected or be
attributed to other causes such as the client’s noncompliance or lack of desire to
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participate or address problems (Lezak, 1995). This then impacts the judgments
others make about the client and possibly resulting in increased stigma.
Deficits in functioning stemming from damage to the frontal cortex can also
affect one’s ability to pay attention, as well as one’s prospective memory (i.e., one’s
ability to remember to remember; Lezak, 1995). Therefore, if a patient has attention
or memory deficits, they will have a difficult time retaining what is said in treatment,
remembering appointments, locations, bus schedules and much more. The deficits in
memory and attention could result in frustration and increased drop out rates.
Likewise, the deficits in memory and attention may also be misperceived by
clinicians and others resulting in continued stigma.
Frontal lobe damage and cognitive functions.
In regards to cognitive functions, frontal lobe disorders usually do not result in
the loss of a specific skill or specific information (Bechara et al., 2000; Salloway,
1994; Shallice & Burgess, 1991). In fact, patients with frontal lobe disorders often
perform within normal ranges on formal ability tests such as tests of intelligence and
tests where they have direction through a series of problems (Bechara et al., 2000;
Shallice & Burgess, 1991). Tests of intelligence often ask for factual information
which is not affected normally with frontal lobe disorders (Bechara et al., 2000;
Shallice & Burgess, 1991). Likewise, in tests where they are directed through a series
of tasks, they have the benefit of the examiner’s direction. Instead, the difficulties in
functioning for people with frontal lobe deficits are related to initiating, planning, and
organizing abilities, and therefore assessment must include tests designed to examine
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the patient’s functioning in initiating action, planning tasks, and organizing abilities
(Bechara et al., 2000; Shallice & Burgess, 1991).
(Often Misinterpreted) Behavioral Problems Associated with Damage to the
Frontal Lobe
Misinterpretation and Stigma
Common complaints from the people around patients with frontal lobe
disorders include that the patient seems apathetic, careless, has poor or unreliable
judgment, poorly adapts to new situations and has a blunted sense of sensibility
(Daffner et al., 2000; Lezak, 1995). In treatment, this might present as someone who
does not want help or is uninterested in what the clinician or others have to say.
Substance abusing patients with deficits such as information processing,
distractibility, difficulty with attention and problem solving can result in the patient
missing parts of what they are told leading to issues such as emotional lability,
hypersensitivity, low frustration tolerance or paranoia in the patient (Fals-Stewart &
Lucente, 1994). Substance abusing patients with such deficits are often described as
irritable, impulsive, perseverative and socially disinhibited (Fals-Stewart & Lucente,
1994). Similarly, Bates, Voelbel, Buckman, Labouvie and Barry (2005) reported that
cognitive deficits in patients in substance abuse treatment “may lead to lack of
motivation and treatment engagement, which are often interpreted as negative client
attributes by treatment providers” (Bates, Voelbel, Buckman, Labouvie & Barry,
2005, p. 373). Furthermore, when therapists were informed of the deficits in
functioning, the therapists rated participation and therapeutic alliance higher and
patients subsequently stayed in treatment longer (Bates et al., 2005).
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As previously discussed, the stigma associated with substance use disorders is
a relevant factor in why individuals do not engage in treatment (Corrigan, 2004).
Understanding and reducing this stigma, which results at least partially from the
neuropsychological deficits associated with substance use disorders, is an important
reason for this study.
Introduction to Behavior Problems
There are five general behavioral problems that are often misinterpreted in
patients with frontal lobe damage adding to the prevalence of stigma associated with
substance use disorders (Lezak, 1995). The five behavioral problems, with much
overlap amongst them, associated with damage to the frontal lobe include (a)
problems in behavior starting, (b) difficulty making mental and behavioral shifts, (c)
problems in stopping, (d) deficient self awareness, and (e) a concrete attitude (Lezak,
1995). These five general behavioral problems are often misinterpreted by clinicians,
family, friends, coworkers and society in general, leading to the development and
perseveration of the stigma that accompanies individuals with frontal lobe damage
(Lezak, 1995). The five behavioral problems and their possible misinterpretations are
discussed below.
Problems in behavior starting.
The problem of behavior starting relates to the previously discussed volition
and purposive action. When compared to their behaviors previous to frontal lobe
damage, individuals who suffer with problems in behavior starting exhibit decreased
spontaneity, decreased productivity, decreased rate at which behavior is emitted and
decreased or lost initiative as compared to the patient’s normal level of functioning
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(Lezak, 1995). As a result of these particular deficits, patients who exhibit problems
in behavior starting may appear lazy or apathetic to the casual observer (Daffner et
al., 2000). Many can “talk a good game” but are unable to transform words into
action. An extreme dissociation between words and actions has been termed
pathological inertia (Lezak, 1995). The frontal lobe patient has no problem in
describing a viable course of action (e.g., verbally describes when, where and how
they will attend a community support meeting), but is unable to carry out the plan
(i.e., never actually go to the meeting; Lezak, 1995).
Difficulty making mental and behavioral shifts.
A second behavioral problem associated with purposive action that may
manifest as a result of damage to the frontal lobe is that of difficulty in making mental
or behavioral shifts (Lezak, 1995). Referred to as perseveration or rigidity (Lezak,
1995), difficulties are seen in the individual’s ability to shift attention from one thing
to another, to make changes in physical movement or to maintain flexibility in
attitude. Specifically, perseveration refers to repetition or continuation of an act or
response to a question or situation (Lezak, 1995). In patients who have damage to the
frontal lobe, perseveration tends to be supramodal, meaning that perseveration is
exhibited in a variety of situations and a variety of tasks (Lezak, 1995). For example,
the client might like to tell the same story of the day they met the president every time
they attend a session anywhere with anyone present. Similarly, activities such as
stopping at the same bar every night or calling the same drinking friends for support
may be due to the individual’s inability to change the behavior as the result of frontal
lobe damage (i.e., perseveration) rather than being due to the individual’s choosing
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the behavior, which is what the casual observer might assume without information to
the contrary. Perseveration can manifest itself as repetitive prolongation or
continuation of an act or sequence of activities, or similar responses to a variety of
questions, tasks or situations (Lezak, 1995). I have heard clinicians become frustrated
with clients who do the same act expecting different results-often the result of
perseveration.
Problems in stopping behaviors or responses.
The third behavioral problem for individuals with frontal lobe damage
involves the effective performance component of frontal lobe damage, or more
specifically, difficulty stopping behaviors or responses (Bechara et al., 2000; Lezak,
1995). The inability to stop behaviors results in the patient’s impulsivity, over
reactivity, disinhibition and difficulty holding back a wrong or unwanted response
(Lezak, 1995). Because of their behaviors, patients exhibiting difficulties with
stopping behaviors are often classified as having a loss of control or control problems
(Lezak, 1995). The difficulty in stopping behaviors could result in verbal outbursts
that some might find offensive, as well as, an inability to maintain abstinence in any
situation where the patient may be exposed to a substance of abuse. These types of
behaviors might be misinterpreted as simple noncompliance by the unaware observer.
Education regarding the inability to stop behaviors and specific behavioral plans for
the client and the clinician could be helpful to the individuals struggling with
disinhibition.
Deficient self awareness.

43

Deficient self awareness, resulting in an inability to perceive performance
errors on any given task (for example, forgetting to butter the bread prior to placing it
in the frying pan to make grilled cheese, and then wondering why the pan is
smoking), inability to appreciate the impact one makes on others, and/or to evaluate
social situations appropriately (for example, not noticing that others are upset with
you or giving you social cues meant to get you to leave) is the fourth behavioral
problem (Lezak, 1995; Stirling, 2002). For example, people with deficient self
awareness may be euphoric and self-satisfied at times when such feelings are
unwarranted (for e.g., feeling satisfied with one’s parenting though only having
contact with the child a couple times per year) causing a client to have multiple
problems in relationships with friends, family or therapy connections (Lezak, 1995).
Deficient self awareness may be misinterpreted as rude, lazy, insensitive or again as
non-compliant. Again, education focused on increasing the individual’s awareness of
the problem and its effects on others, as well as, a plan for alternative actions versus
ineffective actions would be imperative.
Loss of abstract attitude.
The fifth problem associated with frontal lobe disorders is due to the loss of
the abstract attitude (Lezak, 1995). As a result of impairments in abstracting and
conceptual thinking, the patient holds an extremely literal understanding of life where
all objects, behaviors or experiences are evaluated only with regards to face value
(Stirling, 2002). The patient becomes incapable of planning or sustaining goal
directed behavior because they are responding in such a literal manner (Lezak, 1995).
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Frustration can again arise with misinterpretations by clinicians and others. This
client may be misinterpreted as being “difficult” or possibly immature.
Summary of Executive Functioning Deficits Found in Individuals with Frontal Lobe
Damage
Overall, frontal lobe functions, and more specifically, executive functions are
large and complex influences in human functioning and behavior. When examining
the possible deficits caused by frontal lobe damage, several categories of behavioral
problems have been defined (Lezak, 1995; Parsons & Nixon, 1993; Stirling, 2002).
However, the behavioral problems exhibited are not exclusive to the defined
categories; there is a fair amount of overlap, not to mention that much about the
deficits remains unknown (Lezak, 1995; Stirling, 2002). For example, all of the
behavioral problems discussed are described as if existing as separate concepts, but in
real life the behaviors present as a mixture of some or all categories of possible
deficits. Furthermore, the extent to what the exact presentation of behaviors in each
individual will be, as related to any neuropsychological damage, is unknown (Lezak,
1995; Snyder & Nussbaum, 1998). The overlap and complicated nature of frontal
lobe functions makes assessment and identification of problems difficult (Lezak,
1995). Likewise, the complex nature and presentation of the impairment in the
individual, as well as, the misinterpretation by observers provides a breeding ground
for frustration, labeling and stigmatization by those who interact with a person with
frontal lobe damage. Finally, the five specific behavioral problems discussed and
their misinterpretations provide specific areas where stigma is born and magnified
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due to the overlapping and often unrecognized problems associated with the frontal
lobe (Lezak, 1995).
Neuropsychological Functioning and Substance Dependence
Lewis and Sinnett (1987) discussed the fact that there are many “silent
victims” of neuropsychological impairment, referring to the fact that many people’s
impairments go undetected or misdiagnosed. Some of the silent victims include
people with brain injuries, rare metabolic disorders, and more common disorders such
as substance abuse
(Lewis & Sinnett, 1987). Bates, Bowden and Barry (2002) estimated that between
50% and 80% of individuals with alcohol use disorders experience mild to severe
neurocognitive impairment (Bates et al., 2002). Likewise, Parsons and Nixon (1993)
estimated that as many as 50% to 85% of individuals with alcohol use disorders will
manifest mild to moderate impairment in some aspect of neuropsychological
functioning (Parsons & Nixon, 1993).
Substance abuse and dependence can affect many complex areas and
functions of the brain (Lezak, 1995; Parsons & Nixon, 1993). For example, alcohol
dependence has been shown to affect the cerebellum, Pukinje cells and many other
specific areas of the brain resulting in disruption of motor functioning as well as other
specific frontal lobe functions including verbal learning, cognitive planning and
attentional set shifting (Sullivan et al., 2003). However, because this study seeks to
evaluate the relationship of executive functioning and attrition rates in substance use
treatment, I will present a brief overview of the possible effects of alcohol and drug
use on the frontal lobe and executive functioning.
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Effects of Alcohol Use on Frontal Lobe and Executive Functioning
Reduced brain weight, particularly affecting the frontal lobe has been shown
among alcoholic patients upon autopsy and neuroimaging studies (Bates et al., 2002;
Sullivan et al., 2003). With such information about the impact of chronic alcohol use
on the frontal lobe, researchers have begun to look more seriously at executive
functioning and substance use disorders. For instance, Ratti, Giardini and Soragna
(2002) evaluated the neuropsychological functioning of 22 male alcoholics (met DSM
IV criteria for alcohol dependence, no history of significant drug abuse, ages 30-65,
no head injury or medical condition affecting cognitive functions) and 22 non
alcoholic controls (no DSM IV diagnosis, no neurological disorders, healthy, right
hand dominant, habitually drink less than 40 grams of alcohol per day) using results
on several neuropsychological tests. The tests used were Digit Symbol (assessing
psychomotor performance), Stroop (selective and focused attention, ability to
suppress irrelevant information), Digit Cancellation (selective attention), Trail
Making (visual conceptual and visual motor tracking skills, mental flexibility) and the
Wisconsin Card Sort Test (WCST; problem solving, abstraction, cognitive flexibility,
concept identification, hypothesis generation, ability to use feedback; Ratti, Giardini
& Soragna, 2002). This test battery would be appropriate for the author’s purpose of
evaluating executive functions. For all tests, mean and standard deviation were also
calculated. The authors found the alcoholic participants to be impaired in almost
every executive function assessed (Ratti et al., 2002). Specifically, results indicated
statistically significant differences in the functioning levels between alcoholics and
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non-alcoholics (Ratti et al., 2002). The alcoholic participants performed statistically
significantly worse than did the non-alcoholic control group in the digit cancellation
(M = 44.6 +/- 11.2, p = .0001), the digit symbol (M = 28.2 +/- 14.8, p = .005), the
trail making test (M = 167.9 +/- 100.2, p = .01) and reaction test (M = 433 +/- 105, p
= .001; Ratti et al., 2002). On the WCST, which evaluates problem solving and
abstraction abilities, the alcoholics were also found to be impaired (M = 54.5 +/- 20.0,
p = 0.00001). However, they were not impaired on the WCST in the area of
perseveration (Ratti et al., 2002).
The strengths of this study include the author’s use of a control group (i.e., the
non-alcoholic group), and the evaluation of the participant’s physical health, so as to
not interfere with results. Though the test participants and controls were matched for
age, education and IQ, no mention was made of evaluation of socioeconomic status or
ethnicity. If the authors were using assessments that were not normed for their
participant’s socioeconomic status or ethnicity, this could adversely affect the results.
Overall, the authors conclude that executive functions are impaired by alcohol
dependence (Ratti et al., 2002).
Likewise, researchers have found metabolic abnormalities in the left
dorsolateral prefrontal cortex on a study performed on 17 chronic alcoholics
including 11 men and 6 women (Dao-Castellana et al., 1998). The subjects were ages
25 to 65 and had been hospitalized for detox from one week to one month. All
subjects had been abstinent from alcohol and illicit drugs since hospitalization. Nine
normal, non-alcoholic participants were recruited as controls for the imaging studies
and neuropsychological evaluations were performed on eight controls (Dao-
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Castellana et al., 1998). It is unclear within this study why nine were used for the
imaging and only eight for the testing. Likewise, it is unclear why 17 alcoholic
participants were studied and only a total of nine, non-alcoholic controls were
studied. The controls had normal clinical, neurological and psychiatric examinations
and normal MRI images (Dao-Castellana et al., 1998). All subjects had a PET scan
and an MRI on the day they were administered the neuropsychological tests. The PET
scans found a statistically significant decreased cortical metabolism in the left frontal
lobe (p = 0.048), mediofrontal region (p = 0.002) and close to statistical significance
(p =0.084) in the left prefrontal region in the alcoholic participants (Dao-Castellana et
al., 1998). Similarly, the MRI showed significant cortical atrophy in the mediofrontal
(p < 0 .001), right dorsolateral prefrontal (p = 0.005) and left dorsolateral prefrontal
regions (p < 0.001) in the alcoholic participants (Dao-Castellana et al., 1998).
Likewise, statistically significant reduced verbal fluency (p = 0.014) and impaired
performance on the Stroop test (p = 0.003) were noted on these alcoholic participants
(Dao-Castellana et al., 1998). To clarify, the Stroop test evaluates the participant’s
ability to suppress irrelevant information and enhance relevant information (Lezak,
1995). The Stroop is regarded as a measure of executive functions related to mental
control and response flexibility associated with the frontal lobe (Lezak, 1995; Lezak
et al, 2004). Verbal fluency, another measure of executive function, was evaluated by
having subjects name as many animals as they could within a minute and list as many
words as they could that started with the letters m, p, and d in a minute (DaoCastellana et al., 1998) all of which are measures of speed and ease of verbal
production (Lezak, 1995) which was found to be impaired in the alcoholic
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participants. Dao-Castellana et al. (1998), concluded that these neuropsychological
impairments including verbal fluency and ability to suppress irrelevant information
and enhance relevant information may occur prior to other more obvious neurological
impairments (such as severe behavioral abnormalities characterized by aggressiveness
and breakdowns in family life) accounting for some of the behavioral changes.
There are definite strengths and weaknesses of the Dao-Castellana et al.
(1998) study. For example, a follow up study might define the prognosis for the
participants or the reversibility of the impairment. One strength of this study includes
the author’s use of the imaging studies in comparison with the neuropsychological
tests, allowing the reader to understand physical changes in the brain as well as
differences in an individual’s performance when tested. However, the participants in
the Dao-Castellan et al. (1998) study range from one week to one month abstinent
which could have an impact on their functioning or level of impairment from the
substance use. Follow up studies might also want to look at a longitudinal study
comparing the impairments in early and later recovery. In addition, Dao-Castellana et
al. (1998), make no mention of baseline neuropsychological functioning in the
participants so it is unclear how much damage in the participants has occurred due to
the alcohol use. This piece would also be interesting to include in future research.
There is no mention of previous academic or medical records being evaluated for the
possibility of assessing for premorbid functioning or history of trauma and/or injury.
Finally, Dao-Castellana et al. (1998), does not mention if the control group was
matched to the alcoholic group in the areas of education, socioeconomic status or
ethnicity which could all affect how comparable the groups actually are. Overall, this
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study does continue to support the relationship between alcohol use disorders and
impairment in the frontal lobe.
Sullivan, Fama, Rosenbloom and Pfefferbaum (2002) examined differences in
executive functioning between 43 alcoholic women (ages 28-63 years) recruited from
inpatient and outpatient programs at the Veterans Affairs Palo Alto Health Care
System, outpatient programs at Stanford Medical Center and from community
treatment programs and 47 non-alcoholic women (ages 20-85 years) recruited from
the community. It is unclear how many of the controls were over age 63 (the top of
the age range for the alcoholic group) which could affect the comparability of the two
groups. Tests administered to examine executive function included the WCST, Trails
B, digit ordering task, and the picture arrangement subtest of the WAIS-R (Sullivan et
al., 2002). An ANOVA was performed using six composite scores from each of the
two groups including measures of executive function, short term memory, upper limb
motor ability, declarative memory, visuospatial ability and balance (Sullivan et al.,
2002). A statistically significant group effect was found between the alcoholic women
and the control group, F(1,50) = 5.54, p = .02 (Sullivan et al., 2002). Follow up t tests
revealed statistically significant performance deficits in the alcoholic group in five of
the six areas (p </= .04), including all but upper limb motor ability composite
(Sullivan et al., 2002).
One strength of this study was the author’s assessment of premorbid
intellectual functioning in the alcoholic group using the National Adult Reading Test
(NART). The alcoholic group had a statistically significant lower score on the NART
than the controls (p < 0.01; Sullivan et al., 2002). When the authors attempted to
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control for this difference using an ANCOVA, the group differences remained
significant for all domains except executive functioning (p = .41; Sullivan et al.,
2002). Due to the difference in premorbid functioning in alcoholics and controls, it is
unclear if we can attribute the deficits to the substance use of the alcoholic. In
addition, although the authors attempted to control for the difference, complete
confidence can never be attained when simply using an ANCOVA to control for the
difference and to compensate for study design weaknesses (Loftin & Madison, 1991;
Thompson, 1992). Sullivan et al. (2002), noted another weakness of this study was
the fact that most of the alcoholic group reported being depressed and the control
group did not. Previous research has suggested that one factor that may contribute to
cognitive impairment in alcoholics is depression (Penick et al., 1994). Therefore,
while the use of a control group is definitely a strength of the study by Sullivan et al.
(2002), the depression reported by the alcoholic participants is an important
difference between the study groups that may have affected the study’s results. In
addition, the alcoholic group had only 11 of the 43 participants that were free of any
comorbid DSM IV diagnosis. Nine of the alcoholic women met criteria for one other
DSM IV diagnosis whereas the rest met criteria for two of more other Axis I
diagnoses in the DSM IV. On the contrary, the control group was screened with the
Structured Clinical Interview for the DSM IV (SCID) and potential controls were
excluded if they met DSM IV diagnostic criteria. Therefore, it seems a rather large
weakness of the Sullivan et al. (2002), study is the fact that we can not be sure that
the results are due to the alcohol use in the test participants rather than their comorbid
DSM IV diagnosis.
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However, results of other studies examining mood and alcoholism have
contradicted the Penick et al. (1994) study mentioned above. For example,
Uekermann, Daum, Schlebusch, Wiebel and Trenckmann (2002) compared
depressed, non alcoholic (n = 28) nondepressed alcoholic (n = 30) and healthy
controls (n = 28). The assessments used included Wechsler Adult Intelligence ScalesRevised (short term memory), Benton Visual Retention Test (visual memory),
immediate and delayed recall of three word lists (verbal memory), Fragmented
Picture Test (perceptual priming) Mood Rating Scale (mood), three verbal fluency
tests, Hayling Test (response suppression) and Cognitive Estimates Test (reasoning;
Uekermann et al., 2002). For statistical analysis, ANOVA’s with subsequent t-tests
using the Bonferroni correction were performed (Uekermann et al., 2002). ANOVA
for present state mood revealed significantly (statistically) higher scores for the
depressed group when compared to the alcoholic or control group (both p < 0.0001;
Uekermann et al., 2002). Likewise, the patients with primary depression and the
alcoholic group scored significantly higher than the healthy controls (p < 0.013;
Uekermann et al., 2002). To assess the cumulative effect of depression and
alcoholism, the cognitive profiles of depressed and nondepressed alcoholics were
compared with those of the control group (Uekermann et al., 2002). It appears, that
the authors developed a fourth group from the alcoholic group. They compare those
within the alcoholic group that had a significantly higher (p = 0.0001) Beck’s
Depression Inventory score (which is not listed as an instrument used in their section
on the instruments used) to the others in the alcoholic group (Uekermann et al.,
2002). This results in the comparison of patients with alcoholism that are depressed to
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patients with alcoholism that are not depressed. Unfortunately, this process is vaguely
described in the article. In addition, the numbers in each group are not reported so it is
unclear how many depressed alcoholics are being compared to nondepressed
alcoholics. There were no statistically significant differences found with respect to
age, general intelligence or history of alcoholism between the depressed alcoholic
group and non depressed alcoholic group (p > 0.34; Uekermann et al., 2002). The
comparisons of these two groups show no statistically significant differences on
cognitive measures (p > 0.10). In conclusion, the results of the study showed that
patients with primary depression and the alcoholic group were impaired with respect
to executive functions and memory when compared to healthy controls (p < 0.05;
Uekermann et al., 2002). In contradiction to Penick et al. (1994) the authors conclude
that the lack of a significant difference between depressed and nondepressed
alcoholics suggest that the deficits of alcoholics are not necessarily distorted by the
depressive symptoms (Uekermann et al., 2002). Given the contradictory reports of the
role depression plays with respect to executive functioning in alcoholic patients,
further research would be useful in this area. Likewise, current researchers would
need to use caution with regard to these variables when evaluating executive function
in patients with a substance use issue and possible comorbid depression.
Moselhy, Georgiou and Kahn (2001) have also reviewed the results of many
studies that researched the effects of alcohol on the frontal lobe. The studies they
reviewed included detailed testing (such as Halstead Category Test, Wechsler Adult
Intelligence Scale, WCST and Trail Making test) across both genders, various age
groups and multiple countries which indicated that individuals who are diagnosed
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with alcohol dependence exhibit deficits in cognitive flexibility, problem solving,
verbal and non-verbal abstraction, visuo-motor coordination, learning, conditioning
and memory (Moselhy et al., 2001). For example, within Moselhy, Georgiou &
Kahn’s (2001) review of the literature, multiple studies revealed physical changes in
the brain such as wider sulci and fissures. Likewise, younger (mean age 37.5) and
older participants (mean age 52.7) had gray matter volume deficits with the older
group showing more severe deficits in the prefrontal area through use of CT and MRI
scans (Moselhy et al., 2001). Moselhy et al., (2001) referenced eighteen studies with
regard to detailed testing across cultures revealing deficits in cognitive flexibility,
problem solving, verbal and nonverbal abstraction, visuo-motor coordination,
learning, conditioning and memory. Though the specifics of each study are not
described, one study of 35 alcoholics compared to 35 nonalcoholic controls revealed
significant differences on the Trail Making test and the Halstead Battery (Moselhy et
al., 2001). Within this study, the alcoholics were found to be indistinguishable from
the non-alcoholics in terms of I Q (Moselhy et al., 2001). Moselhy et al’s., literature
review (2001) also summarized multiple studies which reported that when several
third variables such as anxiety, depression, head injury and family history of
alcoholism are controlled for, deficits in neuropsychological measures can still be
found. For example, in one of the studies reviewed, 27 alcoholic participants that had
a first degree relative with alcoholism were compared to 21 alcoholic participants
without a first degree relative with alcoholism (Moselhy et al., 2001). No differences
were found between the two groups suggesting that a family history of alcoholism
does not appear to impact the effects of alcoholism on the frontal lobe (Moselhy et
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al., 2001). Overall, Moselhy et al’s extensive literature review provides support for
the relationship between alcohol use disorders and frontal lobe impairment (Moselhy
et al., 2001).
In an attempt to control for confounding variables in the performance of
participants with an alcohol use disorder, Sher, Martin, Wood and Rutledge (1997)
used a MANCOVA to control for family history, anxiety, depression, conduct
disorder, and loss of consciousness. Factor analysis of 17 neuropsychological tests
was performed on 489 undergraduates, half of whom had a history of alcoholism in
their biological fathers (Sher et al., 1997). Of the 489 participants, 88 were diagnosed
with alcohol abuse and 31 with alcohol dependence (Sher et al., 1997). Confounding
variables were diagnosed using the Diagnostic Interview Schedule III to diagnose
conduct disorder and the Brief Symptom Inventory for diagnosis of depression and
anxiety (Sher et al., 1997). Family history was assessed through the Short Michigan
Alcoholism Screening Test (SMAST) and loss of consciousness was assessed with
simple questioning (Sher et al., 1997). This is an interesting study as it was performed
on undergraduate students instead of a clinical sample like many other studies. One
might presume that this non-clinical study might not have the same pattern of deficits
as a clinical population. In addition, the individuals with the alcohol use disorders
were drawn from the same population as the controls (first year undergraduates at the
same institution). The findings from this study indicate that alcohol use disorders are
associated with poorer visual spatial ability and reduced motor speed (Sher et al.,
1997). These results essentially mirror results derived from studies of clinical samples
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(Sher et al., 1997). When all confounds were controlled for through the use of a
MANCOVA, statistically significant differences were still found (Sher et al., 1997).
Effects of Drug Use on Frontal Lobe and Executive Functioning
The effects on the frontal lobe are not only applicable to patients with an
alcohol abuse or dependence diagnosis. Similar results have been found with drug
abusing and dependent patients (Roselli et al., 2001). Forty-two adult (28 male, 14
female) cocaine abusers from a state rehabilitation facility were administered a
neuropsychological test battery including the arithmetic and digit subtests from the
WAIS-R, California Verbal Learning Test (CVLT), Trail making Test (TMT), Rey
Osterrieth Complex Figure (ROCF), WCST, Benton Visual Retention Test (BVRT),
Stroop Neurological Screening Test (SNST) and Hooper Visual Organization (Roselli
et al., 2001). A control group of 11 females and 6 males with no history of alcohol or
drug abuse and no psychiatric or neurological disorders was recruited from student
advertisements (Roselli et al., 2001). The control group was given all of the same
assessments as the drug dependent group. A MANOVA was performed and
statistically significant differences between the drug abusing patient and the controls
for the tests used were found on several of the executive function tests (Roselli et al.,
2001). The most abnormal scores were observed in attention, memory and the
executive functions which could impair participation and retention in treatment
(Rosselli et al., 2001). Specifically, statistically significant differences were observed
in the WAIS-R arithmetic (F = 16.92, p = .001) and digit subtest (F = 13.52, p = .001,
CVLT (F = 3.73, p = .05), TMT Form B (F = 10.28, p = .002), ROCF (F = 5.75, p =
.02), WCST errors (F = 7.82, p = .007), WCST number of categories (F = 5.20, p =
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.026), BVRT (F = 16.49, p = .001) and SNST (F = 4.09, p = .04; Roselli et al., 2001).
Rosenberg, Grigsby, Dreisbach, Busenbark & Grisby (2002) have found similar
results to Roselli et al., using similar assessment tools with solvent abusers. Fifty five
solvent abusers (43 males, 12 females) and 61 users (49 males, 12 females) of other
drugs, especially cocaine and alcohol, were given a battery of neuropsychological
tests including the Wechsler Memory Scale-Revised, Trail Making Test, Digit
Cancellation Test, Stroop test, Boston Naming Test, WCST and Behavioral
Dyscontrol Scale (Rosenberg et al., 2002). All participants performed poorly, scoring
below the mean on most neuropsychological measures (Rosenberg et al., 2002).
Solvent abusers performed even more poorly on executive functions than the others
(Pillai’s Trace = 0.239, p < .001; Rosenberg et al., 2002).
Several neuroimaging techniques have also been used to evaluate the effect of
substance abuse and dependence disorders on the brain. For example, computerized
tomography has been used to confirm cortical shrinkage and ventricular dilatation
among alcoholic samples (Ron, Acker, Shaw & Lishman, 1982). In addition,
magnetic resonance imaging (MRI) studies have shown abnormalities among inhalant
abusers, cocaine abusers and alcoholics (London, Ernst, Grant, Sonson, & Weistein,
2000; Moselhy et al., 2001; Rosenberg et al., 2002). Functional MRI’s (fMRI) have
also been used to support the impact on the frontocerebellar regions in chronic
alcoholics (Sullivan et al., 2003). Likewise, positron emission tomography (PET)
studies have also found abnormalities (Moselhy et al., 2001). Decreased frontal lobe
glucose utilization and reduced cerebral blood flow suggest frontal lobe dysfunction
(Moselhy et al., 2001). Others also found decreased metabolism of glucose and
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reduced cerebral blood flow in the frontal lobes of individuals with alcohol use
disorders which may be part of the cause of impaired executive functions (Bates et
al., 2002). PET and fluorodeoxyglucose studies have also been used to confirm that
specific neuropsychological tests do activate the dorsolateral prefrontal cortex
including the Tower of London test (Moselhy et al., 2001). Likewise, the previously
mentioned executive functions of volition, planning, purposive action and effective
performance can be traced to the frontal lobe (Adams et al., 1995; Dagher, Owen,
Boecker & Brooks, 1999). As these functions are related to the frontal lobe and the
frontal lobe is found to be affected by substance use, the relationship between
impaired executive function and substance dependence is strengthened.
Summary
Overall, research has indicated that we can conclude that alcohol and drug use
are associated with physical changes in the brains of users, including reduced size and
blood flow in the frontal lobe (Bates et al., 2002; Ron et al., 1982; Sullivan, et al.,
2003). Likewise, studies have indicated that individuals who use alcohol and drugs
have lowered functioning on a variety of tasks than do their non-abusing counterparts
including deficits in digit cancellation, digit symbol, trail making, reaction test,
WCST (Roselli et al., 2001), reduced verbal fluency, impaired Stroop performance
(Dao-Castellana et al., 1998) visuo-spatial ability and balance (Sullivan et al., 2002),
cognitive flexibility, problem solving, verbal and non-verbal abstraction, visuo-motor
coordination, learning (Moselhy et al., 2001) and overall executive functions,
attention and memory (Roselli et al., 2001; Rosenberg et al., 2002; Sullivan et al.,
2002). Additionally, there is some discrepancy in the research regarding the influence
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of other factors, such as depression and anxiety on the cognitive functioning in
alcoholic patients, and so we are, at present, uncertain if and how these other factors
may affect functioning (Penick et al., 1994; Moselhy et al, 2001; Uekermann et al.,
2002). However, we do know that the frontal lobe is the area of the brain responsible
for executive functions as we have assessments that can measure cognitive
functioning and we also have proven imaging techniques that validate that specific
neuropsychological tests do indeed examine frontal lobe functioning (Adams et al.,
1995; Dagher et al., 1999; Moselhy et al., 2001; Ratti et al., 2002; Roselli et al., 2001;
Sullivan, et al., 2003). Therefore, within this study, I was able to evaluate the
executive functioning of participants which may be impaired due to their substance
dependence and may impact their ability to remain in treatment.
Neuropsychological Functioning and Dual Diagnosis
It is quite possible that any relationship between substance use and
neuropsychological deficit can be attributed to third variable confounds related to cooccurring mental health disorders (Sher et al., 1997). Therefore, the relationship of
substance use, cognitive/neuropsychological impairment and disorders such as
depression, anxiety, personality disorders and thought disorders including
schizophrenia will be reviewed.
Mood Disorders
Carpenter and Hittner (1997) evaluated the effects of substance use history
and depressive symptoms on the cognitive functioning of 149 male and 72 female
dually diagnosed patients with alcohol abuse or dependence, cocaine abuse or
dependence and comorbid DSM-III-R affective disorder (Carpenter & Hittner, 1997).
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All participants were administered the Beck Depression Inventory (BDI), the Shipley
Institute of Living Scale (SILS) and the Screening Test for the Luria Nebraska
Neuropsychological Battery (ST-LNNB; Carpenter & Hittner, 1997). Results of a
logistic regression analyses using the traditional Shipley abstract indicated a
significant effect for previous months alcohol use on probability of impaired
classification based on the SILS reasoning performance (Z = 2.01; Carpenter &
Hittner, 1997). A marginally significant (statistically) effect for life time alcohol use
also emerged indicating that individuals with 5-10 years of regular drinking
experience were 2.3 times more likely to be classified as impaired that those with less
than 5 years regular consumption (Z = 1.93, p = .05; Carpenter & Hittner, 1997). No
statistically significant parameter estimates were demonstrated for cocaine use,
depressive symptoms, intravenous (IV) drug use or life time substance use (Carpenter
& Hittner, 1997). Results of the logistic regression analyses using the modified
Shipley (possible borderline cases omitted) indicated statistically significant effects
for life time alcohol use (Z = 2.64) and total number of months of life time substance
use other than alcohol and cocaine (Z = 2.23; Carpenter & Hittner, 1997). No
statistically significant effects were found for 10 plus years of alcohol use, previous
month’s alcohol use, cocaine use or depressive symptoms (Carpenter & Hittner,
1997). Logistic regression analyses for the ST-LNNB demonstrated statistically
significant effects for education (Z = -2.14) and life time cocaine use (Z = 2.41;
Carpenter & Hittner, 1997). The effect for life time cocaine use remained even after
controlling for age, education, depressive symptoms, other substance use, IV drug
history and previous months use (Carpenter & Hittner, 1997). Overall, the authors
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found “no statistically significant effects for age, previous month’s cocaine use,
depressive symptoms or any of the interaction terms” (Carpenter & Hittner, 1997, p.
752). Carpenter and Hittner (1997) do acknowledge the weaknesses of their study
such as the fact that they are evaluating an inpatient population from a private
psychiatric facility which may have resulted in higher functioning sample relative to
other studies with other facilities. Likewise, Carpenter and Hittner (1997) did not
assess for previous neurocognitive injuries, premorbid conditions (such as learning
disabilities) or concurrent health conditions which could affect cognitive functioning
such as HIV status. Furthermore, they acknowledged that they did not evaluate Axis
II diagnoses which may have provided additional information (Carpenter & Hittner,
1997).
Likewise, Uekermann, Daum, Schlebusch, Wiebel and Trenckmann (2003)
studied 30 patients suffering from alcoholism, 28 patients with depression but without
alcoholism and 28 healthy controls. After performing an ANOVA, no statistically
significant difference between depressed and alcoholic groups was found for short
term memory (p > 0.27), visual memory (p > 0.13), verbal memory (p > 0.15) and
verbal fluency (p > 0.39; Uekermann et al., 2003). However, the results did show that
patients with primary depression and alcoholism are impaired with respect to
executive functions and memory (Uekermann et al., 2003). The lack of difference
found between depressed and nondepressed alcoholics suggests that the results are
not distorted by the depressive symptoms (Uekermann et al., 2003). The use of the
control group in this study provides interesting information in that we notice that both
alcoholism and depression do indeed have an impact on executive functions vs.
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healthy controls. However, Uekermann et al., (2003) acknowledge that 27% to 69%
of all alcoholics have elevated depression scores and 15% to 28% suffer from major
depression. Therefore, the mood disorders are still important variables to consider.
Others have also reported that mood disorders do appear to have a negative
impact on neuropsychological functioning in clients with a substance use disorder
(Bates et al., 2002; Blume, Davis & Schmaling, 1999; Fals-Stewart & Bates, 2003).
Blume, Davis and Schmaling (1999) studied a sample of 22 psychiatric inpatients all
with a substance abuse or dependence diagnosis and 14 diagnosed with depression, 3
with schizoaffective disorder, 1 with paranoid schizophrenia and 4 with bipolar
disorder (Blume et al., 1999). These authors did find that the full scale IQ scores of
participants were at the low end of normal and that the general memory index of the
Wechsler Memory Scale-Revised was one standard deviation below the mean (Blume
et al., 1999). With these results, the authors stated that dually diagnosed patients
would benefit from a thorough neuropsychological assessment (Blume et al., 1999).
However, there was no distinction made between dually diagnosed and non-dually
diagnosed patients. Therefore, it is unclear if the results of the Blume et al. (1999)
study are attributable to the substance use diagnosis or the co-occurring mental health
disorder. Likewise, the type of the co-occurring disorder is not distinguished.
Therefore, we can not evaluate any possible differences between depression,
schizoaffective, schizophrenia and/or bipolar disorder from the Blume et al. (1999)
study.
Anxiety
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Anxiety, often times along with depression, has been shown to be related to
neuropsychological test performance (Bates et al., 2002; Fals-Stewart & Bates, 2003;
Glenn, Errico, Parsons, King & Nixon, 1993). For example, Glenn, Errico, Parsons,
King & Nixon (1993) reported that neuropsychological test performance was
moderately related to anxiety and depression in alcoholic samples but that these
affective states did not fully explain their performance deficits. In a sample of 83
male and 48 female alcoholics and 47 male and 36 female non alcoholic controls, a
factor analysis revealed three factors including Antisocial Behaviors, Affective
symptoms and Childhood Behavioral Disorders (Glenn et al., 1993). In regards to
these factors, alcoholics and controls were clearly differentiated with no major
difference between genders (multivariate main effect for group, alcoholic > controls,
F(3, 184) = 44.01, p < 0.0001; Glenn et al., 1993). A multivariate analysis was then
conducted using five neuropsychological factors as dependent variables and group,
group times gender, and gender as independent variables. The main effect for group
was again significant with alcoholics scoring lower than controls, F (5,193) = 8.40, p
< 0.0001, with no significant group times gender interaction (Glenn et al., 1993). A
significant main effect for gender was also found with females receiving higher
scores than males on three factors, F(5, 193) = 6.42, p < 0.001 (Glenn et al., 1993).
In the Glenn et al (1993) study, the best predictor of neuropsychological performance
was Childhood Behavioral Disorders. . Secondly, the Affective symptoms were
significant predictors of set shifting flexibility and verbal memory (Glenn et al.,
1993). The Antisocial Behaviors were not a significant predictor of
neuropsychological function in alcoholics or controls (Glenn et al., 1993). The sample
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size and use of a control group are definite strengths of the Glenn et al. (1993) study.
Likewise, Glenn et al. (1993) perform multiple statistical comparisons to allow for
evaluation of gender, alcoholic vs. nonalcoholic, multiple personality variables, mood
variables and others. This resulted in a comprehensive evaluation of variables related
to neuropsychological function, substance abuse and dual diagnosis.
Personality Disorders
Personality disorders in general and antisocial personality disorder
specifically, are acknowledged by many to have an impact on neuropsychological
functioning as well as treatment attrition (Fals-Stewart & Lucente, 1994; Kokkevi,
Stefanis, Anastasopoulou & Kostogianni, 1998; Roselli et al., 2001). For example,
Roselli, Ardila, Lubomski, Murray and King (2001) studied a sample of 42 crack
and/or cocaine dependent men and women. A control group of 17 subjects with no
history of substance abuse or any psychiatric or neurological disorder was also used
in the study (Roselli et al., 2001) The Personality Assessment Inventory (PAI) was
given to all to establish an Axis II diagnosis and a neuropsychological test battery was
given to all to establish any neuropsychological deficits (Roselli et al., 2001). A
MANOVA was used to compare the PAI and neuropsychological test scores of the
drug dependent subjects to the controls (Roselli et al., 2001). Statistically significant
differences were found on the PAI between the drug dependent and controls (p >
0.0001) indicating that there is a positive relationship between personality and drug
dependence (Roselli et al., 2001). This is not an indication that personality is
predicting NP function, but rather an indication of the relationship between
personality and drug dependence. Specifically, 88% of the drug dependent subjects

65

obtained an abnormal PAI score (Roselli et al., 2001). Multiple regression analyses
were then conducted, with all participants using the neuropsychological test scores as
the dependent variable and PAI scores as the independent variable (Roselli et al.,
2001). The PAI score associated with drug use (DRG) did predict the score on the
WAIS-R arithmetic subtest (p = 0.01), California Verbal Learning Test (p = 0.007),
Stroop color word test (p = 0.004) and Benton Visual Retention Test (p = 0.017;
Roselli et al., 2001). In addition, the PAI score associated with antisocial personality
(ANT) predicted the Stroop color word test (p = 0.03) but no others (Roselli et al.,
2001). The authors therefore concluded that personality does not predict
neuropsychological performance, but that there is a relationship between personality
and drug dependence (Roselli et al., 2001).
Fals-Stewart and Lucente (1994) administered a battery of
neuropsychological tests including the Category Test, the Tactual Performance test,
Trails B, Block Design and Digit Symbol tests from the Wechsler Adult Intelligence
Scale (WAIS) to 246 residents of a long term residential substance abuse treatment
facility (Fals-Stewart & Lucente, 1994). In addition, personality was evaluated with
the Millon Clinical Multiaxial Inventory (MCMI-II; Fals-Stewart & Lucente, 1994).
Using a cutoff score of T < 40 on the neuropsychological test battery to indicate
dysfunction, 55 (22.4%) of the residents were classified as cognitively impaired. FalsStewart and Lucente (1994) found that patients with cognitive deficits generally
scored higher on the MCMI-II than those without impairment (p < 0.05). Likewise,
Fals-Stewart and Lucente (1994) found that the cognitively intact group stayed in
treatment longer (M = 206.2 days) versus cognitively impaired (M = 132.4 days). The
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authors did conduct further statistical analysis to evaluate the effect of the MCMI-II
scores on the length of stay as well and concluded that personality and neurocognitive
impairment do affect length of stay in substance abusing patients (Fals-Stewart &
Lucente, 1994). However, Fals-Stewart and Lucente (1994) did not use a control
group that had only cognitive impairment and only personality disorders co-occurring
with the substance use disorder. Therefore, we can see that the cognitive impairment
is related to the personality disorder, but we can not be sure if the cognitive
impairment or the personality disorder affected length of treatment.
Schizophrenia
There are relatively few studies published that evaluate the cognitive status of
dually diagnosed people, and even fewer that compare the neurocognitive
characteristics of dually diagnosed to non-substance-abusing patients with
schizophrenia (Herman, 2004). Part of the difficulty is due to the impaired reality
orientation and therefore invalid or unreliable self report data with regards to
substance use and current functioning (National Institute on Drug Abuse, 1997).
However difficult, Herman (2004) studied 46 dually diagnosed (schizophrenia and
substance abuse) and 43 non-substance abusing patients with schizophrenia. The
subjects were given subtests of the WAIS III to assess intellectual and memory
function, and the Stroop, Controlled Oral Word Association (COWAT) and Trails A
& B to assess executive function (Herman, 2004). In addition, quality of life was
evaluated using the World Health Organization Quality of Life measure (Herman,
2004). A stepwise multiple regression was used and showed no statistically
significant difference between the dually diagnosed group and the non substance
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abusing schizophrenic group on the tests of intelligence and memory (Herman, 2004).
However, the dually diagnosed group did perform significantly better on tests of
executive function including the COWAT (p < 0.01), Trails A (p < 0.00025), Trails B
(p < 0.01) and Stroop (p < 0.05; Herman, 2004). Therefore, Herman’s study (2004)
failed to show that dually diagnosed patients will have greater neurocognitive deficit
than non-abusing patients with schizophrenia.
Herman’s study (2004) could have been even more interesting had he used a
third group of only substance abusing patients to give the reader another comparison.
Similar results to Herman’s (2004) have been found by other researchers as well (see
Cleghorn, Kaplan, Szechtman , Szechtman , Brown, Franco, 1991; Nixon, Hallford,
Tivis, 1996) However, opposite results have also been found. For example, Sevy,
Kay, Opler and van Praag (1990) divided 51 schizophrenic inpatients into two groups
including those with a cocaine use history and those without. Sevy et al. (1990) found
that the dually diagnosed patients were found to be more depressed, less socialized,
and performed worse on conceptual encoding and verbal memory (Sevy, Kay, Opler
& van Praag, 1990).
In general, schizophrenic patients are found to have deficits in cognitive
functions such as information processing and abstract planning (U.S. Department of
Health and Human Services, 1999). Likewise, they are reported to have executive
function deficits in areas including planning and regulating, goal directed behavior,
cognitive flexibility and attention (U.S. Department of Health and Human Services,
1999). More specifically, some believe that schizophrenia is a disorder of the
prefrontal lobe which would therefore have an impact upon executive function
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(Rains, Sauer & Kant, retrieved September 18, 2005; US Department of Health and
Human Services, 1999). Given this information, we will need to be cautious in
evaluating any participant who has been diagnosed with schizophrenia due to the
intervening impact the schizophrenia could have on the neuropsychological test
results.
Summary
Overall, research has suggested the use of caution when evaluating
neuropsychological functioning in substance dependent patients. Evidence suggests
that disorders such as depression, anxiety, personality disorders and schizophrenia
can co-occur with a substance dependence diagnosis and are also possibly related to
neuropsychological functioning (Blume et al., 1999; Kokkevi et al., 1998; Roselli et
al., 2001; Uekermann et al., 1997; U.S. Department of Health and Human Services,
1999). Finally, these co-occurring disorders may also have an impact on treatment
attrition and retention (Fals-Stewart & Lucente, 1994).

Neuropsychological Functioning and Attrition
Of all areas of literature that were researched for this study, the reports on the
relationship of neuropsychological functioning and attrition was the sparsest. As the
field of neuropsychology is still somewhat new and growing, it seems timely for
increased research related to neuropsychology and the impact on attrition rates. More
specifically, there has been advancing technology in the field of neuropsychology and
a lack of information available on the impact neuropsychological functioning has on
attrition.
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Search terms used included “neuropsychology, neuropsychological
functioning and dysfunction, neurocognitive function, executive function, executive
dysfunction, cognitive functioning, cognitive deficits, frontal lobe, frontal lobe
impairment, brain, brain impairment, dysexecutive syndrome, dropout rates, attrition,
mortality, treatment retention, treatment completion, treatment attendance, treatment
outcome, outpatient, substance abuse services, recovery, rehabilitation” and multiple
combinations of all of these. I utilized Marquette University’s search engines,
assistance from Marquette Library staff, a paid literature search by the Medical
College of Wisconsin and all internet offerings such as Google. In addition, I
obtained suggestions and direction from practicing neuropsychologists and
researchers including Dr. Gina Rehkemper of Waukesha Memorial Hospital’s
Neuropsychology Center, Dr. Terry Young of New Life Resources, Dr. Todd
Campbell of Marquette University, Dr. Swartzwelder of Duke University Medical
Center, Dr. Steve Holliday-Chief of Psychological Services at South Texas Veterans
Hospital, Dr. Joe Bleiberg of the National Rehabilitation Hospital in Washington,
DC, and Dr. Lisa Drozdick, a neuropsychology researcher at Psych Corp. Through all
of these efforts, the findings that actually related to neuropsychological functioning
and attrition in outpatient treatment were limited. Over 150 publications were
evaluated and only one (thus far) has specifically reviewed neuropsychological
functioning and attrition rates in substance use treatment. Fals-Stewart and Lucente
(1994) studied neuropsychological impairment along with personality variables and
attrition as described in the previous section on neuropsychological function and dual
diagnosis (Fals-Stewart & Lucente, 1994). However, even this one publication by
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Fals-Stewart and Lucente was not purely addressing neuropsychological impairment
with attrition. Therefore, I will present a brief overview of my current findings and
will continue to research these issues as I pursue this project.
Researchers studying executive functions and attrition have suggested that
executive function deficits might contribute to rates of attrition (Ihara, Berrios &
London, 2000). Seventeen adults with chronic alcoholism, without amnesia, were
given a battery of neuropsychological tests to assess executive function (Ihara et al.,
2000). The results of the Ihara et al. (2000) study showed that the participants
displayed mild but significant dysexecutive syndrome (DES; meaning a syndrome of
impaired executive functioning) even in the presence of unimpaired intelligence and
memory. The results of the Ihara et al (2000) study suggest that alcoholic patients
have difficulty when demonstrating abstract analysis, critical judgment and flexibility
of thought processes. Therefore, the alcoholic patient’s ability to respond and
participate effectively in conventional substance abuse programs may be limited
(Ihara et al., 2000). However, Ihara et al. (2000) did not formally evaluate attrition, it
is only suggested that the impairment would likely affect engagement and success in
treatment. The suggestion of possible impact on attrition versus the actual evaluation
of impact is common in many studies but not empirically investigated (Fals-Stewart
& Bates, 2003; Moselhy et al., 2001; Sullivan et al., 2002). Bates, Bowden and Barry
(2002) stated that “neurocognitive impairment interferes with the process of
alcoholism treatment and is hypothesized to affect outcome as well” (Bates et al.,
2002, p. 193). The authors go on to discuss that clients with executive function
deficits may have trouble getting to appointments, fail to complete assignments,
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behave impulsively and have trouble regulating affect (Bates et al., 2002). Likewise,
others have shown that patients with neurocognitive deficits (including spatial ability,
mental flexibility, concept formation and nonverbal problem solving) in conjunction
with personality disorders stayed in a substance abuse program a shorter amount of
time (Fals-Stewart & Lucente, 1994).
Fals-Stewart and Lucente (1994) administered a battery of
neuropsychological tests including the Category Test, the Tactual Performance test,
Trails B, Block Design and Digit Symbol tests from the Wechsler Adult Intelligence
Scale (WAIS) to 246 patients admitted to a long term residential substance abuse
treatment facility. In addition, personality was evaluated with the Millon Clinical
Multiaxial Inventory (MCMI-II). The neuropsychological tests and the MCMI-II
were not administered until 30 days after admission to ensure that residual effects
from the substance abuse would not adversely affect performance (Fals-Stewart &
Lucente, 1994). Patients who were admitted and stayed less than a month were not
included in the study (Fals-Stewart & Lucente, 1994). There is no way of knowing if
neuropsychological impairment affected the early drop out of those who did not stay
past 30 days. Fals-Stewart and Lucente (1994) found that patients with cognitive
deficits have different personality characteristics, as measured by the MCMI-II, and
both of these factors influenced the length of stay. Specifically, the cognitively intact
group stayed in residential treatment longer (M = 206.2 days and SD = 30.5) than
impaired residents (M = 132.4 days and SD = 39.6) which was found to be a
significant difference in length of stay, F(1,242) = 6.83, p < .01 (Fals-Stewart &
Lucente, 1994). However, the cognitively impaired group was significantly older (M
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= 31 years and SD = 6.6) than the cognitively intact group (M = 26.3 years and SD =
5.1), t(246) = 2.39, p < .01 (Fals-Stewart & Lucente, 1994). The patients in the
impaired group also had longer substance abuse histories (M = 134.8 months and SD
= 67.3) than the intact patients (M = 99.6 months and SD = 55.6), t(246) = 2.41, p <
.01. Finally, using Wilk’s criterion, the impaired and intact group had profiles on the
MCMI-II that were statistically significantly different, F(19,226) = 2.10, p < .01
(Fals-Stewart & Lucente, 1994). The impaired residents generally scored higher on
the MCMI-II subscales than those without impairment, F(1,242) = 5.01, p < .05
(Fals-Stewart & Lucente, 1994). Fals-Stewart and Lucente (1994) controlled for age,
length of drug use and MCMI-II scale scores through statistical means to conclude
that the cognitive deficits indeed affected the length of treatment. However, one
cannot be completely confident that variables are actually ‘controlled for’ without
affecting other variables (Loftin & Madison, 1991; Thompson, 1992). Therefore, it is
not clear if the neurocognitive deficits, the personality disorders, length of substance
use or the combination are responsible for the impact on attrition in this study. In
addition, Fals-Stewart and Lucente (1994) also acknowledge weaknesses in their
study as the neuropsychological battery they chose was used only for screening and
not to identify client strengths and weaknesses.
Multiple studies were reviewed evaluating neuropsychological functioning
and substance abuse treatment and outcomes by Knight and Longmore (1994). The
authors reviewed findings related to length of abstinence, compliance and relapse
rates (Knight & Longmore, 1994). Similarly, cognitive function was compared to
amount and length of alcohol usage. Many important factors to consider when
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treating a patient with neuropsychological impairment are considered including
methods of education, staff response and specific testing techniques (Knight and
Longmore, 1994). For example, with specific neuropsychological tests, a patient’s
strengths and weaknesses can be assessed. Clinicians can be trained on identification
of deficits and more effective treatment options including repetition, concrete
examples and assisting the client with planning and organizing (Knight & Longmore,
1994). However, the specific relationship between level of neuropsychological
impairment and attrition are not formally defined in this publication.
Other authors evaluated executive dysfunction and compared this to
functional outcomes including resumption of drinking and occupational status
(Moriyama et al., 2002). Moriyama et al. (2002) administered twelve
neuropsychological tests to 22 chronic, male alcoholics. These authors found that six
of the subtests of the Behavioral Assessment of Dysexecutive Syndrome (BADS) did
predict an alcohol-nonspecific outcome (occupation) but not an alcohol-specific
outcome (drinking; Moriyama et al., 2002). Other neuropsychological tests used did
not predict either of the two outcomes (Moriyama et al., 2002). One reason given for
the different performance of the neuropsychological tests was that the discriminative
power of the BADS versus the other tests was due to its multicomponent impairment
indices (Moriyama et al., 2002). However, once again, the relationship between
neuropsychological impairment and length of treatment involvement was not
evaluated.
In a more recent study, Zinn, Stein and Swartzwelder (2004) examined
neuropsychological functioning in older, male alcoholics. The participants were 27

74

male, alcohol dependent veterans receiving treatment at the Durham Veterans Affairs
Medical Center. All participants met diagnostic criteria for alcohol dependence
according to the DSM-IV and were abstinent six weeks or less (Zinn et al., 2004).
Control participants (n = 18) were recruited from the Primary Care Clinic of the
Durham Veterans Affairs Medical Center (Zinn et al., 2004). The alcohol dependent
and control group were not significantly different in age or education. However, the
alcohol dependent group had a higher proportion of African Americans (Zinn et al.,
2004). All participants were administered a fixed-order neuropsychological battery of
seven tests including the COWAT (verbal fluency), Ruff Figural Fluency Test (nonverbal fluency), ASI, Rey Osterrieth Complex Figure Test (nonverbal memory),
Hopkins Verbal Learning Test (verbal memory), two subtests of the WAIS-II for
abstract reasoning (similarities and matrix reasoning) and Trails Making Test (Trails
A for psychomotor speed and Trails B for cognitive flexibility; Zinn et al., 2004).
Zinn et al. (2004) found several deficits in executive functioning in treatment seeking,
recently abstinent patients. These deficits included reasoning (similarities, p = .05 and
matrix reasoning, p = .04), nonverbal fluency (p = .002), performance of timed
complex tasks (Trails A, p = .01 and Trails B, p = .003) and discriminative memory
(Rey Osterrieth delayed recall, p = .03; Zinn et al., 2004).
Strengths of this study by Zinn et al. (2004) include the use of a control group
of similar age to control for the relationship between age and executive function
decline and the fact that the authors tested premorbid functioning with an estimated
performance IQ. However, the difference in racial characteristics of the alcohol
dependent versus control group is mentioned but not addressed which may have
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provided interesting information or differences in results. In addition, Zinn et al.
(2004) chose to include individuals with a history of non-severe head injuries (33% of
controls and 52% of substance abuse patients) to reflect this reality in the greater
population of individuals with a substance abuse issue. However, it is unclear what
Zinn et al. (2004) considered ‘non-severe’ or how the results of the study can be
linked to substance use versus the head injury. Finally, the authors acknowledged that
neuropsychological impairment may affect attrition and treatment success but they do
not formally evaluate retention and/or attrition (Zinn et al., 2004). I also had the
pleasure of personal communication with Dr. Swartzwelder (of the Zinn, Stein &
Swartzwelder, 2004) who acknowledged that he did not specifically know of any
research that reviewed neuropsychological functioning and attrition rates (Personal
communication, 10-5-2004). However, Dr. Swartzwelder did suggest other
publications that were reviewed within this paper. Likewise, studies were found
which evaluated length and/or amount of alcohol consumed and severity of
neuropsychological deficits, but again the relationship between severity of the deficit
and attrition was not evaluated, only speculated (Beatty et al., 2000; Munro, Saxton &
Butters, 2000).
Part of the difficulty in evaluating or addressing neuropsychological function
and attrition rates in outpatient might be the treatment provider’s lack of insight or
knowledge. Fals-Stewart (1997) evaluated counselor’s ability to detect
neuropsychological impairment among patients. The author found the counselor’s
ability to detect impairment was poor (Fals Stewart, 1997). Fals-Stewart (1997) offers
several suggestions for improvement including use of specific neuropsychological

76

evaluation tools upon entry into treatment, emphasizing the importance of
incorporating the patient’s neuropsychological status into treatment planning,
development of referral guidelines for neuropsychological testing, supervision by a
trained neuropsychologist and development of more valid and reliable methods of
identifying patients at risk for deficits. Likewise, the author mentioned that this is an
important variable with treatment planning and success, but again does not formally
evaluate the link between neuropsychological deficit and attrition (Fals-Stewart,
1997).
Others also agree that the neurocognitive deficits often go unrecognized in
people with a substance use disorder when they seek treatment (Bates et al., 2002).
What the clinician identifies as lack of motivation, apathy or noncompliance may all
be a result of a neurocognitive deficit. Similarly, few treatment programs for
substance use disorders consider the role of neurocognitive impairment (Bates et al.,
2002) again supporting the stigma often associated with a person with a substance use
disorder. The counselor’s lack of success or lack of attempt at identifying
neuropsychological deficits, as well as the resulting misperceptions by the clinician
again provides reasoning for this current study.
Overall, there is support for the negative impact substance abuse has on
neuropsychological functioning (Bates et al., 2002; Fals-Stewart & Lucente, 1997;
Zinn et al., 2004). Likewise, there is support for the negative impact
neuropsychological deficits have on treatment outcome variables such as relapse rates
or occupational stability (Knight & Longmore, 1994; Moriyama et al., 2002).
However, the issue of the specific relationship between level of neuropsychological
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impairment and attrition rates is still left mostly unanswered. This missing link is
what I will address with this study.
Attrition and Retention
Duration of treatment is one of the best predictors of outcome for substance
abuse treatment populations (Corrigan et al., 2005). In the United States during the
1970s, the Drug Abuse Reporting Program (DARP) began collecting substance abuse
data, followed by Treatment Outcome Prospective Studies (TOPS) that began
collecting data from 1979-1981. To follow, from 1991-1993 the Drug Abuse
Treatment Outcome Studies (DATOS) collected data in 11 cities, from 96 programs,
over 10,000 patients from all treatment types. Together, DARP, TOPS and DATOS
collected information from over 65,000 admissions and 272 programs. One of the
major themes that resulted from these studies is that longer stays are consistently
associated with better outcomes (Franey & Ashton, 2002; DATOS, 2001). For
example, one year after treatment, 80% to 90% of long-stay (at least three months)
clients who had been using heroin or cocaine weekly prior to treatment were no
longer doing so (Franey & Ashton, 2002; DATOS, 2001). However, for clients who
left earlier, the figure was 50% to 60%. Franey and Ashton (2002) reported that there
is “nothing magical” about the retention periods they chose-longer stays were
associated with better outcomes. However, very short stays can also be followed by
great improvements (Franey & Ashton, 2002).
Though the relationship between treatment retention and outcome seems clear,
there were differences between individual programs that DATOS (2001) studied.
Although median lengths of stay were three months in long-term residential (LTR)
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and outpatient drug-free treatments (ODF) and one year for clients in outpatient
methadone treatment (OMT), there was variation between individual treatment
providers. Though specific neuropsychological deficits are not reported, programs
treating individuals with more psychological dysfunction usually had shorter
retention rates (Simpson et al., 1997). Broome, Flynn and Simpson (1999) examined
the psychiatric comorbidity as a predictor of treatment retention using the DATOS
data. The psychiatric indicators included lifetime DSM-III-R diagnoses of
depression/anxiety and antisocial personality (Broome et al., 1999). Dimensional
measures of current symptoms of depression and hostility were also collected. The
data collection included structured interviews with clients, a survey of treatment
program administrators and program discharge records (Broome et al., 1999).
Broome et al. (1999) found that the dimensional measure of current psychiatric
symptoms emerged as better predictors of retention than the DSM-III-R diagnoses. In
addition, on site mental health services in LTR were associated with better retention
for clients with symptoms of hostility (Broome et al., 1999).
So what did DATOS identify as influencing retention? Interestingly enough,
whether the client was black or white, male or female, age and drug use profile all
made little difference according to Franey and Ashton (2002). What they did find was
that more qualitative dimensions related to commitment and motivation were
important for retention (Franey & Ashton, 2002). However, motivation is not a given
in this sense. It arises from the therapeutic relationship between counselor and client
(Franey & Ashton, 2002). In contrast, using logistic regression analysis, Simpson, Joe
and Rowan-Szal (1997) found that 35 different patient attributes were associated with
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increases in the likelihood of having favorable improved retention. Simpson, Joe and
Rowan-Szal (1997) suggested that more comprehensive models of patient attributes,
therapeutic processes and environmental influences are needed. Possibly, the patient
attributes that need more comprehensive evaluation are neuropsychological strengths
and weaknesses. With the DATOS studies, we do not know of the specific training
and techniques of individual therapists. Could it be that the clinicians who were more
successful at promoting the therapeutic relationship were also more sensitive to the
strengths and weaknesses of the client, possibly related to neuropsychological deficit?
Though DATOS, TOPS and DARP did not discuss the neuropsychological
functioning of individuals and treatment retention, the studies did emphasize that the
“key thing is remaining in treatment” (Franey & Ashton, 2002, p. 6). In this study, we
evaluate the impact neuropsychological functioning has on attrition to hopefully
discover additional variables that may assist individuals in staying in treatment.

Relapse
Substance abuse treatment is plagued by high relapse rates following
substance abuse treatment (Walton, 2001). In addition, multiple researchers have
evaluated the relationship between neuropsychological functioning and relapse in
substance use treatment (Miller, 1991; Society for Neuroscience, 2005; Tapert,
Ozyurt, Meyers & Brown, 2004). In the following section, multiple variables related
to relapse, including neuropsychological functioning will be reviewed.
Method and Intensity of Treatment, Drug Type and Relapse
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In the literature reviewed, relapse rates tended to be reported in conjunction
with treatment type or type of drug use. For example, DATOS reported that in the
year after completing at least three months of treatment (residential or nonresidential), 80-90% of weekly heroin or cocaine addicts were abstinent (Franey &
Ashton, 2002). For the clients who left treatment earlier than three months, relapse
rates increase with the number abstinent dropping to 50-60% (Franey & Ashton,
2002). With primary cocaine users, only 15% relapsed to weekly cocaine use after at
least three months of residential treatment (Franey & Ashton, 2002). Similar findings
have been found with other substances. For example, the greatest levels of abstinence
from opioids at one year post treatment were associated with 28 day inpatient versus
shorter treatments (United Nations, 2002). Likewise, patients who stay for at least one
year in outpatient methadone programs have better abstinence rates (specific numbers
not reported) than those that leave earlier (United Nations, 2002). In general, it
appears that more treatment and more intense levels of treatment lead to greater
lengths of abstinence (Franey & Ashton, 2002; United Nations, 2002).
Gender, Support, Pharmacotherapy and Relapse
Just as relapse is related to length and intensity of treatment, relapse is also
related to other variables including gender, support and pharmacotherapy (Stocker,
retrieved September 20, 2005; United Nations, 2002; World Health Organization,
2004). For example, women have been reported to relapse less frequently than men
(Stocker, retrieved September 20, 2005). In a study of 182 women and 148 men in 26
public outpatient drug abuse treatment programs, only 22% of the women versus 32
% of the men relapsed in six months (Stocker, retrieved September 20, 2005). Some
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of the possible reasons explored included the intensity of the women’s drug use prior
to treatment and social support differences (Stocker, retrieved September 20, 2005).
However, when evaluated, the variable that was found to explain the difference in
relapse rates between women and men was women’s willingness to engage in
treatment, particularly group treatment (Stocker, retrieved September 20, 2005).
Though not found to be a determinant of relapse in Stocker’s report (retrieved
September 20, 2005), others have identified social support as an important variable
related to relapse in substance use treatment (United Nations, 2002). According to a
report by the United Nations on a review of evidenced based treatment, social support
such as Alcoholics Anonymous meetings and the level of stressful life events such as
loss of a job might be more powerful in determining relapse than the type of
treatment (United Nations, 2002). Likewise, the United Nations study identifies
treatment retention as an important variable in relapse prevention (United Nations,
2002). Specifically, the United Nations study reported that the longer patients are
retained in treatment, the more likely lifestyle improvements such as abstinence will
be achieved (United Nations, 2002). The United Nations study also reported on the
relationship of pharmacotherapy, retention and relapse prevention (United Nations,
2002). Specifically, the use of methadone, buprenorphine, levoalphacetylmethadol,
naltrexone and acamprosate were all found to improve retention and rates of relapse
(United Nations, 2002; World Health Organization, 2004). However, compliance
with patients using the medications as prescribed is paramount to the success of the
medication (United Nations, 2002).
Neuropsychological Functioning and Relapse
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Another area researchers review with relation to relapse in outpatient
substance abuse treatment is the impact of neuropsychological functioning on rates of
relapse (Miller, 1991; Society for Neuroscience, 2005; Tapert et al., 2004; World
Health Organization, 2004). For example, specific areas of the forebrain have been
shown through imaging techniques to be activated by stimuli that induce cravings in
substance dependent people which could induce a relapse (World Health
organization, 2004). Specifically, the nucleus accumbens area of the forebrain has
been shown to be related to intense cravings in substance dependent individuals
(Leshner, retrieved September 20, 2005; Society for Neuroscience, 2005). Many
neurotransmitters, which are chemical messengers in the brain, have also been studied
with relevance to cravings and relapse (Leshner, retrieved September 20, 2005).
Specifically, dopamine, serotonin, norepinephrine, glutamate, endogenous opioids
and GABA are all neurotransmitters that can affect cravings and relapse (Leshner,
retrieved September 20, 2005; World Health Organization, 2004). Chronic substance
use can affect the way the neurotransmitters function and the individual’s response to
the neurotransmitters which then can impact cravings, mood, sleep, sensitivity to
pain, aggression and memory (Leshner, retrieved September 20, 2005) which all can
impact decision making in recovery.
In a review of the literature, Miller (1991) evaluates neuropsychological and
cognitive variables with regard to predicting relapse in substance abusers (Miller,
1991). Miller finds that neuropsychological studies of substance abuse treatment
outcomes have generally found intact functioning on most measures for successful
recoverers whereas relapsers did more poorly on tests of language, abstract reasoning,
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planning and cognitive flexibility which are related to the left hemisphere and frontal
lobe (Miller, 1991). In addition, personality characteristics of successful recoverers
(with or without treatment) include future goal orientation, frustration tolerance and
self efficacy, whereas the relapsers were characterized by impulsivity, antisocial
personality and affective traits (Miller, 1991). Through Miller’s (1991) review of
multiple studies, he concluded that neuropsychodynamic trait of ego autonomy,
which includes a reflective, nonimpulsive, goal directed cognitive style, is what is
described in successful recoverers. Miller (1991) reported that many researchers
focus on programs and treatment techniques which neglect the individual variables
which he reports are related to predicting relapse. Miller (1991) admitted his review
was not a meta-analysis, but instead a review of what he believed to be substantive
issues related to substance abuse outcome. As his review is a selected group of
studies, the results could be biased based on the studies he chose to review and
include. Miller (1991) concluded with a discussion of individualized treatment
options which may be helpful for this study if we find neuropsychological functioning
to be related to attrition and relapse.
In addition to Miller’s (1991) identified neuropsychodynamic trait of ego
autonomy, another individual characteristic reported to be related to neurocognitive
ability and relapse in substance abuse treatment is coping style (Tapert et al., 2004).
In a study of 43 alcohol dependent male adults, individuals with low levels of coping
in role plays of drinking situations consumed more alcohol in six months following
treatment than did individuals with high levels of coping (Tapert et al., 2004). The
participants were given a neuropsychological battery (including the Halstead-Reitan
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Trails A and B, WAIS-R vocabulary and digit symbol subtest, and the Visual Search
Test) and the Ways of Coping Questionnaire (WOC; Tapert et al., 2004). The results
of this study support a model in which neurocognitive abilities moderated the
relationship between coping and substance use treatment outcome (Tapert et al.,
2004). Specifically, ten coping factors and five neurocognitive scores were evaluated
in hierarchical linear regression with age, years of education and preadmission drinks.
With alpha set at .001, the results indicated that maladaptive coping in potential
relapse risk situations predict subsequent drinking, particularly for patients with
better scores on neuropsychological tests (Tapert et al., 2004). Therefore, poor coping
was particularly detrimental for those with good cognitive skills. It is unclear from
this study if Tapert et al. (2004) is stating that coping skills do not matter if
neurocognitive deficits exist, or that they do not matter as much. In addition, another
limitation of Tapert et al’s (2004) study is that the sample size is small and the
authors seem to be drawing many conclusions off the information gathered. For
example, the coping style evaluated seems to be a self report measure which could be
affected due to changes in responses from cognitively impaired versus not impaired
individuals. Likewise, Tapert et al. (2004) did not discuss any comparison between
coping styles of the impaired and unimpaired which would have been valuable in
assessing this study. However, the issue of coping style as a variable in potential
relapse of people with and without neurocognitive deficits is still an important issue.
Tapert et al. (2004) concluded with suggestions for treatment matching that could
prove valuable for recommendations following this study of the relationship between
neuropsychological function and attrition.
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Summary
In summary, many variables have been related to relapse in substance abuse
treatment. Some of the variables identified include type of drug use (United Nations,
2002), gender (Stocker, retrieved September 20, 2005), support systems (United
Nations, 2002), certain medications (United Nations, 2002; World Health
Organization, 2004), length and intensity of treatment (Franey & Ashton, 2002;
United Nations, 2002) and neuropsychological impairment (Miller, 1991).
Addressing an individual’s neuropsychological impairment might improve treatment
retention resulting in reduced incidence of relapse. This study hopes to identify the
relationship between neuropsychological impairment and relapse and attrition rates
resulting in suggestions for improving retention in outpatient substance use treatment.
Homelessness
As previously mentioned, the majority of data for this study was collected on
homeless male residents of the Guesthouse of Milwaukee, Inc. The assessments were
performed on individuals receiving treatment at the 7C’s Community Counseling
Clinic which is located within the Guesthouse and therefore serves primarily
homeless men. The occurrence of individuals becoming homeless at some point in
their life has been related to substance use issues, neuropsychological deficits, mental
illness, socioeconomic status and other variables (Booth, Sullivan, Koegel & Burnam,
2002; National Coalition for the Homeless, retrieved January 12, 2006). Therefore,
for the purposes of this study, the relationship of homelessness with substance use
issues, neuropsychological functioning and attrition in substance dependence
treatment will be reviewed.
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Defining and Identifying Homeless Individuals
In order to study homelessness, one must be able to define what actually
constitutes homelessness. This is no easy task as the status of homelessness is
oftentimes a temporary condition instead of a permanent condition (National
Coalition for the Homeless, retrieved January 12, 2006). Likewise, many homeless
individuals are invisible to the researchers due to staying in a car, park or other places
researchers cannot effectively search (National Coalition for the Homeless, retrieved
January 12, 2006). Furthermore, the definition itself leads to controversy for
individuals and organizations due to legal issues, funding and allocation of available
resources (Clark & Rich, 2003; National Coalition for the Homeless, retrieved
January 12, 2006; U.S. Department of Health and Human Services, retrieved January
12, 2006). Overall, many individuals have an interest in defining and redefining
homelessness from a variety of perspectives to meet individual and organizational
needs. Therefore, when reviewing the literature on homelessness, it is important to
remain cognizant of the difficulties in defining homelessness.
Though controversy has existed on the definition of what exactly constitutes
homelessness, researchers have still collected information on the occurrence of
homelessness. For example, in a report by the Institute for the Study of Homelessness
and Poverty at the Weingart Center (2005), the numbers of homeless people for 56
cities across the United States were published (Institute for the Study of
Homelessness and Poverty, retrieved January 12, 2006). Included in the results of the
Weingart study (2005) were statistics for Milwaukee, Wisconsin which is where the
data was collected for this study. In 2005, the regional population in Milwaukee was
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583,624 according to the Weingart study (Institute for the Study of Homelessness and
Poverty, retrieved January 12, 2006). The homeless population in Milwaukee was
reported as 2,818 which was 0.5% of the population (Institute for the Study of
Homelessness and Poverty, retrieved January 12, 2006). The results from all of the
cities listed included a homeless population across the cities ranging from less than
0.1% to 1.2% (many cities had <0.1%, Orange County, Arizona had 1.2%; Institute
for the Study of Homelessness and Poverty, retrieved January 12, 2006). Likewise, in
2007, the Milwaukee Continuum of Care estimated that there are 1,470 homeless
adults and children on a given day (Milwaukee Continuum of Care, 2007). The total
reported homeless for the state of Wisconsin in 2007 was 5,648 and for the United
States as a whole was 671,859 (National Alliance to End Homelessness, retrieved
May 25, 2009).
Many reasons are reported for why so many people have episodic or chronic
homelessness including poverty, availability of affordable housing, availability of
health care, domestic violence, weak social support, mental illness and addiction
disorders (National Coalition for the Homeless, 2005; SAMHSA, 2005). Though all
of these issues are important and influential, for the purpose of this study, we are
interested in those related to addiction and mental health.
Substance Use and the Homeless
The rates of alcohol and drug abuse are disproportionately high among the
homeless population (National Coalition for the Homeless, 2005; SAMHSA, 2005).
According to Glasser and Bridgman (1999) alcohol abuse has been found to be as
high as 68% among homeless men and 30% among homeless women (Glasser &

88

Bridgman, 1999). Likewise, in a study by Solliday-McRoy et al., (2004) 93% of the
90 homeless men studied reported having a substance abuse or dependence problem
(Solliday-McRoy et al., 2004). Likewise, in a study by Clark and Rich (2003) of 172
adults (79 male, 73 female) that either were homeless or at immediate risk of
becoming homeless, approximately half had a diagnosis of a substance use disorder.
Even higher numbers are reported by Jainchill, Hawke and Yagelka (2000) who
reported that an estimated two-thirds of the homeless are alcohol abusers and half
abuse other drugs. In addition, Jainchill, Hawke and Yagelka (2000) reported that
among those in shelters, almost 90% are estimated to have alcohol problems and over
60% have problems with other drugs. The extent of the relationship between
homelessness and substance use disorders has also been recorded by treatment
facilities. In a report from the Drug and Alcohol Services Information System (2003),
more than 120,000 admissions to substance abuse treatment facilities were homeless
at the time of admission (SAMHSA, retrieved January 12, 2006). It should be
clarified that this number (120,000 admissions) represents admissions and not
necessarily separate homeless individuals as an individual may have been admitted on
more than one occasion.

Mental Illness and the Homeless
Although some have identified substance abuse as the primary individual
factor related to homelessness (Jainchill et al., 2000), mental illness is also frequently
reported among homeless individuals (Booth et al., 2002; National Coalition for the
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Homeless, retrieved January 12, 2006; SAMHSA, 2005). According to the National
Coalition for the Homeless in a report dated July of 2005, 20-25% of the single adult
homeless population suffers from some form of severe and persistent mental illness
(National Coalition for the Homeless, 2005). Likewise, in a study of 438 individuals
referred to receive acute psychiatric care in a hospital between 1990 and 1992, 24%
were found to be homeless (Kuno, Rothbard, Averyt & Culhane, 2000). However,
Kuno et al. (2000) defined homelessness as anyone who had an admission to a shelter
between 1990 and 1993, they were not necessarily homeless at the time of admission
to the hospital. In Solliday-McRoy et al. (2004) study of 90 homeless men, 50%
reported previous mental health diagnoses with the majority (28%) for mood
disorders. It is important to note that these reports of mental health issues were self
reported by the participants and not specifically investigated by Solliday-McRoy et al
(2004).
Neuropsychological Functioning and the Homeless
Though the mental health diagnosis was not specifically investigated by
Solliday-McRoy et al. (2004), the neuropsychological functioning of homeless men
was assessed. A neuropsychological battery consisting of the Neurobehavioral
Cognitive Status Examination, Wechsler Abbreviated Scale of Intelligence, Digit
Span Subtest of the WAIS, Rey Auditory Verbal Learning Test (RAVLT), Rey
Osterrieth Complex Figure Test (RCFT) and the Letter-Word Identification and
Passage Comprehension subtests for the Woodcock Johnson Psychoeducational
Battery Revised was given to 90 homeless men living in the Guesthouse shelter,
which is the same shelter where I collected the data for this study (Solliday-McRoy et
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al., 2004). Impaired cognitive functioning as demonstrated by performance on the
Cognistat was found in 80% of the participants with the subtest assessing memory
showing the most frequent (64%) impairment (Solliday-McRoy et al., 2004). In
addition, the participants scored below average on general intellectual abilities on the
WASI with mean Verbal IQ score of 83.73 (SD 16.03), mean Performance IQ of
87.07 (SD 14.87) and mean Full Scale IQ of 83.92 (SD 15.24; Solliday-McRoy et al.,
2004). Nearly half of the sample received scores that fell below 85 on the WASI
indicating impaired capacities in a broad range of cognitive abilities (Solliday-McRoy
et al., 2004). Likewise, 28% received scores of less than 85 on the digit span subtest
suggesting attentional deficits and results from the RAVLT suggested memory and
verbal learning deficits in more than half the sample (Solliday-McRoy et al., 2004).
Deficits in processing speeds, visuomotor, visual-perceptual integration skills and
visuospatial memory were indicated for nearly three quarters of the sample from
RCFT results (Solliday-McRoy et al., 2004).
There are many strengths to the Solliday-McRoy et al. (2004) study including
the voluntary participation of individuals, the comprehensive instruments used,
sample size and the use of statistical procedures to attempt to evaluate the impact and
relationship of TBI, substance use and mental illness. In addition, the authors reported
that all participants were asked to abstain from any alcohol or drug use for 8 hours
prior to testing so as to not interfere with the performance during assessment
(Solliday-McRoy et al., 2004). However, it is unclear whether participants were
tested for any alcohol or drugs in their system at time of assessment. In addition, it is
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unclear why Solliday-McRoy et al. (2004) used an 8 hour gap versus a longer period
to allow participants to recover somewhat from any and all substance use.
Results similar to Solliday-McRoy et al. (2004) were found by Gonzalez,
Dieter, Natale and Tanner (2001). Gonzalez et al. (2001) also concluded that large
numbers of homeless individuals are neuropsychologically impaired. Sixty homeless
individuals were given the Abbreviated Halstead-Reitan Battery and the Mini Mental
Status Exam (MMSE; Gonzalez et al., 2001). A high incidence of neuropsychological
dysfunction was concluded with 80% of participants showing impairment on the
Abbreviated Halstead-Reitan and 35% showing impairment on the MMSE (Gonzalez
et al., 2001). One strength of this study was the authors’ use of a regression analysis
to suggest that 29% of the variance in the two instruments used was accounted for by
patient education (Gonzalez et al., 2001). Overall, Gonzalez et al. (2001) concluded
that as large numbers of the homeless are neuropsychologically impaired, this should
be considered for treatment planning.
Other authors have found very similar results to Gonzalez et al. (2001). In a
study of 155 homeless men and 49 homeless women, Buhrich, Hodder and Teesson
(2000) also found cognitive impairment using the MMSE. Buhrich et al. (2000) used
the Composite International Diagnostic Interview, which included an alcohol use
disorder section and the MMSE to assess the 204 participants. Of the 204
participants, 20 (10%) were found to be cognitively impaired as compared to a
reported 1.7% that are impaired in the general adult population (Buhrich et al., 2000).
It is unclear if Buhrich et al. (2000) assessed for current health concerns, head injuries
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or current alcohol or drug consumption which could have affected participant’s
performance on the assessment instruments.
Attrition Rates for Homeless Individuals Receiving Substance Use Services
As previously discussed, many issues influence an individual’s homeless
status and can be influenced by the homeless status of an individual such as poverty,
mental illness, substance use and abuse, health status, access to health care,
transportation, support and neuropsychological deficits (National Coalition for the
Homeless, 2005; National Mental Health Association, retrieved January 12, 2006).
Another variable with an interactive relationship with homelessness, which has been
previously reviewed in this paper, is stigma (NSDUH, 2004). Individuals in need of
treatment for a substance use disorder that are also homeless face the added stigma of
their homeless status (National Mental Health Association, retrieved January 12,
2006). It can be due to any or all of these issues that a homeless individual’s ability to
complete treatment for a substance use disorder can be compromised (National
Mental Health Association, retrieved January 12, 2006).
As mentioned, many variables can affect the rates of attrition for homeless
individuals receiving substance abuse services. The substance abuse treatment
services available for homeless individuals range from outreach offers of engagement
in a human relationship (e.g., the Park Homeless Outreach Project in New York City)
to formalized treatment programs inside of shelters (e.g., the 7C’clinic within the
Guesthouse in Milwaukee; National Institute on Alcohol Abuse and Alcoholism,
retrieved January 27, 2006). Likewise, there are multiple treatment programs of
varying intensity that are open to many populations, including homeless individuals,
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if they meet the admission criteria (e.g., any hospital program with outpatient
treatment, day treatment, inpatient, etc.). Attrition rates for homeless individuals
participating in substance abuse treatment can vary on the level of intensity of the
program they attend (National Institute on Alcohol Abuse and Alcoholism, retrieved
January 27, 2006). As previously discussed, attrition rates in general vary due to
length, type and intensity of drug use as well as length, type and intensity of treatment
(Franey & Ashton, 2002; Simpson, Joe & Rowan-Szal, 1997). However, the variable
of treatment intensity may affect the attrition rates more so in homeless individuals as
they simply have other survival demands to attend to if they are attempting to
participate in a traditional outpatient program or an inpatient program that they are
not immediately admitted into. Indeed, the delay in starting treatment after initial
assessment has been reported by some as one of the main reasons for premature exit
from a substance abuse treatment program (Zerger, 2002). In addition, there are
many variables that often times are depleted or nonexistent in an individual who is
homeless that can also affect client attrition rates including employment status, social
support networks, positive self efficacy and feeling as if one is close to their ideal self
(Northwest Frontier Addiction Technology Transfer Center, 2003). Specifically,
attrition rates as high as 58% to 66% have been reported for homeless individuals in
substance use treatment (National Institute on Alcohol Abuse and Alcoholism,
retrieved January 27, 2006; SAMHSA, 1998) with some reporting rates as high as
80% (Zerger, 2002). The severity of these numbers supports the need for further
research on attrition rates from substance abuse treatment for homeless individuals.
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Summary
The extent of homelessness in the United States and more specifically in
Milwaukee, Wisconsin is a severe and chronic concern (Institute for the Study of
Homelessness and Poverty, retrieved January 12, 2006; U.S. Department of Health
and Human Services, retrieved January 12, 2006). Homelessness has been found to be
related to substance use disorders (Clark & Rich, 2003; Glasser & Bridgman, 1999;
Jainchill et al., 2000), mental illness (Booth et al., 2002; Jainchill et al., 2000;
National Coalition for the Homeless, 2005) and neuropsychological functioning
deficits (Buhrich et al., 2000; Gonzalez et al., 2001; Solliday-McRoy et al., 2004).
Furthermore, due to confounding variables, the attrition rates for homeless individuals
receiving substance use treatment are reported at rates well over fifty percent
(National Institute on Alcohol Abuse and Alcoholism, retrieved January 27, 2006;
SAMHSA, 1998; Zerger, 2002). Though much research has been done on substance
use treatment and the homeless, the research is lacking in regards to attrition from
substance abuse treatment related to neuropsychological deficits. Indeed, not even
one study was found that addressed the relationship between neuropsychological
deficits and attrition rates from substance abuse treatment in homeless men.
Therefore, the importance of this study evaluating neuropsychological functioning
and the relationship to attrition rates in substance use treatment is again validated.
Multicultural Considerations
When evaluating neuropsychological functioning one must remain cognizant
of possible demographic and multicultural issues related to assessment and diagnosis.
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Participant’s age, gender and race can all affect performance on particular test
instruments (Groth-Marnat, 1999; Posner & DiGirolamo, 2000; Sullivan et al., 2002).
For example, aging can affect performance on many neuropsychological tests
(Posner & DiGirolamo, 2000). Older adults are disproportionately disadvantaged on
tests of executive function. Specifically, large age related differences are found on
tasks that involve shifting sets, which is considered a primary example of executive
functioning (Posner & DiGirolamo, 2000).
In relation to gender, Sullivan, Fama, Rosenbloom and Pfefferbaum (2002)
reported that alcohol dependent women exhibit a similar pattern of impairment in
cognitive tests as men. The areas most severely affected in the women, showing at
least a -0.75 standard deviation difference from the healthy controls, involved short
term memory and fluency (fluency involves the ability to write/speak as many words
starting with a certain letter that one can come up with and creating a variety of
designs within prearranged arrays of dots; Sullivan et al., 2002). Scientists have
shown how alcoholism affects the nervous system and the brain for decades, but
primarily in men (Sullivan et al., 2002). With regards to gender, the American
Academy of Neurology (AAN) finds gender to have “consistent but minor effects on
neuropsychological assessment” (American Academy of Neurology, 1996, p. 3). The
AAN goes on to explain that women perform better on tests of verbal memory than
men and suggest that men decline more than women on neuropsychological tests
during the normal course of aging (American Academy of Neurology, 1996).
Not only has most of the research been performed with men, but also more
specifically, it has been done with European American men (Groth-Marnat, 1999).
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Critics believe that most psychological tests are heavily biased and reflect the values
of European American middle class society (Groth-Marnat, 1999). Likewise, a study
in the Journal of the International Neuropsychological Society (2004) reviewed past
studies that investigated cultural bias and neuropsychological testing (Kennepohl,
Shore, Nabors & Hanks, 2004). In summarizing several studies, Kennepohl et al.
(2004) reported that many medically healthy minorities in the United States are
considered cognitively impaired at a much higher rate than European Americans-even
when they controlled for other variables such as years of education and
socioeconomic status (SES). The Kennepohl et al. (2004) study assessed 71
participants using the African American Acculturation Scale with 40 being tested by a
Black examiner and 31 by a White examiner. The results suggested a significant
association between level of acculturation and neuropsychological performance even
after controlling for other confounding variables such as age, sex, years of education
and SES (Kennepohl et al., 2004). Similarly, researchers at Columbia Health Sciences
studied whether quality, rather than quantity of education could help explain lower
neuropsychological test scores (Dougherty, 2002). By administering a reading test to
384 elderly African Americans and Whites, the researchers found they could
eliminate the racial differences in the neuropsychological assessment scores
(Dougherty, 2002). The results of the Columbia Health Science study suggest that
including an assessment of reading skills will help the neuropsychologists know what
scores to expect from people with diverse backgrounds (Dougherty, 2002).
With the issue of bias in mind, one must be cautious when interpreting scores
of ethnic, racial, age or gender categories that a specific assessment tool was not
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normed on (Groth-Marnat, 1999). For the purpose of this study, I needed to be
cautious that the results of the neuropsychological tests are from neuropsychological
deficits, not test bias. I wanted to be sure I was measuring executive function deficit
in all participants, not just the White males. When evaluating the relationship of
executive functioning and attrition, I wanted to be sure to capture those precise
variables and not variables related to gender, ethnicity or test bias. Therefore, all of
these variables were considered in selection and use of assessment materials.
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Chapter III: Methodology
The primary purpose of this chapter is to describe the methodology employed
in this study of the executive function of patients with a substance dependence
diagnosis and effects on attrition. Descriptions of the proposed participants, research
design, instruments and procedures are provided.
Participants
Participants were recruited from the adult males seeking services at the 7C’s
Community Counseling Clinic (7Cs) located within the Guesthouse of Milwaukee.
Upon initial contact with 7C’s, individuals were assessed for substance related
diagnoses. If an individual was identified as having a substance use diagnosis, the
researcher presented the purpose and goals of the project, explained the nature of the
test instruments, described time requirements and reviewed confidentiality
procedures. In addition, it was explained that participation in the study was
completely voluntary and had no effect on shelter admission, length of shelter stay or
any other service offered at the shelter. An assessment was completed for all of those
who agreed to participate.
Funding
In researching various funding opportunities, I contacted major breweries
including Miller Brewery and local substance abuse organizations including Aurora
and Cornerstone. In addition, many options for grants were researched through
National Institute of Health, Division 40 of APA and multiple other online sources.
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Unfortunately, no funding was retrieved through any of these sources. As the
participants were people staying at the guesthouse, the financial incentive was
somewhat less important as we were not be asking them to go anywhere outside of
their home. In addition, as all clients who receive services from the 7C’s clinic in the
Guesthouse are required to complete an initial intake assessment prior to receiving
services, the participants would partake in an assessment whether or not they are part
of the study. If the study participants are then paid for their time, this could cause
discontent for all other and future 7C’s clients who are not paid for their time.
Therefore, no payment was given to study participants. However, offering some form
of payment to participants might have improved participant motivation throughout the
assessment process.
Design
The major domains of this study included executive functioning of people with
a substance use diagnosis and attrition rates. The data collected was intended to be
exploratory in nature and not to be assumed representative as a thorough investigation
of these domains.
Independent and Dependent Variables
The dependent variables for this study include the length of time the
participant remains in treatment and number of sessions. I had also intended to
evaluate time of relapse and frequency of relapse but was unable to gain access to
relapse information. The independent variable is level of executive functioning as
defined by the scores obtained by our chosen neuropsychological battery which
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includes subtests of the Delis Kaplan and the Continuous Performance Test II (CPT
II).

Other Variables
A variety of other variables including demographic characteristics, health
history (including head injury), and subjective level of fatigue and mood at time of
assessment were considered as supplemental variables. All of these variables could be
confounding variables when evaluating the impact of neuropsychological functioning
and attrition. We want to be sure that any relationship found between
neuropsychological functioning and attrition is a true relationship and not one
modified by one of these other variables. In addition, if we found that one of the other
variables was an important predictor, we would highlight this for treatment
suggestions and future research directions as is discussed in detail below.
Sample Size
Sample size is an important variable to consider as the sample size needs to be
large enough that an effect of such magnitude to be of scientific significance will also
be statistically significant. However, it is just as important that the sample size not be
too big that an effect of little scientific importance is still detected as statistically
significant (Lenth, 2001). I intended to exert energy and resources in ways that would
be clinically and statistically significant. Factors that affect sample size include the
Type I error rate, power of the test, and the effect size (Friedman, Furberg & DeMets,
1998). The calculation of sample size, with provisions for adequate levels of
significance, power and effect size is discussed below.
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The level of significance or alpha (α) level is the probability of making of
Type I error or rejecting the null hypotheses when it is true (Grimm & Yarnold,
1995). The determination of where to set alpha is a function of balancing Type I and
Type II errors (Grimm & Yarnold, 1995). Type II error occurs when the researcher
does not reject a false null hypothesis, a probability called beta (β). For example,
raising the level of significance (raising the probability of making a Type I error)
from .05 to .10 decreases the probability of making a Type II error. Therefore, in
order to find an acceptable balance between Type I and Type II errors, alpha was set
at .05 (α = .05) which is the preferred standard alpha of many researchers (Friedman
et al., 1998).
It is also important to consider Power in the design of a study. Power is
defined as the probability of rejecting the null when it is false and is calculated as 1 –
β (Hinkle, Wiersma & Jurs, 1998; Huck, 2000). Due to the inverse relationship of
alpha and beta, as alpha (α) increases, beta (β) decreases and power (1 – β) then
increases. Therefore, the larger the power, the more likely one is to reject the null
when it is false (Norussis, 2002). Hinkle, Wiersma and Jurs (1998) state that several
authors have indicated that Type I errors are typically more serious than Type II
errors and therefore suggest a 4:1 ratio of β to α. Therefore, as we have established
alpha at .05, the corresponding power is 1 – 4(.05) = .80 (Hinkle, Wiersma & Jurs,
1998). This power is large enough to help control for Type II errors, but not too large
to put unrealistic demands on the researcher for huge sample sizes (Huck, 2000).
Effect size is also considered when determining sample size. Cohen defines
effect size as the “degree to which a phenomenon exists” (Cohen, 1977, p. 9). The
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effect size score represents the magnitude of the intervening treatment’s effect
(Grimm & Yarnold, 1995). Huck (2000) describes how Jacob Cohen has suggested
that researchers can set the effect size to .20, .50 and .80 depending on whether they
are interested in detecting a small, medium or large deviation from the null. However,
many researchers warn that identifying the effect size is not so simple (Hinkle,
Wiersma & Jurs, 1998). In fact, Cohen himself warns that it is always better for the
researcher to specify effect size by thinking about the particular study being
conducted rather than just deciding to use one of the accepted values for small,
medium and large effect (Huck, 2000). Therefore, to calculate effect size for this
study, we should not have arbitrarily picked an effect size, but rather considered what
distinguished trivial from meaningful deviations from the null. Although this is not
typically a difficult task, determining this requires knowledge about variability in the
population being studied (Huck, 2000). For this study, I needed to find similar
research on the relationship between neuropsychological function and attrition rates
with an effect size reported. As previously discussed, this specific research is
extremely rare in current publications. In addition, I reviewed similar types of
research, such as attrition rates in outpatient substance dependence treatment, and was
unsuccessful at finding any reported effect sizes. The majority of social research
produces a small to medium effect size (Grimm & Yarnold, 1995). Therefore, I chose
a small effect size as defined by Cohen as an effect size between .20 and .30 realizing
this is an inadequate method of determining effect size.
With alpha set at .05, power at .80 and an effect size of .20 to .30, sample size
can be chosen using a chart on page 651 of Hinkle, Wiersma and Jurs (1998).
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According to this chart, the sample size needed would be between 71 and 155 for a
small effect size between .20 and .30 (Hinkle, Wiersma & Jurs, 1998). Again, this
determination of sample size is not adequate, but instead a result of the limited data I
was working with. Part of the value of this study will be the reported information on
effect size for future researchers interested in similar areas of study.
With the limited information available for calculating sample size, sample size
was determined mostly as a result of practicality related to resources of this study
including time, available participants and manpower to conduct the necessary
assessments. With these variables in mind, as well as the variables of power, alpha
and effect size, the sample size was arbitrarily set at 100. This allowed for a sample
size which is reasonable with the resources available, as well as a sample size that fits
with the partial calculations I was able to perform. The 100 needed assessments was
feasible to obtain but yet we were unable to complete the 100 assessment due to a
change in management of the 7C’s clinic.
Instruments
The instruments used for this study included specific subtests of the DelisKaplan Executive Function System (D-KEFS) and the Conners’ Continuous
Performance Test II (CPT II) for evaluation of neuropsychological strengths and
weaknesses, the Wechsler Abbreviated Scale of Intelligence (WASI) for an estimate
of general intellectual ability. In addition, the Addiction Severity Index (ASI) was
used to evaluate the severity of problem areas associated with alcohol and drug
dependence and the Mini International Neuropsychiatric Interview (MINI) was used
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to establish any other DSM-IV diagnoses. All of these instruments are reviewed in
detail below.
Delis-Kaplan Executive Function System (D-KEFS)
The D-KEFS was published by Dean Delis, Edith Kaplan and Joel Kramer to
assess key components of executive function (Psychological Corporation, n.d.). The
D-KEFS is a neuropsychological test battery consisting of nine subtests that assess
higher level cognitive abilities described as executive functions (Dugbartey &
Ramsden, in press). The D-KEFS is individually administered in a game like format
designed to be engaging for participants to encourage optimal performance in
children and adults (Psychological Corporation, retrieved December 13, 2004). Each
of the nine subtests comprising the D-KEFS were developed as stand alone measures
and include the Trail Making Test, Verbal Fluency Test, Color Word Interference
Test, Sorting Test, Twenty Questions Test, Word Context Test, Design Fluency Test,
Tower Test and Proverb Test (Dugbartey & Ramsden, in press). The tests of interest
for this study included Tower Test, Color Word Interference Test, Trail Making Test
and Verbal Fluency. The decision was made to use four rather than all nine of the
subtests to focus specifically on executive functions and reduce the time commitment
associated with facilitating all nine subtests. These four subtests included in the
battery for this study will be discussed in more detail below.
D-KEFS subtests
The nine subtests of the D-KEFS were designed to be autonomous
instruments that could be used individually or in combination with other D-KEFS
subtests. The selection of which tests to use is determined by the needs and time
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constraints of the examiner (Dugbartey & Ramsden, in press). Each subtest takes
approximately 20 minutes to administer and score (Dugbartey & Ramsden, in press).
In addition, computer scoring software is available which can further reduce the time
involved in manual scoring of the subtests (Psychological Corporation, retrieved
December 13, 2004). Of the nine subtests of the D-KEFS, the decision was made to
use four particular tests to focus specifically on executive functions and reduce the
time commitment associated with facilitating all nine subtests.
The four D-KEFS subtests I used for this project included the Tower Test,
Color Word Interference, Trail Making Test and Verbal Fluency. We had also
intended to use the Sorting Test, but under the guidance of Dr. Terry Young we
decided to eliminate it due to time constraints and repetition with other measures. The
Tower Test is similar to the Towers of Hanoi test and the Tower of London test. The
Tower Test measures spatial planning, rule learning, inhibition of impulsive
responding, inhibition of perseverative responding and establishing and maintaining
the instructional set (Dugbartey & Ramsden, in press). The Tower Test is a task in
which the participant attempts to move five rings across three pegs to build a tower in
the fewest number of moves possible (Dugbartey & Ramsden, in press). The Color
Word Interference Test is a modified version of the Stroop (1935) test. It measures
inhibition of a more autonomic verbal response (reading) in order to generate a
conflicting response naming the dissonant ink colors (Dugbartey & Ramsden, in
press). The third subtest used was the Trail Making Test. The Trail Making Test is a
modified version of the Trail Making test and consists of five conditions instead of
two (Dugbartey & Ramsden, in press). The D-KEFS Trail Making Test measures
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flexibility of thinking on a visual motor task and assesses whether a deficient score on
the switching condition is related to a higher level deficit in cognitive flexibility
(Dugbartey & Ramsden, in press). The last subtest of the D-KEFS I used is the
Verbal Fluency test. The Verbal Fluency test is a modified version of the Controlled
Oral Word Association Test (COWAT, 1969). The Verbal Fluency test is sensitive to
frontal lobe involvement in general and left-frontal lobe damage in particular
(Dugbartey & Ramsden, in press). The Verbal Fluency test measure fluent
productivity in the verbal domain by requiring the participant to generate words in
phonemic format from overlearned concepts (Dugbartey & Ramsden, in press).
D-KEFS psychometrics.
The D-KEFS was standardized on a stratified sample of 1,750
individuals including 700 people aged 8-15 years old, 700 people between 16 and 59
years old and 350 between 60 and 89 years old (Dugbartey & Ramsden, in press).
The D-KEFS is considered to have “adequate psychometric properties and a strong
norming base” (Dugbartey & Ramsden, in press, p. 286). Internal consistency
reliability was adequate for composite scores on the Trail Making Test (from .57 to
.81), Verbal Fluency Test (from .32 to .90) and Color Word Interference Test (.62 to
.86). The test-retest reliability estimate of the D-KEFS was found to be “generally
impressive” though “quite variable across age groupings” (Dugbartey & Ramsden, in
press, p.283).
In regards to validity, the Mental Measurement Yearbook (15th edition)
reported that adequate data was presented on the intercorrelations of various intratest
measures of the D-KEFS (Dugbartey & Ramsden, in press). Likewise, some of the D-
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KEFS subtests (such as the Sorting Test) showed some impressive correlation results
(Dugbartey & Ramsden, in press). However, very limited concurrent validity
evidence was available comparing the D-KEFS and other neurocognitive
assessments. For example, the correlations between the D-KEFS and the California
Verbal Learning Test-Second Edition was rather low (Dugbartey & Ramsden, in
press). Overall, the reliability and validity of the D-KEFS are considered to be
adequate for researchers (Dugbartey & Ramsden, in press). Furthermore, as the DKEFS is able to evaluate multiple aspects of executive functions, which are a primary
focus for this study, the D-KEFS is a necessity for this study.
Conners’ Continuous Performance Test II (CPT II)
The CPT II was developed by C. Keith Conners as a visual performance task
which evaluates attentional variables in individuals age six or older (IPS, 2005). The
response patterns identified by the CPT II provide information on attention,
impulsivity, activation/arousal and difficulties in maintaining vigilance (IPS, 2005).
The CPT II is computer administered and scored in approximately 14 minutes (IPS,
2005). After a practice exercise on the computer, the administration begins requiring
the participant to press the space bar or click the mouse when any letter except ‘X’
appears on the computer screen. The computerized program of the CPT II captures
response times and records them to the nearest millisecond (Klecker & Sime, in
press). Scores are automatically computed, graphed and converted to a text which
explains the results to the administrator (Klecker & Sime, in press). The instructions
and administration are simple for the participant and the administrator.
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CPT II psychometrics.
The CPT II was normed on a sample of 2,682 subjects including clinical and
nonclinical samples (IPS, 2005). Normative data include a clinical sample of 378
cases diagnosed with ADHD, 223 adult individuals with neurological impairment and
a nonclinical sample of 1920 individuals from the general population (Klecker &
Sime, in press). Reliability and validity information is provided in the CPT II
Technical Guide and Software Manual (IPS, 2005). Two types of reliability including
split half and standard error provide support for the psychometric soundness of the
CPT II. The CPT II shows adequate consistency with regards to split half reliability
and the standard error measurement values show that scores from the instrument are a
reasonable match to the true performance of individuals (IPS, 2005). However,
according to a review in the Mental Measurement Yearbook (15th edition), the split
half procedure was found to be difficult to follow and the correlations nearly
impossible to interpret (Klecker & Sime, in press). Test-retest reliability resulted in a
range of .05 to .92 (Klecker & Sime, in press). Statistical validation is discussed in
the CPT II manual with regards to demonstrating the tests ability to discriminate
between general populations and clinical groups (IPS, retrieved April 27, 2006). The
Mental Measurement Yearbook (15th edition) review considers the CPT II a reliable
instrument with moderate validity which can be easily used and interpreted (Klecker
& Sime, in press). However, the authors of the CPT II do caution that it is not to be
used alone as a diagnostic tool (Klecker & Sime, in press). Given the CPT II’s
positive psychometrics, brief administration and the necessity of attentional
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information for evaluating executive function, the CPT II is a valuable tool for this
study in conjunction with the other identified assessment tools.
Wechsler Abbreviated Scale of Intelligence (WASI)
The two subtest format of the WASI was developed in 1999 to provide
clinicians a reliable method to obtain a brief measure of intelligence on individuals
aged 6-89 years old (Harcourt Assessment, retrieved April 27, 2006). Though many
short forms of the Wechsler Scales exist, the WASI was developed to provide a
consistent, well normed, brief measure of intelligence (Keith, Lindskog & Smith,
2004). The WASI is available in a four or two subtest format giving the administrator
control over the time and depth of the assessment (Keith, Lindskog & Smith, 2004).
The four subtest format results in a Full Scale IQ (FSIQ, Verbal IQ (VIQ) and
Performance IQ (PIQ) with a 30 - minute administration time (Harcourt Assessment,
retrieved April 27, 2006). The two subtest form of the WASI includes the Vocabulary
subtest and the Matrix Reasoning subtest resulting in a Full Scale IQ (FSIQ) score
with a 15 - minute administration time (Harcourt Assessment, retrieved April 27,
2006). For all subtests, raw scores are converted to T scores with all IQ scores having
a mean of 100 and a standard deviation of 15 (Keith et al., 2004). For the purposes of
this study, we utilized the two subtest form of the WASI to reduce the time the
participant is involved in testing.
WASI psychometrics.
The Wechsler Abbreviated Scale of Intelligence was standardized on a
national sample of 2,245 children and adults with ages ranging from 6-89 years old
(Keith et al, 2004) is considered to have strong psychometric properties (Harcourt
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Assessment, retrieved April 27, 2006). The average reliability coefficient for adults
on the two subtest format is reported at .96 (Harcourt Assessment, retrieved April 27,
2006). Likewise, the test-retest reliability for the two subtest format is .88 (Harcourt
Assessment, retrieved April 27, 2006). In addition, the validity information on the
WASI included correlations with other tests, and exploratory and confirmatory factor
analysis (Keith et al., 2004). Correlations between the WASI and WAIS III ranged
from .66 to .88 for subtests and .76 to .92 for IQ’s (Keith et al., 2004). The Mental
Measurement Yearbook (2004) review of the WASI considers the correlation with the
WAIS III to be the WASI’s greatest strength and its greatest weakness as it is not
connected to anything but the Wechsler scales (Keith et al., 2004). Overall, the
Mental Measurement Yearbook (2004) review considers the WASI to be well
standardized and have adequate reliability and validity (Keith et al., 2004). As a brief
estimate of intelligence versus a detailed description of intelligence is what we need
for this study, the WASI is an appropriate addition to our battery.
Addiction Severity Index (ASI)
The Addiction Severity Index (ASI) was developed in 1980 by A. Thomas
McLellan and collaborators from the University of Pennsylvania’s Center for the
Studies of Addiction (Treatment Research Institute, retrieved February 3, 2006). The
ASI is a standardized, multidimensional instrument widely used in the field of
substance abuse treatment (Treatment Research Institute, retrieved February 3, 2006).
This semi-structured interview was designed to address seven potential problem areas
in individuals with a substance use disorder. The seven areas include: (a) medical, (b)
employment, (c) alcohol, (d) drug, (e) legal, (f) family/social, and (g) psychiatric
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status (McGahan, Griffith, Parente & McLellan, 1986; McLellan, Luborsky, O’Brien
& Woody, 1980). The interviewer can gather information on recent substance use
(past thirty days) and lifetime problems in all seven of the problem areas (McGahan
et al., 1986; McLellan et al., 1980). Therefore, the ASI provides an overview of the
problems rather than focusing on any one single area.
ASI psychometrics.
The ASI has been normed on treatment groups including users of alcohol,
opiates and cocaine (McLellan et al., 1980). In addition, it has been normed on public
and private inpatient and outpatient treatment (McLellan et al., 1980). Finally, it has
been normed on males, females, psychiatrically ill substance users, gamblers,
homeless, probationers and employee assistance clients (McLellan et al., 1980).
Therefore, it is appropriate for the homeless, male, substance abusing population
included in this research. The ASI has shown test-retest reliability, split half
reliability and internal consistency (McLellan et al., 1980). Likewise, the ASI has
shown content, criterion and construct validity (McLellan et al., 1980). Finally, the
ASI can be administered in approximately 50 to 60 minutes and can be used free of
charge (McLellan et al., 1980) making it a positive part of our chosen assessment
battery.
Mini International Neuropsychiatric Interview (MINI)
The Mini International Neuropsychiatric Interview (MINI) is an abbreviated
psychiatric structured interview first developed in 1992 by David Sheehan and Yves
Lecrubier to meet the need for a short but accurate psychiatric interview (Sheehan et
al., 1998). The MINI is designed to assess the major adult Axis I diagnostic
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categories, one Axis II diagnosis (antisocial personality disorder) and suicidality
(Sheehan et al., 1998). The MINI is available in an electronic version allowing for
simple computer administration and scoring which takes approximately 15 minutes.
MINI psychometrics.
The reliability of the MINI was tested with interrater reliability and test-retest
reliability. The interrater reliability showed kappa values all above .75 (Sheehan et
al., 1998). In addition, 70% of the kappa values were .90 or greater indicating
excellent interrater reliability (Sheehan et al., 1998). The test-retest reliability scores
included 61% with values over .75 and only one value was below .45. With regards to
validity, the MINI was compared to the Structured Clinical Interview for the DSMIII-R (SCID) and the Composite International Diagnostic Interview (CIDI). When
compared to the SCID, the MINI showed good or very good kappa values with only
one score (current drug dependence) falling below .50 (Sheehan et al., 1998). When
comparing the MINI and the CIDI, kappa values were also good or very good for
most diagnoses with only two values (simple phobia and generalized anxiety
disorder) falling below .50 (Sheehan et al., 1998). The MINI has shown high
validation and reliability scores and can be administered in less time (15-30 minutes)
than other comparable instruments such as the Structured Clinical Interview for the
DSM-III (Sheehan et al., 1998) making it a useful instrument for this study.
Procedures
Informed Consent
When participants arrived for their assessment session, they were read an
informed consent document in compliance with current Health Insurance Portability
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& Accountability Act 2004 (HIPAA) regulations. This provided them with
information regarding voluntary participation, confidentiality, the purpose of the
study, and potential risks and/or benefits of participating in this study. Any questions
regarding these issues were answered, they signed the consent and were offered a
copy of it.
Assessment
All clients of the 7C’s clinic are administered the ASI and MINI upon general
admission. These instruments are part of the 7C’s clinic intake process and therefore
all clients entering the clinic are given these assessments, not just the participants for
this study. All administrators were Registered Alcohol and Drug Counselors or
Certified Alcohol and Drug counselors by the state of Wisconsin and were supervised
by Certified Clinical Supervisors. Subsequently, if a substance use diagnosis was
established, the neuropsychological test battery including the D-KEFS, CPT II and
the WASI were administered after completion of the informed consent procedures.
Standard administration was followed for each of the instruments as well as a
standard order of administration. The average length of time to complete the
neuropsychological test battery was approximately 90 minutes. Multiple clinicians
were trained and supervised in the administration of this battery. A licensed
psychologist qualified in administration and scoring of the neuropsychological
assessment instruments (Dr. Terry Young) provided training prior to the time of
assessment and provided supervision throughout the course of this study. All
batteries were hand scored first by the assessor for the WASI. The D-KEFS and CPT
II are computer scored. The hand scored subtests were then rescored by the lead
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investigator to insure accurate scoring. A sample of the assessments were then
reviewed by the supervising neuropsychologist and another psychologist (14 batteries
or approximately 20%).
Follow Up
Participants were asked to provide contact information at intake to allow for
follow up information to be gathered if and when the participant left treatment.
Participants were informed of when this person will be contacted and what
information would be asked of them. The appropriate releases were signed and
attempts were made to contact the listed person when a participant dropped out of
treatment to get information on reaching the participant for information on why they
left treatment. We were hoping this information would provide a qualitative report of
the participant’s perception of why they left treatment allowing the study to evaluate
the relationship between neuropsychological function and attrition to the participant’s
report of reasons for attrition. However, we had limited success actually reaching
people due to wrong names,
wrong numbers, disconnected numbers and the cooperation of the listed contact
person.
Therefore, we were unable to report the intended qualitative piece of this research.

Data Analysis
As we are comparing the relationship between the neuropsychological
functioning, attrition rates and relapse rates in outpatient treatment for substance
dependent males, there are several variables to evaluate requiring multiple data
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analytic techniques. Survival Analysis (SA) and Logistic Regression (LR) are the two
primary statistical applications we will used for this study.
Survival Analysis (SA)
Survival Analysis (SA) refers to a group of techniques designed for studying
the occurrence of events in longitudinal data (Corning & Malofeeva, 2004). Given
that I am evaluating attrition rates from outpatient treatment, which have a welldefined starting point and a ‘failure’ point, this is an appropriate model for my data
(Dobson, 2002; Parmar &Machin, 1995). In SA, the dependent variable is the length
of time to an event (Parmar & Machin, 1995). Classically, the event of interest was
death-hence the term survival analysis (Luke & Homan, 1998). However, for the
purpose of this study, the dependent variables assessed by SA were the number of
outpatient sessions attended and total length of time in treatment prior to dropping
out. In short, SA assists us in predicting the risk of occurrence of an event given the
event has not yet occurred (Corning & Malofeeva, 2004; Luke & Homan, 1998). The
advantages of SA over more traditional means of analysis, such as regression and
analysis of variance (ANOVA), relate to the longitudinal nature of outpatient
treatment that may not be well addressed by other methods (Corning & Malofeeva,
2004). Survival Analysis is important when analyzing data in which risks vary over
time (Gerstman, 2003). Survival Analysis allows us to estimate the survival time of
participants who complete the study as well as those who do not (Gerstman, 2003).
This is considered a distinguishing feature of survival analysis and is referred to as
censoring (Parmar & Machin, 1995; Venables & Ripley, 2002). Data is considered
right censored in the event that we do not observe the outcome (end of treatment) for
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all participants since data collection ends but the people are still in treatment
(Gerstman, 2003; Luke & Homan, 1998). In SA studies, this is the most common type
of censoring. However, if participants become unavailable due to physically moving
out of the area, death or illness, this is considered mid censoring (Gerstman, 2003).
We are no longer able to observe them, but they were not necessarily lost due to
dropping out in the manner we are concerned with in this study. Therefore, if we had
participants in our study that moved, died or otherwise do not represent the
dichotomy of someone participating in treatment or dropping out, we could still
account for the data and not allow it to have as big of a negative impact on our
results. Furthermore, with SA, I could evaluate the time to the event (days or sessions
to drop out) and what is known as censor-status (observation or non-observation of
the event-drop out; Luke & Homan, 1998). Or, I could also investigate other variables
which influenced survival times such as the neuropsychological functioning of the
individual. Survival Analysis can incorporate categorical or continuous variables
(Luke & Homan, 1998). With the multiple types of data that my chosen assessment
battery produces, I had the opportunity to evaluate the data from both perspectives
using impaired vs. non-impaired neuropsychological scores and the continuous type
of data that the CPT II reaction time scores offer. Therefore, I was able to evaluate the
impact of the client’s neuropsychological functioning on survival or time in treatment
prior to relapse or dropping out.
Within Survival Analysis there are parametric and nonparametric approaches
available for our use. Some researchers report that the parametric approaches have
‘fallen out of fashion’ with the advent of the more nonparametric approaches
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(Venables & Ripley, 2002). Some of the analytic techniques offered by SA include
the Cox Proportional Hazards Model, Kaplan-Meier survival function estimation and
Life Table analysis (Parmar & Machin, 1995; StatSoft, retrieved March 16, 2006).
For this study, we used the Cox Model which is discussed later.
Logistic Regression (LR)
In addition to Survival Analysis, Logistic Regression was also used in analysis
of the data. Logistic Regression can be used when the predictor variables are
qualitative or quantitative, continuous or categorical, and the criterion variable is
dichotomous (Grimm and Yarnold, 2000; Huck, 2000). Our predictor variable of
interest is neuropsychological function which is quantitative and continuous and the
dichotomous criterion variable was whether the participant dropped out or not. With
SA we are able to address the participant’s survival in treatment (continuous time
oriented variable) as related to neuropsychological functioning, whereas with LR we
address whether a relationship exists between neuropsychological function and
whether the participant drops out or not (dichotomous variable). Logistic Regression
can be used to determine the increase in probability of dropping out of treatment that
is associated with neuropsychological functioning while controlling for other
variables such age, IQ and types of substances used (Grimm & Yarnold, 2000). Like
Linear Regression, Logistic Regression gives each regressor variable a coefficient
value that measures the regressor’s independent contribution to variations in the
dependent variable (University of Exeter, retrieved May 10, 2006). With LR, we can
assess whether the independent variables, as a whole, significantly affect the
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dependent variable and identify the best variables to use in prediction of treatment
drop out (University of Exeter, retrieved May 10, 2006).
Summary of Data Analysis
Survival Analysis and Logistic Regression were used to answer all study
questions including identifying the level of neuropsychological impairment, if the
impairment predicts rates of attrition from treatment and if a relationship exists
between neuropsychological function and attrition. Using the two forms of statistical
analysis (LR and SA) allowed us to more precisely and accurately evaluate all
variables involved in this study.
In regards to the level of neuropsychological impairment, descriptive statistics
and a verbal summary of findings is reported. As it is possible that
neuropsychological functioning would improve over the course of the study, the
neuropsychological assessment (Delis-Kaplan subtests and CPT II) was to be
administered a second time half way through the 90 days we will be monitoring for
drop out (45 days into treatment) and again at the 90 day mark. This would provide a
quantitative description of any improvement in neuropsychological functioning over
time. However, due to limited participation in this aspect of the research, we were
unable to report any substantial data related to follow up assessments.
Attrition from substance abuse treatment was evaluated using Logistic
Regression with attrition being treated as a dichotomous variable (drop out or no drop
out). We intended to predict drop out from the indicators of neuropsychological
functioning and control for other variables including age, IQ and any other treatment
participation. In addition, Survival Analysis was also used in which the days in
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treatment prior to drop out were the dependent variable and neuropsychological
functioning was the independent variable. The relationship between
neuropsychological function and drop out was evaluated with LR and the relationship
between neuropsychological function and survival in treatment was evaluated with
SA. Finally, the Cox Proportional Hazards model was used with the Survival
Analysis.
In addition to the quantitative data collected, we intended to have a qualitative
component to be reported on from the information gathered through the follow up
procedures. This information would provide us with the participant’s description of
why they left treatment which could be compared to the quantitative data. However,
as discussed above, this information was not successfully gathered.
Finally, as previously mentioned, no relative effect sizes could be found to be
used to determine sample size for this study. Therefore, effect sizes were calculated
and reported on as another valuable outcome of this study.
Overall, the use of the multiple statistical techniques allowed for assessment
of all independent and dependent variables of interest. In addition, the statistical
techniques allowed for evaluation of any confounding variables. Finally, these
methods of analysis will provide an enormous amount of information on any
relationships between neuropsychological function, attrition, relapse and multiple
other potential variables.
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Chapter IV: Results
Demographic Description
The present study utilized data from 68 participants. We had planned an n of
100 but due to a change in management of the clinic where we were collecting data,
our n was reduced. We collected 75 total neuropsychological assessments on adult
males in the 7C’s Clinic of the Guesthouse of Milwaukee. Of the 75 completed
assessments, seven (initial assessments completed) were eliminated due to facilitator
error (initial assessments, facilitator skipped parts of subtest). The average age of our
sample was 45 years (SD = 9 years). Education levels varied widely: 28% did not
finish high school, 37% were high school graduates, and 12% had some college
education or an associates degree, 18% graduated from college, and 5% had further
education beyond college. None of the participants reported being married: 63% of
the participants were single, 23% were divorced, 9% were separated, and 3% were
widowed. Two in every three participants were African-American (66.2%), while
25% were Caucasian, and 9% belonged to other racial or ethnic groups (2.9 %
Hispanic, 2.9% multiple races, 1.5 % Asian, 1.5% Native American), Three in every
four (74.6 %) participants had received prior AODA treatment.
Neuropsychological Functioning
To determine the neuropsychological functioning of the present sample and
answer our first research question, we utilized four subtests of the Delis Kaplan
including the Tower Test, Color Word Interference, Trail Making Test and Verbal
Fluency. We had originally planned to utilize the Sorting Test as well, but for the
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sake of time and due to some duplicate information obtained by the sorting test, we
limited the Delis Kaplan evaluation to these four subtests. We also used the CPTII,
WTAR and WASI to evaluate neuropsychological functioning. All of these results
will be reviewed.
D-KEFS.
The Delis Kaplan Executive Function subtests give us multiple scores for each
subtest administered. A few key variables that are considered more global
achievement measures will be discussed and the rest presented in a table. For most of
the measures provided by the D-KEFS, the raw scores are converted to scaled scores
with a mean of 10 and a standard deviation of 3. In order to determine whether the
sample means in the present study were significantly different than the population
norms for each test, a one-sample z-test was employed. Specifically, a two-tailed test
was employed with an alpha level of .05. With a sample of 68, and the population
parameters specified above, sample means that are 0.71 units higher or lower than the
stated population mean are significantly different than the mean. By this criterion, a
sample mean of 9.29 is significantly lower than the population mean of 10.
In addition to the standardized scores, the D-KEFS also provides contrast
scores that quantify performance on a baseline task and a higher level task or two
higher level tasks. These will be discussed more extensively below.
Tower Test.
The Tower Test measures spatial planning, rule learning, inhibition of
impulsive responding, inhibition of perseverative responding and establishing and
maintaining the instructional set (Dugbartey & Ramsden, in press). To assess how
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the sample performed relative to the norm, the distribution of cases according to
performance standards was examined. Of the 67 valid scores from the participants on
the Tower Test total achievement score, 22 scored below average, 12 scored above
average and 33 scored within average range (M = 9.25, SD = 2.97). In the present
sample, the mean standardized scale scores for the Tower Test was lower than the
criterion level of 9.29 set for rejecting the null hypothesis based on the one-sample z
test. This finding suggests that the sample was drawn from a population with a lower
than average level of performance on this measure.
Table 4.1
Tower Test total achievement score scaled
Cumulative
Percent
Frequency Percent Valid Percent
Valid

2

1

1.4

1.5

1.5

3

1

1.4

1.5

3.0

4

1

1.4

1.5

4.5

5

5

7.2

7.5

11.9

6

6

8.7

9.0

20.9

7

8

11.6

11.9

32.8

8

4

5.8

6.0

38.8

9

8

11.6

11.9

50.7

10

5

7.2

7.5

58.2

11

10

14.5

14.9

73.1

12

6

8.7

9.0

82.1

13

10

14.5

14.9

97.0

14

2

2.9

3.0

100.0

67

97.1

100.0

2

2.9

69

100.0

Total
Missing 999
Total
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Trails.
The Trail Making Test is a modified version of the Trail Making test and
consists of five conditions instead of two (Dugbartey & Ramsden, in press). The DKEFS Trail Making Test measures flexibility of thinking on a visual motor task and
assesses whether a deficient score on the switching condition is related to a higher
level deficit in cognitive flexibility (Dugbartey & Ramsden, in press). The primary
scoring measure for each of the five conditions of the D-KEFS Trail Making Test is
the number of seconds that the examinee takes to complete each condition again with
a mean of 10 and a standard deviation of 3. The first score is the Trail Making test
visual scanning score, which is a timed score where the examinee seeks out the
number 3 on a page of scattered numbers. Of the 68 valid responses, 18 were below
average, 5 were above average and 45 were average (M = 8.8, SD = 3.45). The
second score is the number sequencing score where the participant has to seek out and
sequence numbers in chronological order. Of the 68 valid responses, 30 were below
average, 5 were above average and 33 were average (M = 7.48, SD = 3.95). The third
score is the letter sequencing score where the participant has to seek out and sequence
letters in alphabetical order. Of the 68 valid responses, 28 were below average, 7
were above average and 33 were average (M = 7.48, SD = 3.93). The fourth score is
the number-letter sequencing score where the participant has to sequence numbers
and letters in order alternating between the two. Of the 66 valid responses, 29 were
below average, 4 were above average and 33 were average (M = 7.6, SD = 3.89). The
fifth score is a motor speed score that is calculated by having the participant trace a
line while being timed. Of the 67 valid responses, 19 scored below average, 3 scored
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above average and 45 scored within the average range (M = 8.8, SD = 2.95). In the
present sample, the mean standardized scale scores for the Trail Making Test was
lower than the criterion level of 9.29 set for rejecting the null hypothesis based on the
one-sample z test. This finding suggests that the sample was drawn from a
population with a lower than average level of performance on this measure.

Table 4.2
Trail making test visual scanning scaled
Cumulative
Percent
Frequency Percent Valid Percent
Valid

1

6

8.7

8.8

8.8

2

1

1.4

1.5

10.3

3

1

1.4

1.5

11.8

4

1

1.4

1.5

13.2

5

2

2.9

2.9

16.2

6

1

1.4

1.5

17.6

7

6

8.7

8.8

26.5

8

5

7.2

7.4

33.8

9

10

14.5

14.7

48.5

10

12

17.4

17.6

66.2

11

7

10.1

10.3

76.5

12

11

15.9

16.2

92.6

13

3

4.3

4.4

97.1

14

2

2.9

2.9

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total
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Table 4.3
Trail Making test number sequence scaled
Cumulative
Percent
Frequency Percent Valid Percent
Valid

1

10

14.5

14.7

14.7

2

2

2.9

2.9

17.6

3

1

1.4

1.5

19.1

4

4

5.8

5.9

25.0

5

3

4.3

4.4

29.4

6

6

8.7

8.8

38.2

7

4

5.8

5.9

44.1

8

6

8.7

8.8

52.9

9

5

7.2

7.4

60.3

10

13

18.8

19.1

79.4

11

4

5.8

5.9

85.3

12

5

7.2

7.4

92.6

13

3

4.3

4.4

97.1

15

1

1.4

1.5

98.5

16

1

1.4

1.5

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total
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Table 4.4
Trail Making test letter sequence scaled
Cumulative
Frequency Percent Valid Percent
Percent
Valid

1

10

14.5

14.7

14.7

3

5

7.2

7.4

22.1

4

2

2.9

2.9

25.0

5

4

5.8

5.9

30.9

6

4

5.8

5.9

36.8

7

3

4.3

4.4

41.2

8

10

14.5

14.7

55.9

9

6

8.7

8.8

64.7

10

7

10.1

10.3

75.0

11

6

8.7

8.8

83.8

12

4

5.8

5.9

89.7

13

6

8.7

8.8

98.5

15

1

1.4

1.5

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total
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Table 4.5
Trail Making number letter sequencing scaled score
Cumulative
Frequency Percent Valid Percent
Percent
Valid

1

10

14.5

15.2

15.2

2

1

1.4

1.5

16.7

3

3

4.3

4.5

21.2

4

1

1.4

1.5

22.7

5

3

4.3

4.5

27.3

6

4

5.8

6.1

33.3

7

7

10.1

10.6

43.9

8

5

7.2

7.6

51.5

9

8

11.6

12.1

63.6

10

3

4.3

4.5

68.2

11

9

13.0

13.6

81.8

12

8

11.6

12.1

93.9

13

4

5.8

6.1

100.0

66

95.7

100.0

3

4.3

69

100.0

Total
Missing 999
Total
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Table 4.6
Trail Making motor speed scaled
Cumulative
Frequency Percent Valid Percent
Percent
Valid

1

1

1.4

1.5

1.5

2

1

1.4

1.5

3.0

3

2

2.9

3.0

6.0

4

3

4.3

4.5

10.4

5

6

8.7

9.0

19.4

6

1

1.4

1.5

20.9

7

5

7.2

7.5

28.4

8

5

7.2

7.5

35.8

9

7

10.1

10.4

46.3

10

11

15.9

16.4

62.7

11

16

23.2

23.9

86.6

12

6

8.7

9.0

95.5

13

2

2.9

3.0

98.5

14

1

1.4

1.5

100.0

67

97.1

100.0

2

2.9

69

100.0

Total
Missing 999
Total
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Color Word Interference Test.
The Color Word Interference Test is a modified version of the Stroop (1935) test. It
measures inhibition of a more autonomic verbal response (reading) in order to
generate a conflicting response naming the dissonant ink colors (Dugbartey &
Ramsden, in press). The completion time for each of four measures provides a global
measure of performance, again with a mean of 10 and standard deviation of 3. The
first condition is color naming which tests the speed at which an examinee can name
repeating stimuli of color patches. Of the 68 valid responses, 31 were below average,
4 were above average and 33 were average (M = 7.52, SD = 3.8). The second
condition is word reading, which evaluates the examinee’s ability to read repeating
words as quickly as possible. Of the 68 valid responses, 30 were below average, 5
were above average and 33 were average (M = 7.64, SD = 3.85). The third condition
is inhibition, which reflects the examinee’s ability to inhibit the more automatic task
of reading words in order to name the dissonant ink color. Of the 68 valid responses,
25 were below average, 9 were above average and 34 were average (M = 8.22, SD =
3.78). The fourth condition is inhibition/switching, which requires adequate naming
speed, reading speed, verbal inhibition and cognitive flexibility. Of the 68 valid
responses, 26 were below average, 6 were above average and 36 were average (M =
8.33, SD = 3.64). The mean standardized scale scores for each of the Color Word
measures was lower than the criterion level of 9.29 set for rejecting the null
hypothesis based on the one-sample z test. This finding suggests that the sample was
drawn from a population with a lower than average level of performance on this
measure.
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Table 4.7
Color Word color naming scaled
Cumulative
Percent
Frequency Percent Valid Percent
Valid

1

8

11.6

11.8

11.8

2

1

1.4

1.5

13.2

3

4

5.8

5.9

19.1

4

5

7.2

7.4

26.5

5

1

1.4

1.5

27.9

6

7

10.1

10.3

38.2

7

5

7.2

7.4

45.6

8

3

4.3

4.4

50.0

9

7

10.1

10.3

60.3

10

11

15.9

16.2

76.5

11

9

13.0

13.2

89.7

12

3

4.3

4.4

94.1

13

3

4.3

4.4

98.5

17

1

1.4

1.5

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total
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Table 4.8
Color Word word reading scaled
Cumulative
Percent
Frequency Percent Valid Percent
Valid

1

8

11.6

11.8

11.8

2

2

2.9

2.9

14.7

3

1

1.4

1.5

16.2

4

3

4.3

4.4

20.6

5

6

8.7

8.8

29.4

6

6

8.7

8.8

38.2

7

4

5.8

5.9

44.1

8

10

14.5

14.7

58.8

9

3

4.3

4.4

63.2

10

4

5.8

5.9

69.1

11

10

14.5

14.7

83.8

12

6

8.7

8.8

92.6

14

5

7.2

7.4

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total
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Table 4.9
Color Word inhibition scaled
Cumulative
Frequency Percent Valid Percent
Percent
Valid

1

5

7.2

7.4

7.4

2

2

2.9

2.9

10.3

3

3

4.3

4.4

14.7

4

4

5.8

5.9

20.6

5

5

7.2

7.4

27.9

6

2

2.9

2.9

30.9

7

4

5.8

5.9

36.8

8

4

5.8

5.9

42.6

9

11

15.9

16.2

58.8

10

6

8.7

8.8

67.6

11

7

10.1

10.3

77.9

12

6

8.7

8.8

86.8

13

6

8.7

8.8

95.6

14

3

4.3

4.4

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total
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Table 4.10
Color Word inhibition/switching scaled
Cumulative
Frequency Percent Valid Percent
Percent
Valid

1

5

7.2

7.4

7.4

2

1

1.4

1.5

8.8

3

5

7.2

7.4

16.2

5

3

4.3

4.4

20.6

6

4

5.8

5.9

26.5

7

8

11.6

11.8

38.2

8

4

5.8

5.9

44.1

9

8

11.6

11.8

55.9

10

8

11.6

11.8

67.6

11

9

13.0

13.2

80.9

12

7

10.1

10.3

91.2

13

3

4.3

4.4

95.6

14

1

1.4

1.5

97.1

15

2

2.9

2.9

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total
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Verbal Fluency.
The Verbal Fluency test is a modified version of the Controlled Oral Word
Association Test (COWAT, 1969). The Verbal Fluency test is sensitive to frontal lobe
involvement in general and left-frontal lobe damage in particular (Dugbartey &
Ramsden, in press). The Verbal Fluency test measures fluent productivity in the
verbal domain by requiring the participant to generate words in phonemic format
from over learned concepts (Dugbartey & Ramsden, in press). The total correct score
for each of three conditions provides a global measure of performance on this task,
again with a mean of 10 and standard deviation of 3. The first condition is letter
fluency where the examinee generates lexical items while simultaneously observing
several rules or restrictions. Of the 68 valid responses, 29 were below average, 6 were
above average and 33 were average (M = 8.39, SD = 3.56). The second condition is
category fluency, which requires the examinee to retrieve multiple words from high
frequency semantic categories. Of the 68 valid responses, 24 were below average, 6
were above average and 36 were average (M = 9.2, SD = 6.8). The third condition is
category switching which requires the examinee to retrieve semantic knowledge
shifting between two categories. Of the 68 valid responses, 23 were below average, 6
were above average and 39 were average (M = 8.36, SD =3.98). The mean
standardized scale scores for each of the Verbal Fluency measures was lower than the
criterion level of 9.29 set for rejecting the null hypothesis based on the one-sample z
test. This finding suggests that the sample was drawn from a population with a lower
than average level of performance on this measure.
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As this subtest, as well as all of the D-KEFS subtests were chosen due to their
specific relationship with frontal lobe functioning, it makes sense that we would see
impairment in each of these measures. This is consistent with our expectations of
frontal lobe impairment in this population. More specifically, it is consistent with
impairment in the dorsal lateral frontal lobe that is related to executive functioning.

Table 4.11
Verbal Fluency letter fluency total scaled
Cumulative
Percent
Frequency Percent Valid Percent
Valid

1

2

2.9

2.9

2.9

2

1

1.4

1.5

4.4

3

4

5.8

5.9

10.3

4

4

5.8

5.9

16.2

5

1

1.4

1.5

17.6

6

7

10.1

10.3

27.9

7

10

14.5

14.7

42.6

8

4

5.8

5.9

48.5

9

11

15.9

16.2

64.7

10

5

7.2

7.4

72.1

11

4

5.8

5.9

77.9
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12

9

13.0

13.2

91.2

13

2

2.9

2.9

94.1

14

1

1.4

1.5

95.6

15

2

2.9

2.9

98.5

19

1

1.4

1.5

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total

Table 4.12
Verbal Fluency category fluency total scaled
Cumulative
Percent
Frequency Percent Valid Percent
Valid

1

3

4.3

4.4

4.4

2

2

2.9

2.9

7.4

3

2

2.9

2.9

10.3

4

1

1.4

1.5

11.8

5

6

8.7

8.8

20.6

6

4

5.8

5.9

26.5

7

6

8.7

8.8

35.3

8

11

15.9

16.2

51.5

9

3

4.3

4.4

55.9

10

13

18.8

19.1

75.0

11

2

2.9

2.9

77.9
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Verbal Fluency category fluency total scaled
12

7

10.1

10.3

88.2

13

2

2.9

2.9

91.2

14

2

2.9

2.9

94.1

16

1

1.4

1.5

95.6

18

2

2.9

2.9

98.5

56

1

1.4

1.5

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total

Table 4.13
Verbal Fluency category switching total correct scaled
Cumulative
Frequency Percent Valid Percent
Percent
Valid

1

2

2.9

2.9

2.9

2

3

4.3

4.4

7.4

3

8

11.6

11.8

19.1

4

3

4.3

4.4

23.5

5

2

2.9

2.9

26.5

6

4

5.8

5.9

32.4

7

1

1.4

1.5

33.8

8

6

8.7

8.8

42.6

9

11

15.9

16.2

58.8

10

5

7.2

7.4

66.2

11

11

15.9

16.2

82.4

12

6

8.7

8.8

91.2
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14

1

1.4

1.5

92.6

15

2

2.9

2.9

95.6

16

1

1.4

1.5

97.1

17

2

2.9

2.9

100.0

68

98.6

100.0

1

1.4

69

100.0

Total
Missing 999
Total

CPT II.
The CPT II was developed by C. Keith Conners as a visual performance task
which evaluates attentional variables in individuals age six or older (IPS, 2005). The
response patterns identified by the CPT II provide information on attention,
impulsivity, activation/arousal and difficulties in maintaining vigilance (IPS, 2005).
The CPT II provides a confidence index value that helps evaluate whether the
examinee matches a clinical or non- clinical respondent. In general, values above
50% indicate a closer match to a clinical population, values below 50% indicate a
match closer to a nonclinical profile and values at 50% are inconclusive (Conners,
2004). Of the 66 valid profiles, 46 scored above 50%, 7 scored below 5 % and 13
scored at 50% (M = 68.6, SD = 19.28). Using a one-sample z-test, the chance that this
sample was drawn from a normal population are less than one in one thousand. This
finding confirms that the sample was drawn from a population with lower than
average performance on this measure as well. These findings are comparable to the
results of other reports in the literature related to attention, impulsivity, activation and
arousal being affected in samples of adults with substance use disorders. For example,
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as discussed in the literature review above, others have observed impaired attention in
adults in substance use treatment (Roselli et e al., 2001). Similar to the D-KEFS
results, these results are consistent with defined damage to the frontal lobe and related
skill of attention, impulsivity and perseveration.

Table 4.14
CPT II confidence index
Cumulative
Frequency Percent Valid Percent
Percent
Valid

23.06

1

1.4

1.5

1.5

28.53

1

1.4

1.5

3.0

41.2

1

1.4

1.5

4.5

47.29

1

1.4

1.5

6.1

49.9

3

4.3

4.5

10.6

13

18.8

19.7

30.3

53.27

1

1.4

1.5

31.8

53.43

1

1.4

1.5

33.3

50

140

53.77

1

1.4

1.5

34.8

56.52

2

2.9

3.0

37.9

57.47

1

1.4

1.5

39.4

59.29

1

1.4

1.5

40.9

60.57

1

1.4

1.5

42.4

62.22

1

1.4

1.5

43.9

62.85

1

1.4

1.5

45.5

66.2

1

1.4

1.5

47.0

67.82

1

1.4

1.5

48.5

68.1

1

1.4

1.5

50.0

69.47

1

1.4

1.5

51.5

69.62

1

1.4

1.5

53.0

70.76

1

1.4

1.5

54.5

72.04

1

1.4

1.5

56.1

73.31

1

1.4

1.5

57.6

75.56

1

1.4

1.5

59.1

76.68

1

1.4

1.5

60.6

77.46

1

1.4

1.5

62.1

78.19

1

1.4

1.5

63.6

78.71

1

1.4

1.5

65.2

1

1.4

1.5

66.7

79.66

1

1.4

1.5

68.2

80.48

1

1.4

1.5

69.7

80.61

1

1.4

1.5

71.2

80.67

1

1.4

1.5

72.7

82.02

1

1.4

1.5

74.2

82.67

1

1.4

1.5

75.8

82.7

1

1.4

1.5

77.3

84.28

1

1.4

1.5

78.8

86.3

1

1.4

1.5

80.3

86.64

1

1.4

1.5

81.8

87.08

1

1.4

1.5

83.3

91.1

1

1.4

1.5

84.8

79.48
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91.51

1

1.4

1.5

86.4

93.77

1

1.4

1.5

87.9

99.9

8

11.6

12.1

100.0

Total

66

95.7

100.0

3

4.3

69

100.0

Missing 999
Total

Wechsler Test of Adult Reading (WTAR).
We collected data on the WTAR on all participants with the intention of using
the information for an estimate of premorbid intelligence. However, since we were
only giving the WASI instead of a full WAIS, we were unable to calculate the
premorbid functioning. Personal communication with Amy Gabel, PhD, the Director
of Client Consultation and Training at Pearson confirmed that there is not data on
using the WASI with the WTAR and that the WASI was not intended to replace the
WAIS in this situation. (Personal communication, 11-4-2008). Therefore, the WTAR
results will not be included.
WASI.
Though many short forms of the Wechsler Scales exist, the WASI was
developed to provide a consistent, well normed, brief measure of intelligence (Keith,
Lindskog & Smith, 2004). The WASI is available in a four or two subtest format
giving the administrator control over the time and depth of the assessment (Keith,
Lindskog & Smith, 2004). For this study, we used the two subtest form of the WASI
which includes the Vocabulary subtest and the Matrix Reasoning subtest resulting in
a Full Scale IQ (FSIQ) score with a 15 minute administration time (Harcourt
Assessment, retrieved April 27, 2006). For all subtests, raw scores are converted to T
scores with all IQ scores having a mean of 100 and a standard deviation of 15 (Keith
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et al., 2004). Of the 62 valid profiles for the WASI, 5 scored in the extremely low IQ
range (< 69), 9 scored in the borderline range (70-79), 11 scored in the low average
range (80-89), 28 in the average range (90-109), 8 in the high average range (110119) and 1 in the superior range (120-129). The mean for the WASI IQ score was
92.64 with a standard deviation of 15.2. According to the one-sample z-test, samples
of 68 with mean less than 97.66 have a less than .05 chance of occurring if the sample
was drawn from a population with a mean of 100. The observed sample mean falls
below this threshold level, suggesting that the present sample has a significantly
lower IQ level. Though the WASI is not an assessment that is specifically associated
with the frontal lobe, it does offer additional useful information to incorporate into
our overall assessment of the participants executive functioning.

Table 4.15
WASI IQ score
Cumulative
Frequency Percent Valid Percent
Percent
Valid

60

1

1.4

1.6

1.6

62

2

2.9

3.2

4.8

66

1

1.4

1.6

6.5

69

1

1.4

1.6

8.1

72

1

1.4

1.6

9.7
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WASI IQ score
73

3

4.3

4.8

14.5

75

2

2.9

3.2

17.7

78

1

1.4

1.6

19.4

79

2

2.9

3.2

22.6

80

2

2.9

3.2

25.8

82

1

1.4

1.6

27.4

86

2

2.9

3.2

30.6

88

3

4.3

4.8

35.5

89

3

4.3

4.8

40.3

90

2

2.9

3.2

43.5

91

3

4.3

4.8

48.4

93

1

1.4

1.6

50.0

94

1

1.4

1.6

51.6

96

3

4.3

4.8

56.5

98

3

4.3

4.8

61.3

99

3

4.3

4.8

66.1

101

4

5.8

6.5

72.6

103

1

1.4

1.6

74.2

104

2

2.9

3.2

77.4

105

1

1.4

1.6

79.0

108

2

2.9

3.2

82.3

109

2

2.9

3.2

85.5

110

2

2.9

3.2

88.7

112

1

1.4

1.6

90.3

113

2

2.9

3.2

93.5

115

1

1.4

1.6

95.2

118

2

2.9

3.2

98.4

121

1

1.4

1.6

100.0

62

89.9

100.0

7

10.1

69

100.0

Total
Missing 999
Total
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Drop Out and Survival in Treatment
Of the 68 participants followed in this study, 33 stayed in treatment past 90
days (48.5%) and 35 dropped out prior to 90 days (51.5%). Likewise the participant’s
length of time in treatment from first day of treatment to last day of treatment was a
minimum of 13 days and a maximum of 426 with a mean of 120.2 and a standard
deviation of 97.03.
Summary of Descriptives
This study utilized data from 68 non-married males with an average age of 45.
In our sample 72% had a high school education or beyond, and the majority were
African American (66.2%) or Caucasian (25%). Data was collected and analyzed on
neuropsychological functioning using subtest of the D-KEFS, WASI IQ and the CPT
II. The finding suggests that the sample was drawn from a population with a lower
than average level of performance on all measures. There was no correlation between
age, education and the reported neuropsychological deficits.
Neuropsychological Deficits Predicting Attrition
To answer our second research question both demographic and psychological
variables were considered as potential predictors of treatment attrition (defined in
terms of receiving fewer than 90 days of treatment, versus 90 days or more of
treatment). The 90 day mark is used by many researchers as the cutoff for treatment
retention and is identified as many by an average length of stay (Katz, King,
Schwartz, Weintraub, Barksdale, Robinson and Brown, 2005).
In order to identify demographic predictors of treatment attrition, independent
groups t-tests were conducted to compare levels of continuous variables, such as age,
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between patients who dropped out and those who continued. Chi-squared tests of
independence were employed to determine whether dropping out was significantly
associated with education, marital status, race, and prior experience of having ADOA
treatment. Of these demographic variables, only prior treatment experience was a
significant predictor of dropout. As shown in Table 4.16, patients who had no prior
treatment experience were more likely to drop out (Chi-squared = 4.664; df = 1; p <
.05).

Table 4.16
Dropout Rates By Previous Treatment History
Dropout
Yes

No

_______________________________________________________
Prior Treatment History

22 (44%)

28 (56%)

No Prior Treatment History

12 (75%)

4 (25%)

_______________________________________________________

Initial efforts to identify such predictors employed Pearson’s correlations to
examine the linear relationship between neuropsychological measures and length of
treatment, as well as independent groups t-tests to test the significance of mean
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differences in neuropsychological test scores between participants who dropped out
before completing 90 days of treatment, and those who received 90 or more days of
treatment. No statistically significant linear relationships were found between
neuropsychological measures and these indices of length of treatment.
The absence of significant linear effects might be understandable if the
relationships between neuropsychological variables and length of treatment was
actually curvilinear. Linear correlations may be quite weak when the underlying
relationship between two variables is U-shaped. To detect the presence of curvilinear
relationships, scatterplots of data were inspected. The Classification and Regression
Trees (CART) program was used to identify cut off points for IQ computationally
instead of just visually inspecting the scatterplots and identifying categories
(Breiman, Friedman, Stone & Olshen, 1984). The CART software automatically tries
out different ways of categorizing the WAIS scores. The cutting point that best
predicts the dependent variable is selected. The CART program is regarded as an
exploratory data analysis technique (Breiman, Friedman, Stone & Olshen, 1984). The
distribution of WASI IQ scores with dropping out, as well as with total days of
treatment, appeared to show a curvilinear relationship. As shown in Table 4.17,
patients with IQ scores that were low to average were more likely to drop out.
Patients with average and above IQ scores, as well as those with borderline to low IQ
scores, were less likely to drop out of treatment (Chi-squared = 10.75; df =2 ; p <
.01).
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Table 4.17
Dropout Rates By WASI IQ
Dropout
Yes

No

_______________________________________________________
WASI Below 77

2 (18.2%)

9 (81.8%)

WASI 77-95

16 (76.2%)

5 (23.8%)

WASI Above 95

13 (43.3%)

17 (56.7%)

___________________________________

Prediction of Attrition and Continuation in Treatment
The main analyses of the present investigation utilized logistic regression and
survival analysis to predict attrition and continuation in treatment. Logistic
regression was utilized to assess the unique contributions of predictors (i.e., prior
treatment, WASI IQ level) on the binary outcome of dropping out before 90 days of
treatment or continuing. For the survival analysis, Cox regression was utilized to
examine the association between predictors and length of treatment. WASI IQ level
was coded in the manner described above in order to examine curvilinear effects of
IQ.
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Logistic Regression
Both Prior Treatment and WASI IQ level were entered into a logistic
regression equation to predict the probability of dropping out of treatment before
completing 90 days. The regression analysis was set up so that the medium level of
the WASI IQ variable served as a reference category against which the lowest and
highest levels were contrasted. As shown in Table 4.18, only WASI IQ, not prior
treatment, made a significant unique contribution to the prediction of dropping out.
Specifically, patients with low to average IQ scores (77-95) were more likely to drop
out than those with borderline to low IQ scores (below 77).
Table 4.18
Logistic Regression Predicting Dropout Rates From Prior Treatment and WASI IQ
Level
Beta

SE

Wald df

Significance

____________________________________________________________________

Prior Treatment

-.971 .752

WASI Level

1.660 1

.196

6.409 2

.041

Low vs.Medium

-2.398 .956

6.295 1

.012

High vs. Medium

-0.979 .682

2.061 1

.376

.518 .660

0.615 1

.433

Constant

___________________________________________________________________
The beta weights in logistic regression are conceptually like those in ordinary least
squares regression, only now they are predicting the likelihood of dropping out of
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treatment. A positive beta means that higher scores on the predictor are associated
with a greater likelihood of dropping out. A negative beta means that higher scores on
the predictor are associated with a lower likelihood of dropping out. The Wald
statistic indicates whether the beta weight is statistically significant. Thus, the results
of the logistic regression indicate that subjects with borderline to low IQ scores are
significantly less likely to drop out than those with average or above scores. There is
a non-significant trend toward lower dropout rates for subjects who have had prior
treatment, as well as those who have relatively high IQ scores (i.e.., IQ > 95). While
there is no precise formula for computation of R-squared in logistic regression, there
are methods for the computation of an analogous measure of effect size, or “pseudo
R-squared”. The Cox and Snell R-Square for the logistic regression model presented
above is .182, while the Nagelkerke R-Square is .243. The overall model accounted
for a substantial portion of the variance in the dependent variables.
Survival Analysis/Cox Regression
Both Prior Treatment and WASI IQ Level were entered into a Cox regression
equation to predict the survival in treatment (i.e. number of days between the start and
end of treatment). As in the preceding analyses, the medium level of the WASI IQ
variable (low to average IQ) served as a reference category against which the lowest
(borderline to low) and highest (average and above) levels were contrasted. As
shown in Table 4.19, one of the WASI IQ contrasts, and not prior treatment, made a
significant unique contribution to the prediction of survival. Patients with low to
average IQ scores (77-95) had shorter survival times than those with borderline to
low IQ scores (below 77).
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Table 4.19
Cox Regression Predicting Survival Rates From Prior Treatment and WASI IQ Level
Beta

SE

Wald df

Significance

____________________________________________________________________

Prior Treatment

-0.324 .315

WASI Level

1.054 1

.305

4.911 2

.086

Low vs. Medium

-0.851 .386

4.853 1

.028

High vs. Medium

-0.383 .311

1.518 1

.218

____________________________________________________________________
In the Cox Regression, a negative Beta weight indicates a lower chance of
dropping out. The Wald statistic again provides a test of the null hypothesis that the
Beta population parameter equals zero. Thus, subjects with borderline to low IQ
(below 77) have a significantly lower chance of dropping out across time (i.e., they
will remain in treatment for a longer time). There is a non-significant trends toward
longer survival among subjects with prior treatment histories and average to high IQ
(over 95).
Summary of Logistic Regression and Survival Analysis
The findings of the present study suggest that general intelligence, as assessed
by the WASI, predicts dropout and survival in treatment. The effects of IQ are
significant even after controlling for, or partialling out, the effects of prior treatment
history on dropout rates. Conversely, the effects of prior treatment on dropping out
are no longer significant when WASI IQ is entered into the equation. This suggests
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that the relationship between prior treatment history and dropping out might be
explained in part by differences in WASI IQ. Throughout these analyses, the effects
of WASI IQ are curvilinear: patients with low to average IQ are more likely to drop
out than those with borderline to low IQ, while those with average or above IQ have
an intermediate level of dropping out or persisting in treatment.
Correlations Affecting Attrition and Length of Treatment
In addition to the above statistics, we decided to run further correlations to
evaluate whether there were relationships between the NP variables, IQ and prior
treatment and whether these relationships affected attrition or length of stay in
treatment.
Some correlations were found to exist between the NP variables and IQ which
intuitively makes sense and has been found by other researchers (Zinn, Stein &
Swartzwelder, 2004). All four of the D-KEFS subtests used (Trail Making Test, Color
Word, Verbal Fluency and Tower) had sections that were significantly correlated with
IQ. These results can be viewed in table 4.20 below.
Table 4.20
NP and WASI Correlations

NP Measure
TMTvisscRW Trail making test visual
scanning raw

TMTvisscSC Trail making test visual
scanning scaled

Correlation with
WASI IQ
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N

TMTnumRW trail making test number

Pearson Correlation

-.299
.018
62
.297
.019
62
-.492
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sequence raw
Sig. (2-tailed)
N

.000
62

TMTnumSC trail making test number
sequence scaled

TMTletRW trail making test letter
sequence raw

TMTletSC trail making test letter
sequence scaled

TMTNLSRAW Trail Making
Num/Letter Raw Score

TMTNLSSC Trail Making Number
letter sequencing Scaled score

TMTmsRAW Trails motor speed raw

TMTmsSC trails motor speed scaled

TMTcmbSS trails combined number +
letter sum of scaled scores

TMTcmbCS trails combined number+
letter sequencing composite scaled
score

TMTSvVSSSD trails switching vs.
visual scanning scaled score dif

TMTSvVSCS trailsswitching vs.
visual sanning contrast scaled score

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

.508
.000
62
-.489
.000
62
.542
.000
62
-.667
.000
60
.672

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

.000
60
-.359
.005
61
.344
.007
61

Sig. (2-tailed)
N
Pearson Correlation

.000
62

.572

.575
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)

.000
62
.394
.002
60
.416
.001
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TMTSvNSSSD trails switching vs
number sequencing scaled score dif

TMTSvNSCS trails switiching vs.
number sequencing contrast sclaed
score

N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
TMTSvLSSD Trails switching vs letter Pearson Correlation
sequencing scaled score dif
Sig. (2-tailed)
N
TMTSvLSCS trailsswitching vs. letter Pearson Correlation
sequencing scaled score contrast scaled
score
Sig. (2-tailed)
N
TMTSvCmbSSD trails switching
Pearson Correlation
vs.combined scaled score dif
Sig. (2-tailed)
N
TMTSvCmbCS trails switching vs.
Pearson Correlation
combined contrasst scaled score
Sig. (2-tailed)
N
TMTSvMSSSD trails switching vs.
Pearson Correlation
motor speed scaled score dif
Sig. (2-tailed)
N
TMTSvMSCS trails switching vs.
Pearson Correlation
motor speed contrast scaled score
Sig. (2-tailed)
N
VFLFtotalRW verbal fluency letter
Pearson Correlation
fluency total raw
Sig. (2-tailed)
N
VFLFtotalSC verbal fluency letter
Pearson Correlation
fluency total scaled
Sig. (2-tailed)
N
VFCFtotalRW verbal fluency category Pearson Correlation
fluency total raw
Sig. (2-tailed)

60
.192
.141
60
.178
.173
60
.150
.251
60
.146
.266
60
.103
.432
60
.098
.456
60
.423
.001
60
.416
.001
60
.579
.000
62
.573
.000
62
.601
.000
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VFCFtotalSC verbal fluency category
fluency total scaled

VFCatSwRW verbal fluency category
switching total correct raw

VFCatSwSC verbal fluency category
switching total correct scaled

N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
VFtotalSwRW verbal fluency category Pearson Correlation
switching total switching Raw
Sig. (2-tailed)
N
VFtotalSwSC verbal fluency category Pearson Correlation
switching total switching scaled
Sig. (2-tailed)
N
Pearson Correlation
VFLFvsCFSSD verbal fluency letter
fluency vs category fluency Scaled
Score Difference
Sig. (2-tailed)
N
Pearson Correlation
VFLFvsCFCSS verbal fluency letter
fluency vs category fluency Contrast
Scaled Score
Sig. (2-tailed)
N
VFCSvsCFSSD verbal fluency
Pearson Correlation
category switching vs category fluency
Scaled Score Difference
Sig. (2-tailed)
N
VFCSvsCFCSS verbal fluency
Pearson Correlation
category switching vs category fluency
Contrast Scaled Score
Sig. (2-tailed)
N
VF1stRW verbal fluency 1st interval
Pearson Correlation
total correct raw
Sig. (2-tailed)
N
VF1stSC verbal fluency 1st interval
Pearson Correlation

62
.171
.185
62
.434
.000
62
.418
.001
62
.494
.000
62
.482
.000
62
-.023
.862
62
-.023
.862
62
-.139
.281
62
-.125
.333
62
.526
.000
62
.517
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total correct scale

VF2ndRW verbal fluency 2nd interval
total correct raw

VF2ndSc verbal fluency 2nd interval
total correct scale

VF3rdRW verbal fluency 3rd interval
total correct raw

VF3rdSC verbal fluency 3rd interval
total correct scale

VF4thRW verbal fluency 4th interval
total correct raw

VF4thSC verbal fluency 4th interval
total correct scale

VFSLerrRW verbal fluency set loss
errors raw

VFSLerrSC verbal fluency set loss
errors scaled

VFREPerrRW verbal fluency
repetition errors raw

VFREPerrSC verbal fluency repetition
errors scaled

VFtotrespRW verbal fluency total
responses-correct and incorrect-raw

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)

.000
62
.611
.000
62
.599
.000
62
.562
.000
62
.549
.000
62
.555
.000
62
.553
.000
62
-.186
.147
62
.177
.168
62
-.011
.931
62
-.015
.910
62
.545
.000
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N
CWclrnmRW color word color naming Pearson Correlation
raw
Sig. (2-tailed)
N
CWclrnmSC color word color naming Pearson Correlation
scaled
Sig. (2-tailed)
N
CWreadRW color word word reading Pearson Correlation
raw
Sig. (2-tailed)
N
CWreadSC color word word reading
Pearson Correlation
scaled
Sig. (2-tailed)
N
CWinhibRW color word inhibition raw Pearson Correlation
Sig. (2-tailed)
N
CWinhibSC color word inhibition
Pearson Correlation
scaled
Sig. (2-tailed)
N
CWinswitRW color word
Pearson Correlation
inhibition/switching raw
Sig. (2-tailed)
N
CWinswitSC color word
Pearson Correlation
inhibition/switching scaled
Sig. (2-tailed)
N
CWcmbSSS color word combined
Pearson Correlation
naming and reading Sum of Scaled
Scores
Sig. (2-tailed)
N
CWcmbCSS color word combined
Pearson Correlation
naming and reading Composite Scaled
Score
Sig. (2-tailed)
N
CWErCNRW color word error Color
Pearson Correlation
naming raw
Sig. (2-tailed)
N

62
-.487
.000
62
.435
.000
62
-.454
.000
62
.425
.001
62
-.555
.000
62
.541
.000
62
-.534
.000
62
.505
.000
62
.459
.000
62
.462
.000
62
-.458
.000
62
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CWErCNSC color word error color
naming scaled

CWErWRRW Color word error Word
reading Raw

CWErWRSC Color word error Word
reading scaled

CWErInhRW Color word error
inhibition raw

CWErInhSc Color word error
inhibition scaled

CWErInSwRw Color Word Error
inhibition/Switching raw

CWErInSwSc Color Word Error
Inhibition/Switching Scaled

TTtotalRW Tower Test total
achievement score raw

TTtotalSC Tower Test total
achievement score scaled

TTrulesRW Tower Test total rule
violations raw

TTrulesPR Tower Test total rule
violations cumulative percentile rank

TT1stmvtmR Tower test mean 1st
move time ratio score

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

.357
.004
62
-.338

Sig. (2-tailed)
N
Pearson Correlation

.007
62

Sig. (2-tailed)
N
Pearson Correlation

.002
62

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

.394

-.543
.000
62
.553
.000
62
-.560
.000
62
.592
.000
62
.463
.000
61
.448
.000
61
-.616
.000
61
.577
.000
61
.026
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TT1stmvtmS Tower test mean 1st
move time Scaled score

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
TTtmprmvR Tower test time per move Pearson Correlation
ratio score
Sig. (2-tailed)
N
TTtmprmvS Tower test time per move Pearson Correlation
scaled score
Sig. (2-tailed)
N
TTmvaccR Tower test move accuracy Pearson Correlation
ratio score
Sig. (2-tailed)
N
TTmvaccSc Tower test move accuracy Pearson Correlation
scaled score
Sig. (2-tailed)
N
TTruleitemR Tower test rule violations Pearson Correlation
per item ratio score
Sig. (2-tailed)
N
TTruleitemS Tower test rule violations Pearson Correlation
per item scaled score
Sig. (2-tailed)
N
CPTconfind CPT II confidence index
Pearson Correlation
Sig. (2-tailed)
N

.845
61
-.011
.935
61
-.219
.090
61
.180
.165
61
-.239
.064
61
.226
.080
61
-.651
.000
61
.645
.000
61
-.178
.170
61
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Even more interesting, is that the NP variables are significantly correlated
with attrition and length of stay in treatment for cases that have below median IQ for
this sample (IQ < 94). Three of the four D-KEFS subtests used correlated
significantly on cases with IQ below 94 (Trail Making, Verbal Fluency and Tower
Test). The results of this correlation can be viewed in table 4.21 below.
Table 4.21
Correlations (IQ less than 94)

(IQ less than 94)
Drop out
TMTvisscRW Trail making test
visual scanning raw

TMTvisscSC Trail making test
visual scanning scaled

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N

TMTnumRW trail making test
number sequence raw

Pearson Correlation
Sig. (2-tailed)
N

TMTnumSC trail making test
number sequence scaled

TMTletRW trail making test
letter sequence raw

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
TMTletSC trail making test letter Pearson Correlation
sequence scaled
Sig. (2-tailed)

daysintx
number of days
from 1st day of
treatment to
last day

-.224

.055

.226
31

.769
31

.215

-.022

.245

.906

31

31

-.494

.240

.005

.193

31

31

.446

-.259

.012
31

.159
31

-.259

.119

.159
31

.524
31

.147

-.051

.429

.786
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TMTNLSRAW Trail Making
Num/Letter Raw Score

TMTNLSSC Trail Making
Number letter sequencing Scaled
score

N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
TMTmsRAW Trails motor speed Pearson Correlation
raw
Sig. (2-tailed)
N
TMTmsSC trails motor speed
Pearson Correlation
scaled
Sig. (2-tailed)
N
TMTcmbSS trails combined
Pearson Correlation
number + letter sum of scaled
scores
Sig. (2-tailed)
N
TMTcmbCS trails combined
Pearson Correlation
number+ letter sequencing
composite scaled score
Sig. (2-tailed)
N
TMTSvVSSSD trails switching
Pearson Correlation
vs. visual scanning scaled score
dif
Sig. (2-tailed)
N
TMTSvVSCS trailsswitching vs. Pearson Correlation
visual sanning contrast scaled
score
Sig. (2-tailed)
N
TMTSvNSSSD trails switching
Pearson Correlation
vs number sequencing scaled
score dif
Sig. (2-tailed)
N
TMTSvNSCS trails switiching
Pearson Correlation
vs. number sequencing contrast
sclaed score

31

31

-.257

.256

.178
29

.180
29

.269

-.231

.159
29

.228
29

.005

.106

.979
30

.578
30

-.035

-.079

.854
30

.678
30

.338

-.177

.063
31

.340
31

.325

-.146

.074
31

.432
31

.093

-.276

.631
29

.148
29

.140

-.320

.468
29

.090
29

-.246

.114

.198
29

.556
29

-.253

.124
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Sig. (2-tailed)
N
TMTSvLSSD Trails switching vs Pearson Correlation
letter sequencing scaled score dif
Sig. (2-tailed)
N
TMTSvLSCS trailsswitching vs. Pearson Correlation
letter sequencing scaled score
contrast scaled score
Sig. (2-tailed)
N
TMTSvCmbSSD trails switching Pearson Correlation
vs.combined scaled score dif
Sig. (2-tailed)
N
Pearson Correlation
TMTSvCmbCS trails switching
vs. combined contrasst scaled
score
Sig. (2-tailed)
N
TMTSvMSSSD trails switching
Pearson Correlation
vs. motor speed scaled score dif
Sig. (2-tailed)
N
TMTSvMSCS trails switching
Pearson Correlation
vs. motor speed contrast scaled
score
Sig. (2-tailed)
N
VFLFtotalRW verbal fluency
Pearson Correlation
letter fluency total raw
Sig. (2-tailed)
N
VFLFtotalSC verbal fluency
Pearson Correlation
letter fluency total scaled
Sig. (2-tailed)
N
VFCFtotalRW verbal fluency
Pearson Correlation
category fluency total raw
Sig. (2-tailed)
N
VFCFtotalSC verbal fluency
Pearson Correlation
category fluency total scaled
Sig. (2-tailed)
N
VFCatSwRW verbal fluency
Pearson Correlation

.185
29

.522
29

.173

-.178

.368
29

.355
29

.167

-.163

.387
29

.397
29

-.046

-.062

.813
29

.749
29

-.059

-.042

.761
29

.827
29

.278

-.162

.144
29

.401
29

.305

-.184

.108
29

.338
29

.354

-.309

.051
31

.090
31

.340

-.317

.062
31

.082
31

.305

-.186

.095
31

.315
31

-.096

-.041

.609
31
.134

.829
31
-.002
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category switching total correct
raw

VFCatSwSC verbal fluency
category switching total correct
scaled

VFtotalSwRW verbal fluency
category switching total switching
Raw

VFtotalSwSC verbal fluency
category switching total switching
scaled

VFLFvsCFSSD verbal fluency
letter fluency vs category fluency
Scaled Score Difference

VFLFvsCFCSS verbal fluency
letter fluency vs category fluency
Contrast Scaled Score

VFCSvsCFSSD verbal fluency
category switching vs category
fluency Scaled Score Difference

VFCSvsCFCSS verbal fluency
category switching vs category
fluency Contrast Scaled Score

VF1stRW verbal fluency 1st
interval total correct raw

VF1stSC verbal fluency 1st
interval total correct scale

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)

.473
31

.990
31

.099

.010

.595
31

.956
31

-.001

.067

.998
31

.719
31

-.013

.068

.947
31

.717
31

.047

-.088

.803
31

.639
31

.047

-.088

.803
31

.639
31

-.181

.251

.331
31

.173
31

-.181

.251

.331
31

.173
31

.308

-.207

.092
31

.263
31

.278

-.209

.130

.260
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VF2ndRW verbal fluency 2nd
interval total correct raw

VF2ndSc verbal fluency 2nd
interval total correct scale

VF3rdRW verbal fluency 3rd
interval total correct raw

VF3rdSC verbal fluency 3rd
interval total correct scale

VF4thRW verbal fluency 4th
interval total correct raw

VF4thSC verbal fluency 4th
interval total correct scale

VFSLerrRW verbal fluency set
loss errors raw

VFSLerrSC verbal fluency set
loss errors scaled

VFREPerrRW verbal fluency
repetition errors raw

VFREPerrSC verbal fluency
repetition errors scaled

VFtotrespRW verbal fluency
total responses-correct and
incorrect-raw

N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N

31

31

.401

-.294

.025
31

.108
31

.373

-.313

.039
31

.087
31

.223

-.180

.229
31

.332
31

.155

-.158

.404
31

.395
31

.232

-.146

.210
31

.433
31

.231

-.155

.212
31

.405
31

.216

-.120

.244
31

.519
31

-.214

.135

.248
31

.468
31

-.062

.278

.741
31

.130
31

-.061

-.162

.743
31

.384
31

.339

-.205

.063
31

.268
31
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CWclrnmRW color word color
naming raw

CWclrnmSC color word color
naming scaled

CWreadRW color word word
reading raw

CWreadSC color word word
reading scaled

CWinhibRW color word
inhibition raw

CWinhibSC color word
inhibition scaled

CWinswitRW color word
inhibition/switching raw

CWinswitSC color word
inhibition/switching scaled

CWcmbSSS color word
combined naming and reading
Sum of Scaled Scores

CWcmbCSS color word
combined naming and reading
Composite Scaled Score

CWErCNRW color word error
Color naming raw

Pearson Correlation

-.325

.183

.075
31

.324
31

.225

-.164

.224
31

.378
31

-.052

.030

.783
31

.874
31

.124

-.045

.505
31

.811
31

-.180

.220

.333
31

.233
31

.126

-.209

Sig. (2-tailed)
N
Pearson Correlation

.500
31

.260
31

.091

-.020

Sig. (2-tailed)
N
Pearson Correlation

.626
31

.916
31

-.068

.005

.715
31

.977
31

.186

-.112

.315
31

.549
31

.166

-.096

.372
31

.607
31

-.009

-.073

.961
31

.697
31

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
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CWErCNSC color word error
color naming scaled

CWErWRRW Color word error
Word reading Raw

CWErWRSC Color word error
Word reading scaled

CWErInhRW Color word error
inhibition raw

CWErInhSc Color word error
inhibition scaled

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
CWErInSwRw Color Word Error Pearson Correlation
inhibition/Switching raw
Sig. (2-tailed)
N
CWErInSwSc Color Word Error Pearson Correlation
Inhibition/Switching Scaled
Sig. (2-tailed)
N
TTtotalRW Tower Test total
Pearson Correlation
achievement score raw
Sig. (2-tailed)
N
TTtotalSC Tower Test total
Pearson Correlation
achievement score scaled
Sig. (2-tailed)
N

.182

-.076

.326
31

.684
31

-.191

.004

.304
31

.984
31

.275

-.095

.134
31

.612
31

-.167

.073

.369
31

.697
31

.129

-.164

.491
31

.379
31

-.130

-.016

.487
31

.934
31

.144

-.040

.439
31

.831
31

.300

-.120

.108
30

.529
30

.293

-.112

.116

.554
30

30
TTrulesRW Tower Test total rule Pearson Correlation
violations raw
Sig. (2-tailed)
N
TTrulesPR Tower Test total rule Pearson Correlation
violations cumulative percentile
rank
Sig. (2-tailed)

-.495

.453

.005
30

.012
30

.433

-.353

.017

.055
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TT1stmvtmR Tower test mean
1st move time ratio score

TT1stmvtmS Tower test mean
1st move time Scaled score

TTtmprmvR Tower test time per
move ratio score

TTtmprmvS Tower test time per
move scaled score

TTmvaccR Tower test move
accuracy ratio score

TTmvaccSc Tower test move
accuracy scaled score

TTruleitemR Tower test rule
violations per item ratio score

TTruleitemS Tower test rule
violations per item scaled score

CPTconfind CPT II confidence
index

30

30

.041

.015

.828
30

.939
30

-.039

-.040

Sig. (2-tailed)
N
Pearson Correlation

.837
30

.835
30

.091

.006

Sig. (2-tailed)
N
Pearson Correlation

.634
30

.975
30

-.117

.020

.537
30

.917
30

-.137

.135

Sig. (2-tailed)
N
Pearson Correlation

.471
30

.476
30

.145

-.132

Sig. (2-tailed)
N
Pearson Correlation

.444
30

.487
30

-.533

.446

.002
30

.014
30

.486

-.419

.006
30

.021
30

-.335

.259

.070
30

.166
30

N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
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With IQ equal to or greater than 94, none of the NP variables were statistically
significantly correlated with attrition and survival in treatment.
In addition to the correlation with IQ below 94, some of the NP variables are
correlated significantly with drop out and length of stay in treatment for cases that
had no prior AODA treatment. It appears that the NP variables are more important in
cases that have had no prior treatment than in cases that had prior treatment. Again,
caution must be taked due to the small sample sizes. Two of the four D-KEFS
subtests used correlated significantly in cases with no prior treatment (Verbal Fluency
and Tower Test). The results can be reviewed in table 4.22.
Table 4.22
Correlations (No Prior AODA Treatment)

(No Prior AODA Treatment)
Drop out
TMTvisscRW Trail making test
visual scanning raw

TMTvisscSC Trail making test
visual scanning scaled

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N

TMTnumRW trail making test
number sequence raw

Pearson Correlation
Sig. (2-tailed)
N

TMTnumSC trail making test
number sequence scaled

Pearson Correlation
Sig. (2-tailed)
N

daysintx
number of days
from 1st day of
treatment to
last day

.235

-.225

.381
16

.402
16

-.225

.202

.402

.453

16

16

-.288

.097

.279

.722

16

16

.346

-.139

.189
16

.609
16
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TMTletRW trail making test
letter sequence raw

Pearson Correlation

Sig. (2-tailed)
N
TMTletSC trail making test letter Pearson Correlation
sequence scaled
Sig. (2-tailed)
N
TMTNLSRAW Trail Making
Pearson Correlation
Num/Letter Raw Score
Sig. (2-tailed)
N
TMTNLSSC Trail Making
Pearson Correlation
Number letter sequencing Scaled
score
Sig. (2-tailed)
N
TMTmsRAW Trails motor speed Pearson Correlation
raw
Sig. (2-tailed)
N
TMTmsSC trails motor speed
Pearson Correlation
scaled
Sig. (2-tailed)
N
Pearson Correlation
TMTcmbSS trails combined
number + letter sum of scaled
scores
Sig. (2-tailed)
N
Pearson Correlation
TMTcmbCS trails combined
number+ letter sequencing
composite scaled score
Sig. (2-tailed)
N
TMTSvVSSSD trails switching
Pearson Correlation
vs. visual scanning scaled score
dif
Sig. (2-tailed)
N
TMTSvVSCS trailsswitching vs. Pearson Correlation
visual sanning contrast scaled
score
Sig. (2-tailed)
N
TMTSvNSSSD trails switching
Pearson Correlation

.199

-.223

.459
16

.405
16

-.179

.205

.507
16

.446
16

-.106

.136

.696
16

.617
16

.206

-.252

.444
16

.346
16

-.079

.163

.771
16

.546
16

.073

-.166

.789
16

.539
16

.090

.040

.740
16

.883
16

.064

.081

.814
16

.765
16

.413

-.431

.112
16

.096
16

.409

-.431

.115
16
-.146

.096
16
-.117
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vs number sequencing scaled
score dif

TMTSvNSCS trails switiching
vs. number sequencing contrast
sclaed score

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
TMTSvLSSD Trails switching vs Pearson Correlation
letter sequencing scaled score dif
Sig. (2-tailed)
N
TMTSvLSCS trailsswitching vs. Pearson Correlation
letter sequencing scaled score
contrast scaled score
Sig. (2-tailed)
N
TMTSvCmbSSD trails switching Pearson Correlation
vs.combined scaled score dif
Sig. (2-tailed)
N
Pearson Correlation
TMTSvCmbCS trails switching
vs. combined contrasst scaled
score
Sig. (2-tailed)
N
TMTSvMSSSD trails switching
Pearson Correlation
vs. motor speed scaled score dif
Sig. (2-tailed)
N
TMTSvMSCS trails switching
Pearson Correlation
vs. motor speed contrast scaled
score
Sig. (2-tailed)
N
VFLFtotalRW verbal fluency
Pearson Correlation
letter fluency total raw
Sig. (2-tailed)
N
VFLFtotalSC verbal fluency
Pearson Correlation
letter fluency total scaled
Sig. (2-tailed)
N
VFCFtotalRW verbal fluency
Pearson Correlation
category fluency total raw

.590
16

.666
16

-.163

-.106

.546
16

.696
16

.342

-.405

.195
16

.119
16

.328

-.384

.216
16

.142
16

.135

-.320

.619
16

.228
16

.109

-.293

.688
16

.272
16

.146

-.108

.589
16

.692
16

.146

-.108

.589
16

.692
16

-.172

.040

.525
16

.882
16

-.187

.064

.487
16

.813
16

.112

-.110
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VFCFtotalSC verbal fluency
category fluency total scaled

VFCatSwRW verbal fluency
category switching total correct
raw

VFCatSwSC verbal fluency
category switching total correct
scaled

VFtotalSwRW verbal fluency
category switching total switching
Raw

VFtotalSwSC verbal fluency
category switching total switching
scaled

VFLFvsCFSSD verbal fluency
letter fluency vs category fluency
Scaled Score Difference

VFLFvsCFCSS verbal fluency
letter fluency vs category fluency
Contrast Scaled Score

VFCSvsCFSSD verbal fluency
category switching vs category
fluency Scaled Score Difference

VFCSvsCFCSS verbal fluency
category switching vs category
fluency Contrast Scaled Score

Sig. (2-tailed)
N
Pearson Correlation

.679
16

.686
16

.163

-.174

Sig. (2-tailed)
N
Pearson Correlation

.547
16

.518
16

-.065

-.017

.810
16

.949
16

-.047

-.046

.861
16

.867
16

-.115

-.026

.671
16

.925
16

-.105

-.038

.698
16

.889
16

-.323

.215

.223
16

.424
16

-.323

.215

.223
16

.424
16

-.185

.088

.493
16

.747
16

-.185

.088

.493
16

.747
16

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N

171

VF1stRW verbal fluency 1st
interval total correct raw

VF1stSC verbal fluency 1st
interval total correct scale

VF2ndRW verbal fluency 2nd
interval total correct raw

VF2ndSc verbal fluency 2nd
interval total correct scale

VF3rdRW verbal fluency 3rd
interval total correct raw

VF3rdSC verbal fluency 3rd
interval total correct scale

VF4thRW verbal fluency 4th
interval total correct raw

VF4thSC verbal fluency 4th
interval total correct scale

VFSLerrRW verbal fluency set
loss errors raw

VFSLerrSC verbal fluency set
loss errors scaled

VFREPerrRW verbal fluency
repetition errors raw

VFREPerrSC verbal fluency
repetition errors scaled

Pearson Correlation

.238

-.267

.375
16

.318
16

.259

-.298

.333
16

.262
16

.156

-.236

.565
16

.378
16

.168

-.274

.533
16

.305
16

-.462

.357

.071
16

.175
16

-.593

.464

.015
16

.070
16

-.403

.287

.121
16

.281
16

-.410

.286

.115
16

.283
16

-.133

.256

.623
16

.338
16

.182

-.289

Sig. (2-tailed)
N
Pearson Correlation

.501
16

.277
16

.217

-.257

Sig. (2-tailed)
N
Pearson Correlation

.419
16

.336
16

-.238

.263

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
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VFtotrespRW verbal fluency
total responses-correct and
incorrect-raw

CWclrnmRW color word color
naming raw

CWclrnmSC color word color
naming scaled

CWreadRW color word word
reading raw

CWreadSC color word word
reading scaled

CWinhibRW color word
inhibition raw

CWinhibSC color word
inhibition scaled

CWinswitRW color word
inhibition/switching raw

CWinswitSC color word
inhibition/switching scaled

CWcmbSSS color word
combined naming and reading
Sum of Scaled Scores

CWcmbCSS color word
combined naming and reading

.374
16

.325
16

-.041

-.051

.881
16

.851
16

-.374

.441

.153
16

.087
16

.406

-.472

.119
16

.065
16

-.011

.088

.969
16

.746
16

.123

-.152

.649
16

.574
16

-.433

.512

.094
16

.043
16

.372

-.466

.156
16

.069
16

-.276

.440

Sig. (2-tailed)
N
Pearson Correlation

.302
16

.088
16

.272

-.461

Sig. (2-tailed)
N
Pearson Correlation

.308
16

.072
16

.278

-.329

.296
16

.213
16

.242

-.298

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation
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Composite Scaled Score

CWErCNRW color word error
Color naming raw

CWErCNSC color word error
color naming scaled

CWErWRRW Color word error
Word reading Raw

CWErWRSC Color word error
Word reading scaled

CWErInhRW Color word error
inhibition raw

CWErInhSc Color word error
inhibition scaled

Sig. (2-tailed)
N
Pearson Correlation

.367
16

.261
16

.148

-.147

.584
16

.588
16

-.137

.144

.614
16

.594
16

.000

-.144

Sig. (2-tailed)
N
Pearson Correlation

1.000
16

.594
16

.197

.083

Sig. (2-tailed)
N
Pearson Correlation

.464
16

.760
16

-.238

.296

.374
16

.266
16

.257

-.344

.336
16

.193
16

.044

.096

.872
16

.724
16

-.041

-.100

.881
16

.713
16

.644

-.506

.007
16

.046
16

.625

-.478

.010
16

.061
16

-.756

.669

.001

.005

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation

Sig. (2-tailed)
N
CWErInSwRw Color Word Error Pearson Correlation
inhibition/Switching raw
Sig. (2-tailed)
N
CWErInSwSc Color Word Error Pearson Correlation
Inhibition/Switching Scaled
Sig. (2-tailed)
N
TTtotalRW Tower Test total
Pearson Correlation
achievement score raw
Sig. (2-tailed)
N
TTtotalSC Tower Test total
Pearson Correlation
achievement score scaled
Sig. (2-tailed)
N
TTrulesRW Tower Test total rule Pearson Correlation
violations raw
Sig. (2-tailed)
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TTrulesPR Tower Test total rule
violations cumulative percentile
rank

TT1stmvtmR Tower test mean
1st move time ratio score

TT1stmvtmS Tower test mean
1st move time Scaled score

TTtmprmvR Tower test time per
move ratio score

TTtmprmvS Tower test time per
move scaled score

TTmvaccR Tower test move
accuracy ratio score

TTmvaccSc Tower test move
accuracy scaled score

TTruleitemR Tower test rule
violations per item ratio score

TTruleitemS Tower test rule
violations per item scaled score

CPTconfind CPT II confidence
index

N
Pearson Correlation

Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
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16

.572

-.553

.020
16

.026
16

-.197

.220

.465
16

.414
16

.277

-.327

.298
16

.217
16

-.468

.506

.068
16

.045
16

.454

-.523

.077
16

.038
16

-.113

.132

.677
16

.625
16

.084

-.091

.756
16

.737
16

-.747

.671

.001
16

.004
16

.701

-.661

.003
16

.005
16

-.168

.254

.534
16

.343
16
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Summary of Correlations
Most importantly, the correlations show that some of the NP variables are
correlated significantly with attrition and survival in treatment for cases that have
below median (94) IQ. Furthermore, some of the NP variables are correlated
significantly with drop out and survival in treatment in cases that had no prior
treatment. The NP variables that show statistically significant correlations include
Trail Making, Verbal Fluency and Tower test for cases with below median IQ and
Verbal Fluency and Tower test for no prior AODA treatment. The Color Word
Subtest did correlate with IQ but not when looking at the relationship with drop out or
length of stay in treatment. The CPT II test showed no statistically significant
correlation. These results will be discussed in further detail in the discussion section.
Effect Size
Finally, as previously mentioned, no relative effect sizes could be found to be
used to determine sample size for this study. Therefore, effect sizes were calculated
and reported on as another valuable outcome of this study. Information on effect sizes
is valuable as it can help determine which variables look most promising as possible
predictors of attrition and to provide information on how many more cases one would
have to add to the sample size to obtain sufficient statistical power. Effect sizes were
computed as the square of the correlation between each NP measure and each
outcome. As can be seen in Table 4.23, the effect sizes overall are fairly small. The
largest effect size is for the variable Tower Test Rule Violations Per Item Ration
Score which has an effect size close to 6% (.059). Again, caution must be taken with
interpreting these effect sizes due to small sample size. Using the G-Power software
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package (Erdfelder, Faul & Buchner, 1996) power and sample size were calculated.
In order to attain statistical power of .80 (meaning there is an 80% chance of rejecting
the null hypothesis) we would need a sample size of 98 (Erdfelder, Faul & Buchner,
1996). To obtain a power of .95, we would need a sample size of 170 (Erdfelder, Faul
& Buchner, 19696).
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Table 4.23
Effect Sizes for NP Measures on Length of Treatment and Dropout.

Correlation
Length of
treatment-days

Trail making test visual scanning
raw
Trail making test visual scanning
scaled
trail making test number
sequence raw
trail making test number
sequence scaled
trail making test letter sequence
raw
trail making test letter sequence
scaled
Trail Making Num/Letter Raw
Score
Trail Making Number letter
sequencing Scaled score
Trails motor speed raw
trails motor speed scaled
trails combined number + letter
sum of scaled scores
trails combined number+ letter
sequencing composite scaled
score
trails switching vs. visual
scanning scaled score dif
trailsswitching vs. visual sanning
contrast scaled score
trails switching vs number
sequencing scaled score dif
trails switiching vs. number
sequencing contrast sclaed
score
Trails switching vs letter
sequencing scaled score dif
trailsswitching vs. letter
sequencing scaled score
contrast scaled score
trails switching vs.combined
scaled score dif
trails switching vs. combined
contrasst scaled score
trails switching vs. motor speed
scaled score dif
trails switching vs. motor speed
contrast scaled score
verbal fluency letter fluency total
raw
verbal fluency letter fluency total
scaled
verbal fluency category fluency
total raw

Effect Size
Length of
treatment -days

Correlation
Dropout

Effect Size
Dropout

-0.028

0.000784

0.064

0.004096

0.025

0.000625

-0.046

0.002116

0.133

0.017689

-0.23

0.0529

-0.128

0.016384

0.172

0.029584

0.043

0.001849

-0.082

0.006724

-0.01

0.0001

-0.007

0.000049

0.032

0.001024

-0.017

0.000289

-0.014

0.000196

0.011

0.000121

0.155

0.024025

-0.065

0.004225

-0.147

0.021609

0.042

0.001764

-0.075

0.005625

0.09

0.0081

-0.058

0.003364

0.083

0.006889

-0.037

0.001369

0.057

0.003249

-0.039

0.001521

0.062

0.003844

0.159

0.025281

-0.183

0.033489

0.163

0.026569

-0.184

0.033856

0.002

0.000004

0.048

0.002304

0.01

0.0001

0.044

0.001936

0.075

0.005625

-0.075

0.005625

0.084

0.007056

-0.081

0.006561

0.113

0.012769

-0.036

0.001296

0.103

0.010609

-0.024

0.000576

-0.065

0.004225

0.095

0.009025

-0.043

0.001849

0.067

0.004489

-0.109

0.011881

0.149

0.022201
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verbal fluency category fluency
total scaled
verbal fluency category switching
total correct raw
verbal fluency category switching
total correct scaled
verbal fluency category switching
total switching Raw
verbal fluency category switching
total switching scaled
verbal fluency letter fluency vs
category fluency Scaled Score
Difference
verbal fluency letter fluency vs
category fluency Contrast Scaled
Score
verbal fluency category switching
vs category fluency Scaled
Score Difference
verbal fluency category switching
vs category fluency Contrast
Scaled Score
verbal fluency 1st interval total
correct raw
verbal fluency 1st interval total
correct scale
verbal fluency 2nd interval total
correct raw
verbal fluency 2nd interval total
correct scale
verbal fluency 3rd interval total
correct raw
verbal fluency 3rd interval total
correct scale
verbal fluency 4th interval total
correct raw
verbal fluency 4th interval total
correct scale
verbal fluency set loss errors raw
verbal fluency set loss errors
scaled
verbal fluency repetition errors
raw
verbal fluency repetition errors
scaled
verbal fluency total responsescorrect and incorrect-raw
color word color naming raw
color word color naming scaled
color word word reading raw
color word word reading scaled
color word inhibition raw
color word inhibition scaled
color word inhibition/switching
raw
color word inhibition/switching
scaled
color word combined naming
and reading Sum of Scaled
Scores
color word combined naming
and reading Composite Scaled
Score

-0.055

0.003025

-0.036

0.001296

-0.038

0.001444

0.024

0.000576

-0.045

0.002025

0.023

0.000529

-0.03

0.0009

-0.06

0.0036

-0.032

0.001024

-0.066

0.004356

0.1

0.01

-0.089

0.007921

0.1

0.01

-0.089

0.007921

0.083

0.006889

-0.123

0.015129

0.084

0.007056

-0.136

0.018496

-0.04

0.0016

0.101

0.010201

-0.035

0.001225

0.091

0.008281

-0.154

0.023716

0.142

0.020164

-0.153

0.023409

0.124

0.015376

-0.061

0.003721

0.082

0.006724

-0.049

0.002401

0.054

0.002916

-0.067

0.004489

0.087

0.007569

-0.069

0.004761

0.092

0.008464

0.014

0.000196

0.051

0.002601

-0.03

0.0009

-0.021

0.000441

0.207

0.042849

-0.077

0.005929

-0.138

0.019044

0.02

0.0004

-0.049

0.002401

0.141

0.019881

0.161

0.025921

-0.193

0.037249

-0.175

0.030625

0.144

0.020736

0.081

0.006561

-0.056

0.003136

-0.121

0.014641

0.11

0.0121

0.157

0.024649

-0.016

0.000256

-0.171

0.029241

0.01

0.0001

0.067

0.004489

0.075

0.005625

-0.101

0.010201

-0.047

0.002209

-0.158

0.024964

0.136

0.018496

-0.152

0.023104

0.129

0.016641
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color word error Color naming
raw
color word error color naming
scaled
Color word error Word reading
Raw
Color word error Word reading
scaled
Color word error inhibition raw

-0.086

0.007396

0.055

0.003025

0.034

0.001156

-0.027

0.000729

-0.02

0.0004

-0.109

0.011881

-0.001

0.000001

0.126

0.015876

0.076

0.005776

-0.103

0.010609

-0.127

0.016129

0.065

0.004225

-0.053

0.002809

-0.008

0.000064

0.001

0.000001

0.027

0.000729

-0.058

0.003364

0.187

0.034969

-0.052

0.002704

0.183

0.033489

0.232

0.053824

-0.212

0.044944

-0.135

0.018225

0.095

0.009025

0.103

0.010609

-0.07

0.0049

-0.074

0.005476

0.045

0.002025

0.175

0.030625

-0.115

0.013225

-0.178

0.031684

0.121

0.014641

-0.118

0.013924

0.097

0.009409

0.116

0.013456

-0.089

0.007921

0.243

0.059049

-0.244

0.059536

-0.214

0.045796

0.206

0.042436

-0.033

0.001089

0.035

0.001225

WASI vocab T-score
WASI matrix reasoning raw
score
WASI matrix reasoning T-score

-0.047

0.002209

0.036

0.001296

-0.146

0.021316

0.14

0.0196

-0.155

0.024025

0.135

0.018225

WASI sum of T-scores

-0.135

0.018225

0.128

0.016384

Color word error inhibition scaled
Color Word Error
inhibition/Switching raw
Color Word Error
Inhibition/Switching Scaled
Tower Test total achievement
score raw
Tower Test total achievement
score scaled
Tower Test total rule violations
raw
Tower Test total rule violations
cumulative percentile rank
Tower test mean 1st move time
ratio score
Tower test mean 1st move time
Scaled score
Tower test time per move ratio
score
Tower test time per move scaled
score
Tower test move accuracy ratio
score
Tower test move accuracy
scaled score
Tower test rule violations per
item ratio score
Tower test rule violations per
item scaled score
WASI vocab raw score

WASI IQ score

-0.13

0.0169

0.109

0.011881

CPT II confidence index

-0.025

0.000625

-0.021

0.000441

WTAR Standard Score

0.003

0.000009

-0.053

0.002809

180

Chapter V: Discussion
The purpose of this study was to assess the neuropsychological functioning of
clients who meet diagnostic criteria for substance dependence according to the
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - Text
Revision (DSM IV-TR; APA, 2000) and to examine the relationship between
neuropsychological functioning and treatment attrition rates. Specifically, the
executive functioning of individuals was evaluated. Furthermore, the relationships
between substance use diagnosis, treatment attrition, and neuropsychological
functioning was investigated. It may be that understanding how deficits in
neuropsychological functioning affect an individual’s behaviors (e.g., relapse,
missing treatment sessions, and dropping out of treatment) may help to change
attitudes of clinicians and others who may currently negatively stigmatize those with
substance use disorders (e.g., believing that the individual is lazy, unmotivated, etc.).
Understanding the relationships between substance use diagnosis, attrition, and
neuropsychological functioning could prove extremely useful in substance use
disorder program development, treatment planning, clinician training and stigma
reduction.
Neuropsychological and cognitive impairment in substance abusing
participants as well as homeless participants has also been reported in existing
research as discussed previously. Therefore, the results of this study add to the
existing research that confirms that people with a substance abuse issue as well as
homeless individuals have a much greater occurrence of NP deficit than the general
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population. Though much has been written about impairment in homeless substance
abusing people, very little has been written about the relationship of
neuropsychological impairment and attrition in treatment. As there is still a paucity of
research in this area, the results of this study with regards to neuropsychological
deficit, drop out and attrition add to the existing research.

Interpretation of Findings
Summary
This study examined the neuropsychological functioning of homeless,
substance dependent men and how this affected attrition, survival in treatment and
relapse. In summary, the neuropsychological (NP) functioning of this group of 68
adult males located in the Guesthouse Shelter of Milwaukee as a whole, showed
statistically significant impaired functioning on all measures; though not every
individual was impaired on every measure, some were impaired on each measure. For
example, using a threshold of two standard deviations below the mean, (the threshold
of two SD was used as this is often used as a threshold of abnormality, for example, T
scores of 70 or higher are noted on psychodiagnostic measures such as the MMPI)
24.6% were impaired on the Trail Making Test Number Sequencing and Letter
Sequencing Scaled score, 23.2% were impaired on the Verbal Fluency Category
Switching Scaled score and 26.1% were impaired on the Color Word Naming Scaled
score. Likewise, with a score of greater than 50% indicating impairment, 66.7% were
impaired on the CPT II. Finally, the WASI IQ score showed 7.2 % impaired. Of the
neuropsychological variables, only the WASI IQ predicted attrition and length of stay
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except not in the expected linear relationship. The WASI IQ showed a curvilinear
relationship to drop out and attrition. Prior to examining the results of this study, I
had expected to see a linear relationship exist between low IQ and high attrition. The
results of this study showed that participants with a low to average WASI IQ score
(77-95) were statistically significantly more likely (than those with a borderline to
low IQ - <77 or average to high IQ - >95) to drop out (p = .012) and more likely to
have shorter lengths of stay in treatment (p = .028). In addition, some NP variables
did show a relationship with drop out and length of stay when looking at cases with a
median IQ below 94 and those with no prior AODA treatment.
Neuropsychological Impairment as Indicated by the D-KEFS, CPT II, and WASI
The results of this study indicated that this sample was drawn from a population
with a lower than average level of performance on all measures. Specifically, the
mean standardized scores for all of the D-KEFS subtests including the Tower Test,
Verbal Fluency, Color Word and Trail Making test was lower than the criterion level
of 9.29 set for rejecting the null hypothesis based on the one sample z test. These
assessments were all chosen based on their ability to assess executive functions which
are specifically associated with the frontal lobe- the brain area of primary interest in
this study. Likewise, using a one sample z-test, the chance that this sample was drawn
from a normal population on the CPT II test are less than one in one thousand.
Finally, according to the one-sample z-test, the results of the WASI IQ subtest show
that samples of 68 with mean less than 97.66 have a less than .05 chance of occurring
if the sample was drawn from a population with a mean of 100. The observed sample
mean falls below this threshold level, suggesting that the present sample has a
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significantly lower IQ level. In practical terms, this indicates that our sample of
substance abusing homeless men have a much lower level of cognitive functioning
than the general population of non-homeless, non-substance abusing men. We cannot
assume causation – that substance use or homelessness causes the impairment- or that
the impairment causes homelessness or substance use. However, we can state that this
sample in general is impaired and this information needs to be utilized when treating
homeless, substance using men.
There are multiple implications of the severity of the NP deficit found in this
sample. The NP impairment found by this study, as well as other studies (Burra,
Stergiopoulos, & Rourke, 2009; Spence, Stevens & Parks, 2004), suggests that more
thorough evaluation of NP strengths and weaknesses should be afforded to all
homeless and/or substance abusing clients to develop better-tailored treatment
programs and resources. Although we cannot make definitive causal connections
from this study this information will be helpful for treatment providers to recognize
the deficits as a limitation in the population they are serving. Though not presuming
causation from these results, it is the opinion of this writer that a circular relationship
exists between NP function, substance use, homelessness and attrition with each of
these variables having a cause and effect relationship with each other. For example,
substance use can cause NP impairment; NP impairment can cause individuals to
make poor choices about substance use. Likewise, NP function can affect attrition;
attrition/dropping out of treatment can cause one to be more likely to abuse
substances causing more NP damage. Clinicians need to be cognizant that the
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discussed deficits likely impair a homeless person’s ability to maintain stable housing
and follow clinician/staff recommendations.
The NP deficits examined in this study primarily address executive function
skills which are specifically associated with the frontal lobe and include four
components of (a) volition, (b) planning (c) purposive action, and (d) effective
performance (Lezak, 1995; Lezak et al, 2004). These primary skill areas need to be
taken into consideration with all goal and treatment planning. For example, clients
would benefit from assistance in developing concrete goals, reduced to small, short
term objectives. Likewise, they would need encouragement and instruction on how to
begin addressing each goal. All instruction and education should be given in multiple
media (written, verbal, auditory, etc) with frequent reminders. In addition to the NP
components examined by the D-KEFS, the CPT II provides information on attention,
impulsivity, activation/arousal and difficulties in maintaining vigilance (IPS, 2005).
These specific skills are associated with the dorsal lateral prefrontal cortex. The CPT
II is a simple, fast, computer generated instrument that would be easy for clinician to
utilize upon primary assessment of clients that are homeless or struggling with
substance abuse. This information could be used to increase client and clinician
insight and develop goals specific to maintaining attention. For example, clients
might be given a binder with all important information to bring with them to each
appointment. Likewise, they could be given a wallet size card with reminders of
important dates or aspects of treatment. Furthermore, calendars could be given to all
clients and clinicians could be trained to remind the client to write all goals on the
calendar- including self-care goals, formal appointments and social activities.
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Though overall, all four D-KEFS subtests showed impairment in skills
associated with the frontal lobe, it is the opinion of this writer that much detail related
to frontal lobe function was still missed. For example, I do not believe any of these
instruments adequately evaluate the frontal lobe function of behavior starting. With a
guided assessment, someone facilitating the moves of the participant, behavior
starting is difficult to assess. Likewise, purposive action, the gap between a client
stating their intentions, and actually following through on the necessary behaviors is
an important component of the frontal lobe (Lezak, 2004). This actual skill is difficult
to assess during formal assessment as the facilitator again constantly guides the
participant. In real life, people do not have someone with them prompting all the
necessary, appropriate behaviors. This appears to be the paradoxical nature of all of
the assessments used in the battery for this research. As these are formal, structured
assessments, it is difficult to assess some of the more discretionary frontal lobe
functions. However, all of the assessments were chosen due to their proclaimed
ability to capture these skills. It is the opinion of this writer that these assessments did
not adequately capture those components of the dorsal lateral frontal lobe.
Cognitive Functioning Predictive of Attrition and Survival in Treatment
For this study, general intelligence, as assessed by the WASI, predicts drop
out and survival in treatment. Specifically, subjects with average to above IQ (>95),
as well as those with borderline to low IQ (<77) were less likely to drop out of
treatment, whereas subjects with an IQ between 77-95 were more likely to drop out.
Likewise, subjects with low to average IQ (77-95) had shorter survival times (i.e.,
“time in treatment”) than those with borderline to low IQ (<77). More precisely,
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participants with a low to average WASI IQ score (77-95) were statistically
significantly more likely to drop out (p = .012) and more likely to have shorter
lengths of stay in treatment (p= .028). These findings indicate that one can predict
drop out and length of time in treatment by evaluating the IQ of the participant.
However, as previously mentioned, caution must be taken given the small sample
size. Confidence in these results could be increased with a study that used a larger
sample. Specifically, a Beta of -2.398 (p = .012) was found for predicting drop out
and a Beta of -851 (p = .028) was found for predicting survival in treatment.
Evaluating the strength of this Beta can be complicated with a binary logistic
regression as there is no precise equivalent to an effect size measure like r-squared
when predicting a binary outcome (Garson, 2009, retrieved June 9, 2009). We have
no exact equivalent to r-squared because our dependent variable is not a continuous
variable. Rather, the dependent variable is dichotomous- the odds of dropping out or
not. Table 4.17 above shows the percentage of drop out by IQ. The group with IQ
between 77 and 95 were over four times more likely to drop out than those with an IQ
below 77, and almost twice as likely to drop out than those with an IQ over 95.
To compare these results to existing research, cognitive impairment has been
found by multiple researchers in substance abusing adults (Grohman & Fals Stewart,
2004) as well as homeless males (Buhrich, Hodder & Teesson, 2000; Burra,
Stergiopoulos & Rourke, 2009; Spence, Stevens & Parks, 2004 ). In addition,
cognitive deficits predicting low treatment retention have also been found by other
researchers (Aharonovich, Hasin, Brooks, Liu, Bisage & Nunes, 2005: Fals Stewart &
Lucente, 1994). On the contrary, other researchers have found no difference in
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treatment retention between high and low cognitive ability (Katz, King, Schwartz,
Weintraub, Barksdale, Robinson and Brown, 2005).
The finding that low to average cognitive functioning (IQ between 77 and 95)
(as opposed to borderline to low functioning, IQ below 77) is predictive of drop out
and survival in treatment has implications for barriers to treatment, treatment
planning, clinician training, and continued substance use in clients. These factors, in
turn, can have an effect on the community, family and funding sources. To speculate,
it appears that patients need to have a minimal level of cognitive functioning in order
to drop out of treatment. For example, the results of this study indicate that those with
an IQ between 77 and 95 were statistically significantly more likely to drop out (p =
.012). To be precise, the group with IQ between 77 and 95 were over four times more
likely to drop out than those with an IQ below 77, and almost twice as likely to drop
out than those with an IQ over 95. Again, in speculation, for the borderline to low IQ
patients, treatment might serve as a kind of sheltered environment. Patients with low
to average IQ may have just enough cognitive functioning to follow through on a bad
decision about dropping out. Patients with average and above IQ are perhaps more
likely to make a good decision regarding persistence in treatment. Those with average
and above IQ might be better able to recognize the benefits of treatment such as
abstinence, improved mood, improved family functioning and resolution of legal
conflicts. Likewise, those with average and above IQ might also be better able to
recognize the negative consequences of dropping out such as continued substance
use, health issues and family disappointment. However, there are many words of
caution when using and interpreting the results of IQ tests. For example, the Wechsler
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Adult Intelligence Scales were not designed to assess brain damaged patients and are
considered “insensitive to their neurobehavioral problems and cognitive deficits”
(Sbordone, Saul & Purisch, 2007, p.357). Likewise, there are many additional
concerns reported about the use of the Wechsler IQ including over-interpretation of
subtest scores, belief that norms may not be applicable for ethnic minorities,
complexity of scoring lending itself to clerical errors by examiners, and subjectivity
in scoring (Groth-Marnat, 2003). Furthermore, there is question related to the actual
meaning of IQ scores. Many misconceptions are made regarding IQ scores. IQ scores
are not fixed and they are “not exact, precise measurements” (Groth-Marnat, 2003, p.
140). When interpreting intelligence scores, one needs to remember that IQ scores are
estimates that can be related to a variety of environmental factors (Groth-Marnat,
2003).
Clinicians need to be cognizant of the prevalence of cognitive impairment in
substance using clients and the potential negative impact this can have on drop out
and survival in treatment. In addition, clinicians might be more likely to give
additional attention to the clients with borderline to low IQ. However the results of
this study indicate that it is actually the clients in the low to average, not borderline to
low range, who may need extra effort. Clinicians should partake in additional training
to increase assessment skills to identify clients with low to average IQ. Utilizing a
simple, brief, assessment tool, such as the WASI, could provide valuable information
to clinicians if included in the standard intake assessment. All clients should be
screened for cognitive impairment during the initial assessment with those with low
to average IQ being offered additional support services through the treatment process.
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Clients that appear to be struggling may need to be referred to a more structured or
intense program during the initial months of recovery.
Specific techniques can be employed toward improving outcomes for
substance users with cognitive deficits. For example, drug counseling that makes use
of mapping techniques has been shown to improve treatment outcome by addressing
planning and problem solving issues (Czuchry & Dansereau, 2003b). Mapping
techniques would not only be helpful for the client with cognitive deficit, but also the
clients with NP deficits addressed above. Using mapping techniques that address
planning and problem solving would offer support to clients with NP impairment,
especially executive function impairment. Any and all repetition and guidance in
planning and problem solving skills will assist these individuals in compensating for
such deficits.
Strategies used to address cognitive dysfunction in patients with traumatic
head injuries can also be helpful with cognitively impaired substance abusers (Ersche
& Sahakian, 2007). For example, information should be presented to clients in a
variety of modalities such as written, oral, auditory and visual. Education should be
done slowly with repetition and paraphrasing encouraged by the client (William &
Evans, 2003). In addition, communication between all clinical staff will help to
ensure that cognitively impaired clients are not perceived as deceitful or
manipulative. Likewise, treatment providers must keep in mind that cognitively
impaired clients' nonadherence to treatment may be a result of the impairment and not
caused by denial, resistance, or unwillingness to accept care (SAMHSA, 1998).
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Clients demonstrating a low to average IQ warrant special attention in regard
to disengaging from services. The client should be made aware of their risk of
dropping out or not staying in treatment. This should be discussed thoroughly and
goals implemented to address this risk. For example, clients could be given a list of
people to call when having thoughts of not returning to treatment. Likewise, the topic
of dropping out of treatment should be added to the agenda of regularly addressed
issues in the treatment process. Finally, therapist awareness could be elevated by
providing a visual cue on the charts of at risk clients. For example, clients at high risk
could have a different color label on their chart.

Neuropsychological Function and Attrition/Survival in Treatment
Although some research has indicated a possible relationship (with the
assumption that poor NP function would increase attrition) between
neuropsychological functioning and attrition rates (Zinn et al., 2004) there is still a
paucity of research on this topic. Some authors acknowledged that
neuropsychological impairment may negatively affect attrition and treatment success
but they have not formally evaluated retention and/or attrition (Zinn et al., 2004). As
discussed above, researchers suggest that a relationship between neuropsychological
functioning and treatment outcome exists, but empirical attempts to document this
relationship have been met with limited success.
The results of this study show that there is a relationship between the
neuropsychological variables (D-KEFS) and attrition rates with below median IQ
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(below 94) and no prior AODA treatment. However, caution must be taken regarding
the confidence in this data due to the small sample size. Specifically, the NP variables
that show statistically significant correlations include Trail Making, Verbal Fluency
and Tower test for cases with below median IQ and Verbal Fluency and Tower test
for no prior AODA treatment. The results indicate that for most of the subtest
relationships, there was a negative correlation indicating that the better the subject
performed on the measure, the more likely he was to drop out of treatment and/or
have a shorter length of stay in treatment. Although perhaps counterintuitive the
results are indeed interesting.
The three subtests shown to be predictive of drop out and/or length of stay
include the Trail Making test, the Verbal Fluency and the Tower Test. (All three were
predictive for subjects with below median IQ and Verbal Fluency and Tower test
were predictive in subjects with no prior treatment) The Trail making test measures
flexibility of thinking on a visual motor task. There is a negative correlation between
the trail making test number sequencing raw score and participant drop out for
subjects with below median IQ (r = -.494, p = .005) indicating that the better they
scored, the more likely they were to drop out. The r squared for this correlation is .24
indicating that 24% of the variance of the drop out can be accounted for by trail
making test predictor. This is a relatively strong prediction. (As a general rule,
correlations that account for 10% or less of the variance are weak, those that account
for more than 25% are quite strong; Cohen, 1977)
This subtest requires the individual to visually scan and sequence numbers. This
subtest might be more of an indication of cognitive functioning and therefore may be
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an indication of participants with moderate functioning being more likely to drop out
as indicated by the WASI scores being predictive of drop out. Likewise, two of the
Tower Test scores, which measure spatial planning, rule violation, inhibition of
impulsive responding, inhibition of perseverative responding and establishing and
maintaining an instructional set, also showed a negative correlation. Specifically the
tower test total rule violations raw score was r = -.495, p = .005 (with an r squared of
.24, again relatively strong prediction) and tower test rule violations per item ratio
score was r = -.533, p = .002 (with an r squared of .28). This score indicates that the
more rule violations a participant had, the less likely they were to drop out or the
better they did, the more likely they were to drop out. Similarly, two of the Tower
test subtests for subjects that had no prior treatment also showed a correlation that
indicates the better the participant performed, the more likely they were to drop out or
have a decreased length of stay. The tower test total achievement raw score has a
correlation of r = .644, p = .007 (with an r squared of .40, predictive strength
increasing) and tower test total rule violations raw score has a correlation of r = -.756,
p = .001 (a very strong prediction with an r squared of .56). The only NP subtests
that indicated that the better a subject performed, the less likely they were to drop out
was the Verbal Fluency third interval for subjects with no prior treatment (r = -.593, p
= .015, r squared of .34) and the Verbal Fluency second interval total correct score
showed a correlation of r = .401, p = .025 (a somewhat weaker predictor with an r
squared of .16) However, these scores are simply an indication of a subject’s ability
to sustain a verbal response over time and are therefore not one of the more global or
primary scores.

193

We initially had expected to see those with lower NP performance be more
likely to drop out and have a lower length of treatment. Though initially the present
study results appear counterintuitive, the fact that the groups either had below median
IQ or no prior treatment might assist in interpretation. It may be that those with lower
IQ that scored better on the NP measures had greater confidence to feel they do not
need treatment. The higher NP function and lower cognitive ability might lend itself
to poor decisions and an inability to see the potential benefits of treatment. Likewise,
as discussed above, any impairment in cognitive functioning can affect a person’s
ability to make a good decision. It may be that the lower cognitive functioning
encouraged a bad decision to drop out of treatment. However, it may also be that
those with lower IQ do not benefit as quickly as others. The difference may not be
related to decision-making abilities, but simply that they are slower to benefit from
treatment. Furthermore, it could be that the WASI IQ score is more an indication of
personality functioning than previously believed and that is what is actually affecting
the decision to drop out. Personality variables are considered important when
evaluating intelligence (Groth-Marnat, 2003). Indeed, Wechsler himself believed that
intelligence is influenced by personality as well as other component such as anxiety
(Groth-Marnat, 2003). Caution must be taken when interpreting the results of those
with no prior treatment as only 16 individuals had no prior treatment. Re-evaluating
this issue with a larger sample size could help clarify the results. Other factors that
we were not able to formally evaluate in this study also need to be considered in
future research. For example, personality was not directly assessed by this study and
would be an interesting piece to incorporate in future research.
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Also interesting is that the NP subtests that showed no correlation with drop
out or attrition - Color Word and CPT II - are both tests of inhibition and impulsivity.
Though participants were statistically significantly impaired on both of these
measures, neither showed a correlation for participants with below median IQ or
those with no prior treatment. This suggests that these aspects of NP impairment are
less important when evaluating treatment retention (though still important for
treatment planning). It may be that once individuals are engaged in treatment, the
impulsivity and inhibition are affecting their performance in treatment, but not
whether or not they stay in treatment.
The extent of neuropsychological and cognitive deficit found in individuals
with a substance use disorder and/or homeless individuals suggests that increased
assessment upon intake should be standard to accurately evaluate the specific needs
of individuals, effective treatment planning and efficient disbursement of resources.
These results indicate that clinicians need to develop highly individualized treatment
plans utilizing specific strengths and identifying weaknesses for each individual for
those with and without NP deficits to decrease attrition and increase length of stay. In
addition, based on the results of this study, special attention may need to be paid to
those with below median IQ and those with no prior treatment. As discussed above,
special measures can be taken to help flag the clients that may be more at risk.
Likewise, the clients that are identified to be at greater risk of dropping out should be
educated about this and specific treatment goals implemented regarding treatment
attendance and completion. These clients would also benefit from education
regarding the specific expectations and timeline of treatment. One of the subtests
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negatively correlated with drop out is the Tower Test. This test addresses the ability
to follow rules. In this study, the better the client did with this, the more likely they
were to drop out. Clinicians could make use of this strength and actually implement
rules that the clients are asked to follow about staying in treatment. Clients could sign
an agreement at the beginning of treatment specifying the required attendance and
length of treatment and their willingness to comply. The ability to follow rules was
shown to be one of the predictors to drop out. This is not to say that following rules
caused drop out, however making use of this strength might actually help improve
retention. Likewise, behavior modification and contingency management approaches
could also be implemented. Participants could be rewarded at intervals in treatment
with products such as tokens indicating length of sobriety (as used in AA), products
with clinic insignia (t-shirts, pens, bags) or gift certificates to healthy social functions
such as movies or restaurants.
Though the results of this study do not specifically support the need for
increased NP and cognitive assessment at time of intake, they do seem to suggest that
clients would benefit from increased assessment. Increased NP assessment at time of
intake can provide specific strengths and weaknesses of each individual to allow the
clinician to develop treatment approaches that may best suit a clients needs. The
importance of individualized treatment planning cannot be overstated and is well
supported in the literature (Adams, 2004). In addition, this would aid in educating the
clinician and reducing stigma. The “lazy” “unmotivated” client might actually have
serious NP and/or cognitive deficits. This could impact provider perception and
expectations. If a provider understands the issues of the client and is given tools to
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address the issues, the provider will be more effective. This alone could lead to
improved retention. Conversely, if the provider is frustrated and misidentifies the
deficits as a lazy client, the provider might direct their energy and resources to other
clients they perceive as more receptive. Likewise, funding sources would be more
likely to direct resources to clients to assist in situations where a deficit is identified
vs. directing resources to someone they think is not wanting or ready for treatment. In
order for programs to implement a more thorough assessment at time of intake,
clinicians would need further training and programs would need funding for the
assessment. Therefore, funding sources, such as private insurance and government
resources, all need to be informed of the benefits to increased assessment to allow for
allocation and reallocation of resources. Providers and funders alike, all need to
rethink priorities when it comes to direction of energy to the assessment process. As
discussed above, the current statistics on attrition and survival in treatment show
limited success of current treatment programs. This has an overall negative financial
impact on individuals, families, employers and funding sources (SAMHSA 2008;
TEDS, 2005). Therefore, additional funding up front, could save money overall for
the funding sources. By improving assessment, we could provide better treatment,
and therefore have a positive impact on the rates of substance abuse. Multiple
researchers and agencies have commented on the high cost of substance use on a
personal and societal level as discussed thoroughly above (SAMHSA, 2008: TEDS,
2005).
Additional research is warranted to continue to evaluate the relationship
between NP functioning, attrition and survival in treatment. Additional research, with
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a larger sample size, as well as a sample that included women and non-homeless
individuals could prove quite useful. With a larger sample size, more variables that
are useful for predicting drop out and attrition might be found. Furthermore, the
ability to evaluate all people with a substance use problem, not just homeless men,
would provide much useful information that can be generalized to more of the
population.
Effect Size
As noted previously, no relative effect sizes could be found to be used to
determine sample size for this study. Therefore, in addition to the information
presented on neuropsychological functioning, cognitive functioning, drop out and
attrition rates, effect sizes were calculated and reported on as another valuable
outcome of this study. Information on effect sizes is valuable as it can help determine
which variables look most promising as possible predictors of attrition and to provide
information on how many more cases one would have to add to the sample size to
obtain sufficient statistical power. Specifically, results of calculations on effect size
and post-hoc power analysis, with alpha set at .05, showed that with a larger sample
size (98-170) we could increase the possibility that the neuropsychological variables
would predict drop out and attrition and could attain statistical power between .80 and
.95. This information will be valuable to future researchers when planning similar
studies.
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Limitations/Suggestions for Improvements and Future Research
These results were limited initially by the location we chose to collect the
data. As we were collecting data on men living in a homeless shelter, we were bound
by rules and regulations of the shelter. We were unable to access urine screen
information, which resulted in no information on relapse. The impact on relapse rates
could not be calculated as we were not able to access urine analysis information. As
urine screens were given by case managers in the Guesthouse, and not by counselors
in the 7Cs clinic, we did not have consent to access that information. Future
researchers operating in a homeless shelter environment will be well-served to
establish a written agreement with the shelter and the participants to be able to access
any objective screening measures used. In addition, our study was cut short by a
transition of management at the clinic which stopped our data collection at 68
completed batteries instead of the intended 100 batteries.
Another important limitation of this study is that the men living in the shelter
were required to attend substance abuse treatment. Therefore, the participation in
treatment was not completely voluntary which could affect the participants desire to
perform on the given assessments.
In addition, as it is a population of homeless men, the physical state of the
participant at the time of testing such as fatigue or hunger could also impact
performance affecting the validity of the results we obtained. Future researchers
should consider utilizing a brief screening instrument to evaluate a participants
general level of hunger or fatigue at various intervals to attempt to control for these
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issues. The fact that all participants were homeless men also limits the
generalizability of this information to other populations such as women and nonhomeless individuals. Likewise, the fact that this treatment took place at the homeless
shelter is different from other treatment providers. The men lived in the shelter where
they were given treatment. If discharged from the shelter, the men were unlikely to
return to the shelter for treatment. This might have been a result of feeling
unwelcome at the shelter in general, or maybe a desire to leave that part of their lives
behind once they had moved on with independent housing. Most outpatient treatment
facilities are not tied physically or emotionally to a person’s residence.
Limitations might also arise from the use of multiple assessors to facilitate the
neuropsychological assessments. All assessors were masters level students that were
trained by a licensed neuropsychologist. However, all of the assessors were new to
the neuropsychological battery, which could affect the facilitation of the battery.
Moreover, only subjective assessments were used to verify abstinence at time of
testing. Future researchers may want to invest in saliva tests or quick urine screens to
verify abstinence at time of testing. No patron is allowed to enter the Guesthouse if
they are believed to be impaired by any substance so all are subjectively screened at
the door. Likewise, no neuropsychological batteries were given to anyone thought to
be impaired at the time of the assessment, but again, this was a subjective screening.
Similarly, no objective measures were used to evaluate abstinence during treatment.
Urine screens, blood tests, saliva samples and breathalyzers would have all provided
objective evidence of a participant’s use. We did not have access to any of these
results during this study.
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As suggested by the effect size and power calculations discussed above,
another limitation of this study is the sample size. As stated previously, caution must
be taken when interpreting this data due to the small sample size. Specifically, much
caution needs to be taken when interpreting any relationship between IQ and
attrition/length of stay due to the very small sample sizes of those calculations. Our
calculations suggest that if we had a larger sample size (98-170) we could increase
the possibility that the neuropsychological variables would predict drop out and
attrition and could attain power between .80 and .95. This would mean that we are
more likely to reject a null hypothesis and therefore increase the likelihood that what
our results state is in fact true. Therefore, future researchers would be wise to include
a larger sample size.
Finally, the mental health diagnoses were not included in this research and
could offer another important variable when evaluating level of neuropsychological
impairment and treatment attrition. We are not able to evaluate the possibility of
depression, anxiety or any other mental health diagnosis that could have been a
variable in these results. It is quite likely that many of these participants did indeed
have a dual diagnosis. A diagnosis of a mood disorder, anxiety disorder or personality
disorder all could impact results of cognitive and NP functioning. Likewise, these
mental health issues could impact one’s desire and ability to remain in treatment. We
are not able to identify if these issues existed or how they may have impacted the
results of this study. Future researchers would be wise to evaluate these variables and
attempt to control for them when looking at NP function and attrition.
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Likewise, we did not distinguish between types of substances used or length
of substance use, which could also offer interesting information. Though we are
interested in treating all substance abuse, the types and length of use could have
provided more detailed information regarding drop out and survival in treatment.
Alcohol, marijuana, cocaine and opiates all can have a negative impact on one’s
ability to perform on cognitive and NP assessments. Furthermore, different
substances can produce different frequency and intensity of cravings for individuals.
The cravings alone could have a significant impact on ability to stay in treatment –
especially in a program that will remove you from your housing if you are actively
using. Likewise, support systems, cognitive function, neuropsychological function
and physical health can all be impacted by type of substance used and length of use.
This would also be another useful variable for future research for all the reasons
stated.
Limitations also arise from the difference between actuarial and qualitative
components of assessment. As previously discussed in this paper, in strict actuarial
approaches, the neuropsychologist need not even see the patient, but rather draw
conclusions from scores obtained by a technician (Lezak, 1995). This approach can
be helpful for gathering statistics, but important information is lost from the missing
qualitative component. Through the development of testing batteries developed by
some of the leaders in the field, neuropsychology has developed into more of a mix of
the intuitive and actuarial (Lezak, 1995). However, given that this study utilized
multiple facilitators and the primary researcher did not meet many of the participants,
the benefits of a more process-oriented approach were lost. Qualitative comments
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were gathered on each participant, but the depth of the qualitative component that can
be gathered through each assessment was lost.

Reliability and Validity
There are multiple factors that can affect reliability and validity of data
obtained in any research. First and foremost are the reliability and validity of the data
yielded from the measures used. The reliability and validity of the data used in this
study is discussed in detail in Chapter III under the psychometrics of each instrument.
In addition to the specifics of each instrument, a number of authors have elaborated
on the difficulties of using standardized assessments with ethnic minorities. Given
that 75% of the participants in this study are non-White, this is an important factor to
consider. Specifically, Suzuki and Kugler, 1995 (as cited in Pope-Davis & Coleman,
1996) summarize areas of concern including inappropriate test content, inappropriate
standardization samples, examiner and language bias, inequitable social
consequences, measurement of different constructs, differential predictive validity
and differences in test taking skills. Therefore, the development of additional norms
for these tests and others used on non -White individuals as well as homeless
individuals would be of benefit to future researchers.
Furthermore, limitations in the setting could also affect the results of this study. The
homeless shelter setting can be loud and distracting at times, which could affect the
participant’s performance. Likewise, issues related to being homeless, such as hunger
and fatigue can also affect one’s performance. The use of multiple assessors with
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limited experience in facilitating NP assessments is also an important factor to
consider when reviewing reliability and validity of the given results. Finally, though
the D-KEFS and CPT II both have computerized scoring, the WASI was all hand
scored. To ensure accurate scoring, licensed psychologists reviewed 20% of the
batteries.

Conclusion
In conclusion, the purpose of this study was to assess the neuropsychological
functioning of clients with a substance dependence issue and to examine the
relationship between neuropsychological functioning, length of stay in treatment and
whether one dropped out of treatment or not. Specifically, the executive functioning
of individuals was evaluated, as well as IQ and compared to attrition rates. In this
study, a battery of tests including four subtests of the D-KEFS, the WASI IQ and the
CPT II were administered to a group of 68 homeless adult males residing at the
Guesthouse of Milwaukee. The results indicate that the neuropsychological
functioning of this group of adult males showed statistically significant impaired
functioning on all measures. Of the neuropsychological variables, only the WASI IQ
predicted attrition and length of stay which showed a curvilinear relationship to drop
out and attrition. Participants with a low to average WASI IQ score (77-95) were
significantly more likely to drop out (p = .012) and more likely to have shorter
lengths of stay in treatment (p = .028). In addition, the NP variables did show a
relationship with drop out and length of stay when looking at cases with a median IQ
below 94 and those with no prior AODA treatment. However, caution regarding
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interpretation was indicated due to the small sample sizes. Finally, results of
calculations on effect size and power analysis show that with a larger sample size (98170) we could increase the possibility that the neuropsychological variables would
predict drop out and attrition and could attain power between .80 and .95.
As there is still a paucity of research related to NP functioning, homeless
individuals and attrition rates, this information is a valuable addition to existing
research. In addition, this study identified implications for professionals that work
with substance abusing individuals, specifically Individuals that are homeless with a
substance use issue and individuals struggling with a NP deficit. As this study is
limited to homeless males, the generalizability of this research is limited. Therefore,
suggestions were also made for future research.
Overall, the importance of this research is multifaceted. The information
regarding specific variables that are predictive of client success in treatment cannot be
underestimated. As discussed, the severity of addiction rates and attrition rates in the
United States dictates the need for more information regarding variables that affect
client success in treatment. The suggestions from this research regarding therapist
approaches, funding allocation and treatment interventions will help reduce drop
out/attrition and ultimately help reduce the rates of relapse and continued substance
use. Likewise, the more educated providers and the public are on neuropsychological
function and substance use disorders/treatment, the greater reduction we will see in
stigma. Furthermore, the information regarding effect size will help future researchers
plan effective research designs to continue to gather information regarding NP
function and attrition/drop out. Individuals with a substance use disorder deserve the
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very best care we can offer. With this addition to the literature, and others, we will
develop efficient, effective and successful treatment plans for individuals and families
affected by substance use disorders.
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